ticker,rpa_date_utc,rpa_time_utc,rp_entity_id,entity_name,relevance,event_sentiment_score,group,sub_type,event_text,news_type,source_name,headline
TECH,2024-01-26,07:30:03,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep appoints Morten Meier as new CEO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep appoints Morten Meier as new CEO
TECH,2024-01-26,07:30:03,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep appoints Morten Meier as new CEO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Morten Meier as new CEO
TECH,2024-01-26,07:30:04,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep Appoints Morten Meier As New Ceo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Appoints Morten Meier As New Ceo
TECH,2024-01-26,07:30:04,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep Appoints Morten Meier As New Ceo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Appoints Morten Meier As New Ceo
TECH,2024-02-23,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2023 results on Thursday 29 February 2024 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2023 Financial Results
TECH,2024-02-23,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2023 results on Thursday 29 February 2024 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2023 Financial Results
TECH,2024-02-28,13:12:24,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Signs Strategic Partnership Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Strategic Partnership Agreement With Devicenow For Lifecycle Portal
TECH,2024-02-28,13:12:24,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Signs Strategic Partnership Agreement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Strategic Partnership Agreement With Devicenow For Lifecycle Portal
TECH,2024-02-29,06:00:13,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q4 2023 results
TECH,2024-02-29,06:00:13,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2023 results
TECH,2024-02-29,06:00:13,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed frame agreement with the public sector purchasing agency Kammarkollegiet in Sweden,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2023 results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed frame agreement with the public sector purchasing agency Kammarkollegiet in Sweden,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed frame agreement with the public sector purchasing agency Kammarkollegiet in Sweden,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,-0.68,revenues,down,Techstep ASA: Consafe Logistics has decided to wind-down its hardware sales,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,-0.68,revenues,down,Techstep ASA: Consafe Logistics has decided to wind-down its hardware sales,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-29,20:47:12,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Wednesday 29 May 2024 at 10:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2024-04-29,20:47:12,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Wednesday 29 May 2024 at 10:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2024-05-08,11:15:20,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its first quarter 2024 results on Wednesday 15 May 2024 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2024 Financial Results
TECH,2024-05-08,11:15:20,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its first quarter 2024 results on Wednesday 15 May 2024 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2024 Financial Results
TECH,2024-05-15,05:00:06,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2024 results
TECH,2024-05-15,05:00:06,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2024 results
TECH,2024-05-15,05:05:26,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2024 Results
TECH,2024-05-15,05:05:26,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2024 Results
TECH,2024-06-24,15:09:41,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Primary insider notifications
TECH,2024-06-24,15:09:41,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Primary insider notifications
TECH,2024-06-24,15:09:43,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Primary Insider Notifications
TECH,2024-06-24,15:09:43,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Primary Insider Notifications
TECH,2024-08-06,11:49:48,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Upgrades To Gold In Ecovadis Sustainability Rating
TECH,2024-08-06,11:49:48,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Upgrades To Gold In Ecovadis Sustainability Rating
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-19,06:44:38,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep wins large frame agreement with the Norwegian procurement agency Tradebroker
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:30,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Oslo Bors News,Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:30,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Oslo Bors News,Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,20:30:08,03C304,Techstep ASA,99,0.49,equity-actions,,Techstep ASA: The Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private Placement successfully completed
TECH,2024-10-09,20:30:08,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Private Placement successfully completed
TECH,2024-10-09,21:27:10,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Mandatory notification of trade in connection with Private Placement
TECH,2024-10-10,14:27:28,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Disclosure of large shareholding and mandatory notification of trade
TECH,2024-10-17,14:02:27,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Disclosure of large shareholding and mandatory notification of trade
TECH,2024-11-08,09:00:13,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its third quarter 2024 results on Friday 15 November 2024 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2024 Financial Results
TECH,2024-11-08,09:00:13,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its third quarter 2024 results on Friday 15 November 2024 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2024 Financial Results
TECH,2024-11-15,06:00:10,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: q3-2024-results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2024 results
TECH,2024-11-15,06:00:10,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q3 2024 results
TECH,2024-01-26,07:30:03,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep appoints Morten Meier as new CEO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep appoints Morten Meier as new CEO
TECH,2024-01-26,07:30:03,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep appoints Morten Meier as new CEO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Morten Meier as new CEO
TECH,2024-01-26,07:30:04,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep Appoints Morten Meier As New Ceo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Appoints Morten Meier As New Ceo
TECH,2024-01-26,07:30:04,03C304,Techstep ASA,100,0.53,labor-issues,,Techstep Appoints Morten Meier As New Ceo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Appoints Morten Meier As New Ceo
TECH,2024-02-23,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2023 results on Thursday 29 February 2024 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2023 Financial Results
TECH,2024-02-23,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2023 results on Thursday 29 February 2024 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2023 Financial Results
TECH,2024-02-28,13:12:24,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Signs Strategic Partnership Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Strategic Partnership Agreement With Devicenow For Lifecycle Portal
TECH,2024-02-28,13:12:24,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Signs Strategic Partnership Agreement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Strategic Partnership Agreement With Devicenow For Lifecycle Portal
TECH,2024-02-29,06:00:13,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q4 2023 results
TECH,2024-02-29,06:00:13,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2023 results
TECH,2024-02-29,06:00:13,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed frame agreement with the public sector purchasing agency Kammarkollegiet in Sweden,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2023 results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed frame agreement with the public sector purchasing agency Kammarkollegiet in Sweden,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-02-29,06:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed frame agreement with the public sector purchasing agency Kammarkollegiet in Sweden,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2023 Results
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,-0.68,revenues,down,Techstep ASA: Consafe Logistics has decided to wind-down its hardware sales,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,0.49,partnerships,,Techstep: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-22,07:31:11,03C304,Techstep ASA,100,-0.68,revenues,down,Techstep ASA: Consafe Logistics has decided to wind-down its hardware sales,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Expands Its Rugged Device And Services Business Through Strategic Partnership With Consafe Logistics
TECH,2024-04-29,20:47:12,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Wednesday 29 May 2024 at 10:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2024-04-29,20:47:12,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Wednesday 29 May 2024 at 10:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2024-05-08,11:15:20,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its first quarter 2024 results on Wednesday 15 May 2024 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2024 Financial Results
TECH,2024-05-08,11:15:20,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its first quarter 2024 results on Wednesday 15 May 2024 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2024 Financial Results
TECH,2024-05-15,05:00:06,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2024 results
TECH,2024-05-15,05:00:06,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2024 results
TECH,2024-05-15,05:05:26,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2024 Results
TECH,2024-05-15,05:05:26,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: Positive EBITA,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2024 Results
TECH,2024-06-24,15:09:41,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Primary insider notifications
TECH,2024-06-24,15:09:41,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Primary insider notifications
TECH,2024-06-24,15:09:43,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Primary Insider Notifications
TECH,2024-06-24,15:09:43,03C304,Techstep ASA,99,0.22,acquisitions-mergers,,"Chairman of Techstep ASA, acquired 30,000 Techstep shares",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Primary Insider Notifications
TECH,2024-08-06,11:49:48,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Upgrades To Gold In Ecovadis Sustainability Rating
TECH,2024-08-06,11:49:48,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Upgrades To Gold In Ecovadis Sustainability Rating
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-08,07:00:07,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its second quarter and first half 2024 results on Thursday 15 August 2024 at 07:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2024 Financial Results
TECH,2024-08-19,06:44:38,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep wins large frame agreement with the Norwegian procurement agency Tradebroker
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:28,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Underwritten contemplated Private Placement
TECH,2024-10-09,14:36:30,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Oslo Bors News,Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:30,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Oslo Bors News,Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.4,equity-actions,completed,Techstep ASA: The completion of the Private Placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,14:36:45,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: the Company has entered into an underwriting agreement with Datum AS, Karbon Invest AS and Valset Invest",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Underwritten Contemplated Private Placement
TECH,2024-10-09,20:30:08,03C304,Techstep ASA,99,0.49,equity-actions,,Techstep ASA: The Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private Placement successfully completed
TECH,2024-10-09,20:30:08,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Private Placement successfully completed
TECH,2024-10-09,21:27:10,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Mandatory notification of trade in connection with Private Placement
TECH,2024-10-10,14:27:28,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Disclosure of large shareholding and mandatory notification of trade
TECH,2024-10-17,14:02:27,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Disclosure of large shareholding and mandatory notification of trade
TECH,2024-11-08,09:00:13,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its third quarter 2024 results on Friday 15 November 2024 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2024 Financial Results
TECH,2024-11-08,09:00:13,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its third quarter 2024 results on Friday 15 November 2024 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2024 Financial Results
TECH,2024-11-15,06:00:10,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA: q3-2024-results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2024 results
TECH,2024-11-15,06:00:10,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q3 2024 results
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-24,08:00:38,03C304,Birdstep Technology ASA,99,0.47,labor-issues,,Birdstep Technology ASA: changes-to-the-board,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Changes to the Board - nomination of Michael Jacobs as new chairperson
TECH,2023-01-25,11:57:43,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-01-25,11:57:43,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-01-25,11:57:49,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-25,11:57:49,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-25,11:58:04,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-25,11:58:04,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-26,07:00:31,03C304,Birdstep Technology ASA,99,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep strengthens executive management team
TECH,2023-01-26,07:00:31,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep strengthens executive management team
TECH,2023-01-26,07:00:33,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-01-26,07:00:33,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-01-26,07:00:48,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-01-26,07:00:48,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-02-10,11:39:16,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its fourth quarter 2022 financial results on Friday 17 February 2023 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2022 Financial Results
TECH,2023-02-10,11:39:16,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its fourth quarter 2022 financial results on Friday 17 February 2023 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2022 Financial Results
TECH,2023-02-17,06:00:08,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: Signed extended agreement with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2022 results
TECH,2023-02-17,06:00:08,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: Q4 EBITA,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2022 results
TECH,2023-02-17,06:00:08,03C304,Birdstep Technology ASA,99,-0.32,equity-actions,,Birdstep Technology ASA: Capital raise of NOK 103 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2022 results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: Signed extended agreement with,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: Q4 EBITA,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,-0.32,equity-actions,,Birdstep Technology ASA: Capital raise of NOK 103 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: Signed extended agreement with,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: Q4 EBITA,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,-0.32,equity-actions,,Birdstep Technology ASA: Capital raise of NOK 103 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-03-16,07:00:15,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep To Deliver Mobile Solutions To The Norwegian Health Sector With Potential Value Of Up To Nok 650 Million
TECH,2023-03-16,07:00:15,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile solutions to the Norwegian Health Sector with potential value of up to NOK 650 million
TECH,2023-03-16,07:00:15,03C304,Birdstep Technology ASA,99,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile solutions to the Norwegian Health Sector with potential value of up to NOK 650 million
TECH,2023-03-16,07:00:17,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Deliver Mobile Solutions To The Norwegian Health Sector With Potential Value Of Up To Nok 650 Million
TECH,2023-03-16,07:00:18,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep to deliver mobile solutions to the Norwegian Health Sector with potential value of up to NOK 650 million
TECH,2023-03-29,06:05:58,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs New Agreements Worth Nok 2.1 Million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs New Agreements Worth Nok 2.1 Million Recurring Revenue Per Year
TECH,2023-03-29,06:05:58,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs New Agreements Worth Nok 2.1 Million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs New Agreements Worth Nok 2.1 Million Recurring Revenue Per Year
TECH,2023-04-28,11:07:44,03C304,Birdstep Technology ASA,98,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2023-04-28,11:07:44,03C304,Birdstep Technology ASA,98,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2023-04-28,11:07:52,03C304,Birdstep Technology ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2023-04-28,11:07:52,03C304,Birdstep Technology ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2023-04-28,11:35:13,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Key information relating to the proposed share reverse split
TECH,2023-04-28,11:35:13,03C304,Birdstep Technology ASA,92,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Key information relating to the proposed share reverse split
TECH,2023-04-28,11:35:13,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Key information relating to the proposed share reverse split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-05-10,10:34:24,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its first quarter 2023 financial results on Thuesday 16 May 2023 at 07:00 CET,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2023 Financial Results
TECH,2023-05-10,10:34:24,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its first quarter 2023 financial results on Thuesday 16 May 2023 at 07:00 CET,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2023 Financial Results
TECH,2023-05-16,05:00:09,03C304,Birdstep Technology ASA,99,-0.32,revenues,down,"Birdstep Technology ASA: Total revenue of NOK 292 million, down 16%",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2023 results
TECH,2023-05-16,05:05:25,03C304,Birdstep Technology ASA,99,-0.32,revenues,down,"Birdstep Technology ASA: Total revenue of NOK 292 million, down 16%",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2023 Results
TECH,2023-05-16,05:05:25,03C304,Birdstep Technology ASA,99,-0.32,revenues,down,"Birdstep Technology ASA: Total revenue of NOK 292 million, down 16%",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2023 Results
TECH,2023-05-24,05:00:16,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Key information relating to the share reverse split
TECH,2023-05-24,05:05:25,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-24,05:05:25,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-24,09:15:39,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Cision News,Techstep ASA: Correction - Techstep ASA: Key information relating to the share reverse split
TECH,2023-05-24,09:15:40,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Correction - Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-24,09:15:40,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Correction - Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-30,06:39:30,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: Ex-date for the reverse share split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Today 30 May 2023 Ex-Date for Reverse Share Split and new ISIN number
TECH,2023-05-30,06:39:32,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: Ex-date for the reverse share split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Today 30 May 2023 Ex-Date For Reverse Share Split And New Isin Number
TECH,2023-05-30,06:39:32,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: Ex-date for the reverse share split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Today 30 May 2023 Ex-Date For Reverse Share Split And New Isin Number
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep to deliver mobile technology solutions to the Municipality of Oslo,PRESS-RELEASE,Cision News,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,PRESS-RELEASE,Cision News,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep to deliver mobile technology solutions to the Municipality of Oslo,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-08,09:10:21,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: The reverse share split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Registration of reverse share split
TECH,2023-06-08,09:10:23,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: The reverse share split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Registration Of Reverse Share Split
TECH,2023-06-08,09:10:23,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: The reverse share split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Registration Of Reverse Share Split
TECH,2023-06-19,11:45:44,03C304,Birdstep Technology ASA,95,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Temporary injunction relating to the Oslo Kommune award
TECH,2023-06-26,10:44:25,03C304,Birdstep Technology ASA,96,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep ASA: Temporary injunction related to the Oslo Kommune award withdrawn, contract to be signed shortly"
TECH,2023-07-05,06:58:17,03C304,Birdstep Technology ASA,99,0.38,credit,,"Birdstep Technology ASA: The outstanding seller's credit amounted to NOK 14,427,855",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Refinancing secures more flexible and long-term bank financing and converts all remaining seller's credits to shares
TECH,2023-07-05,06:58:17,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: the company has signed a term sheet with a new bank relation for the refinancing of,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Refinancing secures more flexible and long-term bank financing and converts all remaining seller's credits to shares
TECH,2023-07-05,06:58:17,03C304,Birdstep Technology ASA,99,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Refinancing secures more flexible and long-term bank financing and converts all remaining seller's credits to shares
TECH,2023-07-05,06:58:18,03C304,Birdstep Technology ASA,99,0.38,credit,,"Birdstep Technology ASA: The outstanding seller's credit amounted to NOK 14,427,855",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Refinancing Secures More Flexible And Long-Term Bank Financing And Converts All Remaining Seller's Credits To Shares
TECH,2023-07-05,06:58:18,03C304,Birdstep Technology ASA,99,0.38,credit,,"Birdstep Technology ASA: The outstanding seller's credit amounted to NOK 14,427,855",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Refinancing Secures More Flexible And Long-Term Bank Financing And Converts All Remaining Seller's Credits To Shares
TECH,2023-08-11,08:06:40,03C304,Techstep ASA,94,0.0,earnings,,Techstep ASA will release its second quarter 2023 financial results on Friday 18 August 2023 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2023 Financial Results
TECH,2023-08-11,08:06:40,03C304,Techstep ASA,94,0.0,earnings,,Techstep ASA will release its second quarter 2023 financial results on Friday 18 August 2023 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2023 Financial Results
TECH,2023-08-18,05:00:08,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: Signed a frame agreement with Oslo Municipality worth NOK 480 million, a potential",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2023 results
TECH,2023-08-18,05:00:08,03C304,Techstep ASA,99,0.72,revenues,up,Techstep ASA: We expect the increased sales,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2023 results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed term sheet with,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.72,revenues,up,Techstep ASA: We expect the increased sales,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed term sheet with,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.72,revenues,up,Techstep ASA: We expect the increased sales,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-09-05,19:39:38,03C304,Techstep ASA,96,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep: New bank agreement and refinancing in place
TECH,2023-09-22,10:14:19,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-09-22,10:14:19,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-09-22,10:14:26,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-09-22,10:14:26,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-10-10,07:55:26,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Disclosure of voting proxies for the Extraordinary General Meeting
TECH,2023-10-10,07:55:26,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Disclosure of voting proxies for the Extraordinary General Meeting
TECH,2023-10-10,07:55:27,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-10-10,07:55:27,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-10-10,07:55:42,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Oslo Bors News,Techstep: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-10-10,07:55:42,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Dow Jones Newswires,Techstep: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-11-01,12:00:16,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep ASA: Brge Astrup resigns as CEO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Brge Astrup resigns as CEO
TECH,2023-11-01,12:00:16,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep ASA: Brge Astrup resigns as CEO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Brge Astrup resigns as CEO
TECH,2023-11-01,12:00:17,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep Asa: Brge Astrup Resigns As Ceo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Brge Astrup Resigns As Ceo
TECH,2023-11-01,12:00:17,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep Asa: Brge Astrup Resigns As Ceo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Brge Astrup Resigns As Ceo
TECH,2023-11-03,10:33:55,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2023 financial results
TECH,2023-11-03,10:33:55,03C304,Techstep ASA,97,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2023 financial results
TECH,2023-11-03,10:33:59,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2023 Financial Results
TECH,2023-11-03,10:33:59,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2023 Financial Results
TECH,2023-11-10,06:00:14,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q3 2023 results
TECH,2023-11-10,06:00:14,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised up 2% from previous quarter to NOK 306 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2023 results
TECH,2023-11-10,06:00:14,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2023 results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised up 2% from previous quarter to NOK 306 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised up 2% from previous quarter to NOK 306 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:18,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: After signing the first contract with ISS more than 12 years ago, Techstep is",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-23,07:00:33,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution will be deployed during Q2,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Extends Agreement With Iss Facility Services As Worth Nok 850 000 Arr To Include Smartdevice
TECH,2023-01-24,08:00:38,03C304,Birdstep Technology ASA,99,0.47,labor-issues,,Birdstep Technology ASA: changes-to-the-board,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Changes to the Board - nomination of Michael Jacobs as new chairperson
TECH,2023-01-25,11:57:43,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-01-25,11:57:43,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-01-25,11:57:49,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-25,11:57:49,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-25,11:58:04,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-25,11:58:04,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-01-26,07:00:31,03C304,Birdstep Technology ASA,99,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep strengthens executive management team
TECH,2023-01-26,07:00:31,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep strengthens executive management team
TECH,2023-01-26,07:00:33,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-01-26,07:00:33,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-01-26,07:00:48,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-01-26,07:00:48,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: The new CCO and CFO,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Strengthens Executive Management Team
TECH,2023-02-10,11:39:16,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its fourth quarter 2022 financial results on Friday 17 February 2023 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2022 Financial Results
TECH,2023-02-10,11:39:16,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its fourth quarter 2022 financial results on Friday 17 February 2023 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2022 Financial Results
TECH,2023-02-17,06:00:08,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: Signed extended agreement with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2022 results
TECH,2023-02-17,06:00:08,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: Q4 EBITA,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2022 results
TECH,2023-02-17,06:00:08,03C304,Birdstep Technology ASA,99,-0.32,equity-actions,,Birdstep Technology ASA: Capital raise of NOK 103 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2022 results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: Signed extended agreement with,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: Q4 EBITA,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,-0.32,equity-actions,,Birdstep Technology ASA: Capital raise of NOK 103 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: Signed extended agreement with,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: Q4 EBITA,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-02-17,06:05:25,03C304,Birdstep Technology ASA,99,-0.32,equity-actions,,Birdstep Technology ASA: Capital raise of NOK 103 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2022 Results
TECH,2023-03-16,07:00:15,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep To Deliver Mobile Solutions To The Norwegian Health Sector With Potential Value Of Up To Nok 650 Million
TECH,2023-03-16,07:00:15,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile solutions to the Norwegian Health Sector with potential value of up to NOK 650 million
TECH,2023-03-16,07:00:15,03C304,Birdstep Technology ASA,99,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile solutions to the Norwegian Health Sector with potential value of up to NOK 650 million
TECH,2023-03-16,07:00:17,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Deliver Mobile Solutions To The Norwegian Health Sector With Potential Value Of Up To Nok 650 Million
TECH,2023-03-16,07:00:18,03C304,Birdstep Technology ASA,99,0.39,products-services,,Techstep has been awarded a frame agreement with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep to deliver mobile solutions to the Norwegian Health Sector with potential value of up to NOK 650 million
TECH,2023-03-29,06:05:58,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs New Agreements Worth Nok 2.1 Million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs New Agreements Worth Nok 2.1 Million Recurring Revenue Per Year
TECH,2023-03-29,06:05:58,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs New Agreements Worth Nok 2.1 Million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs New Agreements Worth Nok 2.1 Million Recurring Revenue Per Year
TECH,2023-04-28,11:07:44,03C304,Birdstep Technology ASA,98,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2023-04-28,11:07:44,03C304,Birdstep Technology ASA,98,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2023-04-28,11:07:52,03C304,Birdstep Technology ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2023-04-28,11:07:52,03C304,Birdstep Technology ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 23 May 2023 at 16:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2023-04-28,11:35:13,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Key information relating to the proposed share reverse split
TECH,2023-04-28,11:35:13,03C304,Birdstep Technology ASA,92,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Key information relating to the proposed share reverse split
TECH,2023-04-28,11:35:13,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Key information relating to the proposed share reverse split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-04-28,11:35:15,03C304,Birdstep Technology ASA,92,0.0,investor-relations,,Annual general meeting of Techstep ASA (TECH) to be held on 23 May 2023,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Key Information Relating To The Proposed Share Reverse Split
TECH,2023-05-10,10:34:24,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its first quarter 2023 financial results on Thuesday 16 May 2023 at 07:00 CET,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2023 Financial Results
TECH,2023-05-10,10:34:24,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its first quarter 2023 financial results on Thuesday 16 May 2023 at 07:00 CET,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2023 Financial Results
TECH,2023-05-16,05:00:09,03C304,Birdstep Technology ASA,99,-0.32,revenues,down,"Birdstep Technology ASA: Total revenue of NOK 292 million, down 16%",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2023 results
TECH,2023-05-16,05:05:25,03C304,Birdstep Technology ASA,99,-0.32,revenues,down,"Birdstep Technology ASA: Total revenue of NOK 292 million, down 16%",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2023 Results
TECH,2023-05-16,05:05:25,03C304,Birdstep Technology ASA,99,-0.32,revenues,down,"Birdstep Technology ASA: Total revenue of NOK 292 million, down 16%",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2023 Results
TECH,2023-05-24,05:00:16,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Key information relating to the share reverse split
TECH,2023-05-24,05:05:25,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-24,05:05:25,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-24,09:15:39,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Cision News,Techstep ASA: Correction - Techstep ASA: Key information relating to the share reverse split
TECH,2023-05-24,09:15:40,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Correction - Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-24,09:15:40,03C304,Birdstep Technology ASA,94,0.0,equity-actions,,Birdstep Technology ASA: Reverse split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Correction - Techstep Asa: Key Information Relating To The Share Reverse Split
TECH,2023-05-30,06:39:30,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: Ex-date for the reverse share split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Today 30 May 2023 Ex-Date for Reverse Share Split and new ISIN number
TECH,2023-05-30,06:39:32,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: Ex-date for the reverse share split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Today 30 May 2023 Ex-Date For Reverse Share Split And New Isin Number
TECH,2023-05-30,06:39:32,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: Ex-date for the reverse share split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Today 30 May 2023 Ex-Date For Reverse Share Split And New Isin Number
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep to deliver mobile technology solutions to the Municipality of Oslo,PRESS-RELEASE,Cision News,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,PRESS-RELEASE,Cision News,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep to deliver mobile technology solutions to the Municipality of Oslo,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:37,03C304,Birdstep Technology ASA,100,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep to deliver mobile technology solutions to the Municipality of Oslo with potential contract value up to NOK 480 million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.0,products-services,,Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-06,11:32:38,03C304,Birdstep Technology ASA,100,0.58,products-services,,Techstep has been awarded a frame agreement with the Municipality of Oslo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Deliver Mobile Technology Solutions To The Municipality Of Oslo With Potential Contract Value Up To Nok 480 Million
TECH,2023-06-08,09:10:21,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: The reverse share split,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Registration of reverse share split
TECH,2023-06-08,09:10:23,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: The reverse share split,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Registration Of Reverse Share Split
TECH,2023-06-08,09:10:23,03C304,Birdstep Technology ASA,96,0.0,equity-actions,,Birdstep Technology ASA: The reverse share split,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Registration Of Reverse Share Split
TECH,2023-06-19,11:45:44,03C304,Birdstep Technology ASA,95,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Temporary injunction relating to the Oslo Kommune award
TECH,2023-06-26,10:44:25,03C304,Birdstep Technology ASA,96,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep ASA: Temporary injunction related to the Oslo Kommune award withdrawn, contract to be signed shortly"
TECH,2023-07-05,06:58:17,03C304,Birdstep Technology ASA,99,0.38,credit,,"Birdstep Technology ASA: The outstanding seller's credit amounted to NOK 14,427,855",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Refinancing secures more flexible and long-term bank financing and converts all remaining seller's credits to shares
TECH,2023-07-05,06:58:17,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: the company has signed a term sheet with a new bank relation for the refinancing of,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Refinancing secures more flexible and long-term bank financing and converts all remaining seller's credits to shares
TECH,2023-07-05,06:58:17,03C304,Birdstep Technology ASA,99,0.57,equity-actions,listing,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Refinancing secures more flexible and long-term bank financing and converts all remaining seller's credits to shares
TECH,2023-07-05,06:58:18,03C304,Birdstep Technology ASA,99,0.38,credit,,"Birdstep Technology ASA: The outstanding seller's credit amounted to NOK 14,427,855",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Refinancing Secures More Flexible And Long-Term Bank Financing And Converts All Remaining Seller's Credits To Shares
TECH,2023-07-05,06:58:18,03C304,Birdstep Technology ASA,99,0.38,credit,,"Birdstep Technology ASA: The outstanding seller's credit amounted to NOK 14,427,855",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Refinancing Secures More Flexible And Long-Term Bank Financing And Converts All Remaining Seller's Credits To Shares
TECH,2023-08-11,08:06:40,03C304,Techstep ASA,94,0.0,earnings,,Techstep ASA will release its second quarter 2023 financial results on Friday 18 August 2023 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2023 Financial Results
TECH,2023-08-11,08:06:40,03C304,Techstep ASA,94,0.0,earnings,,Techstep ASA will release its second quarter 2023 financial results on Friday 18 August 2023 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2023 Financial Results
TECH,2023-08-18,05:00:08,03C304,Techstep ASA,99,0.39,products-services,,"Techstep ASA: Signed a frame agreement with Oslo Municipality worth NOK 480 million, a potential",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2023 results
TECH,2023-08-18,05:00:08,03C304,Techstep ASA,99,0.72,revenues,up,Techstep ASA: We expect the increased sales,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2023 results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed term sheet with,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.72,revenues,up,Techstep ASA: We expect the increased sales,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed term sheet with,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-08-18,05:05:23,03C304,Techstep ASA,99,0.72,revenues,up,Techstep ASA: We expect the increased sales,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 2023 Results
TECH,2023-09-05,19:39:38,03C304,Techstep ASA,96,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep: New bank agreement and refinancing in place
TECH,2023-09-22,10:14:19,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-09-22,10:14:19,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2023-09-22,10:14:26,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-09-22,10:14:26,03C304,Techstep ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2023-10-10,07:55:26,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Disclosure of voting proxies for the Extraordinary General Meeting
TECH,2023-10-10,07:55:26,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Disclosure of voting proxies for the Extraordinary General Meeting
TECH,2023-10-10,07:55:27,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-10-10,07:55:27,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-10-10,07:55:42,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Oslo Bors News,Techstep: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-10-10,07:55:42,03C304,Techstep ASA,96,0.0,investor-relations,,Techstep ASAs notice of Extraordinary General Meeting to be held on 13 October 2023,PRESS-RELEASE,Dow Jones Newswires,Techstep: Techstep Asa: Disclosure Of Voting Proxies For The Extraordinary General Meeting
TECH,2023-11-01,12:00:16,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep ASA: Brge Astrup resigns as CEO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Brge Astrup resigns as CEO
TECH,2023-11-01,12:00:16,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep ASA: Brge Astrup resigns as CEO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Brge Astrup resigns as CEO
TECH,2023-11-01,12:00:17,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep Asa: Brge Astrup Resigns As Ceo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Brge Astrup Resigns As Ceo
TECH,2023-11-01,12:00:17,03C304,Techstep ASA,100,-0.57,labor-issues,,Techstep Asa: Brge Astrup Resigns As Ceo,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Brge Astrup Resigns As Ceo
TECH,2023-11-03,10:33:55,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2023 financial results
TECH,2023-11-03,10:33:55,03C304,Techstep ASA,97,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2023 financial results
TECH,2023-11-03,10:33:59,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2023 Financial Results
TECH,2023-11-03,10:33:59,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2023 results on Friday 10 November 2023 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2023 Financial Results
TECH,2023-11-10,06:00:14,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q3 2023 results
TECH,2023-11-10,06:00:14,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised up 2% from previous quarter to NOK 306 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2023 results
TECH,2023-11-10,06:00:14,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2023 results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised up 2% from previous quarter to NOK 306 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised up 2% from previous quarter to NOK 306 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2023-11-10,06:05:39,03C304,Techstep ASA,99,0.53,labor-issues,,Appointed interim CEO of Techstep,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2023 Results
TECH,2021-02-05,11:06:05,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2020 results on Friday 12 February 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2020 results
TECH,2021-02-05,11:06:05,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2020 results on Friday 12 February 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2020 results
TECH,2021-02-05,11:06:05,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2020 results
TECH,2021-02-05,11:06:07,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2020 results on Friday 12 February 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,Techstep: Techstep Asa: Invitation To Presentation Of Q4 2020 Results
TECH,2021-02-12,06:00:16,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Stable full-year 2020 revenues,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 and FY 2020 results
TECH,2021-02-12,06:00:16,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q4 and FY 2020 results
TECH,2021-02-12,06:05:45,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Stable full-year 2020 revenues,PRESS-RELEASE,Oslo Bors News,Techstep: Techstep Asa: Q4 And Fy 2020 Results
TECH,2021-03-19,14:29:17,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Annual Report 2020
TECH,2021-03-25,09:31:03,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Employee Share Purchase Program - resolution to increase the share capital
TECH,2021-03-25,09:34:18,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - notifiable transactions in connection with Employee Share Purchase Program
TECH,2021-03-26,06:00:09,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Optidev one of Sweden's Best Workplaces - again!
TECH,2021-03-26,06:00:09,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: As CEO,PRESS-RELEASE,Cision News,Techstep ASA: Optidev one of Sweden's Best Workplaces - again!
TECH,2021-03-26,06:05:47,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: As CEO of Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Optidev One Of Sweden's Best Workplaces - Again!
TECH,2021-03-29,08:01:55,03C304,Birdstep Technology ASA,100,0.52,products-services,,Techstep ASA: Techstep to deliver MMS solution,PRESS-RELEASE,Cision News,"Techstep ASA: Techstep to deliver MMS solution with 1,000 managed devices to Vy in Sweden"
TECH,2021-03-29,08:01:55,03C304,Birdstep Technology ASA,100,0.52,products-services,,Techstep ASA: Techstep to deliver MMS solution,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep to deliver MMS solution with 1,000 managed devices to Vy in Sweden"
TECH,2021-03-29,08:01:55,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep to deliver MMS solution with 1,000 managed devices to Vy in Sweden"
TECH,2021-03-29,08:01:57,03C304,Birdstep Technology ASA,100,0.52,products-services,,Techstep: Techstep To Deliver Mms Solution,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep To Deliver Mms Solution With 1,000 Managed Devices To Vy In Sweden"
TECH,2021-04-06,05:00:10,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: The agreement with Svevia includes Platform Management, Advisory Services and support for 2,600 managed devices",PRESS-RELEASE,Cision News,Techstep ASA: Techstep signs Managed Mobility Service (MMS) agreement with infrastructure company Svevia
TECH,2021-04-06,05:00:10,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep signs Managed Mobility Service (MMS) agreement,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep signs Managed Mobility Service (MMS) agreement with infrastructure company Svevia
TECH,2021-04-06,05:00:10,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep signs Managed Mobility Service (MMS) agreement with infrastructure company Svevia
TECH,2021-04-06,05:05:40,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: The agreement with Svevia includes Platform Management, Advisory Services and support for 2,600 managed devices",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Service (Mms) Agreement With Infrastructure Company Svevia
TECH,2021-04-07,08:17:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - share capital increase registered
TECH,2021-05-03,11:13:56,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2021 results on Monday 10 May 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2021 results
TECH,2021-05-03,11:13:56,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2021 results on Monday 10 May 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2021 results
TECH,2021-05-03,11:13:56,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2021 results
TECH,2021-05-03,11:13:57,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2021 results on Monday 10 May 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2021 Results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Cision News,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.58,acquisitions-mergers,completed,Techstep executes its M&A,PRESS-RELEASE,Cision News,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.38,credit,,Techstep has also secured an acquisition loan of NOK 34 million,PRESS-RELEASE,Cision News,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,"Techstep ASA (""Techstep""), has signed an agreement to",FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.58,acquisitions-mergers,completed,Techstep executes its M&A,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue was NOK 306 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.38,credit,,Techstep has also secured an acquisition loan of NOK 34 million,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep acquires software company,PRESS-RELEASE,Cision News,Techstep ASA: Techstep acquires software company -2-
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep acquires software company,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep acquires software company -2-
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue was NOK 306 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,-0.75,revenues,down,Birdstep Technology ASA: we did see slower sales,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.51,products-services,,Birdstep Technology ASA: We signed eight new MMS contracts,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep's Q1 2021 results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep's Q1 2021 results,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Acquires Software Company Famoc Adding Mms Capabilities, Increasing Arr By 40% And Announce Fully Underwritten Private Placement Of Nok 100 Million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.58,acquisitions-mergers,completed,Techstep executes its M&A,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Acquires Software Company Famoc Adding Mms Capabilities, Increasing Arr By 40% And Announce Fully Underwritten Private Placement Of Nok 100 Million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.38,credit,,Techstep has also secured an acquisition loan of NOK 34 million,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Acquires Software Company Famoc Adding Mms Capabilities, Increasing Arr By 40% And Announce Fully Underwritten Private Placement Of Nok 100 Million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep Acquires Software Company,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Acquires Software Company -2-
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,-0.75,revenues,down,Birdstep Technology ASA: we did see slower sales,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,0.51,products-services,,Birdstep Technology ASA: We signed eight new MMS contracts,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep's Q1 2021 results,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-12,09:16:52,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Provide Managed Mobility Services (Mms) Solution To Posten Norge
TECH,2021-05-20,20:07:52,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The Private Placement was successfully completed,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - Private placement of NOK 100 million successfully completed
TECH,2021-05-20,14:30:09,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The completion of the Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Fully underwritten private placement of NOK 100 million
TECH,2021-05-20,14:30:09,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Fully underwritten private placement of NOK 100 million
TECH,2021-05-20,14:30:11,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The completion of the Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Fully Underwritten Private Placement Of Nok 100 Million
TECH,2021-05-20,20:07:52,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - Private placement of NOK 100 million successfully completed
TECH,2021-05-20,20:07:52,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Private placement of NOK 100 million successfully completed
TECH,2021-05-21,13:04:18,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Primary insider notification
TECH,2021-05-31,07:32:28,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - share capital increase registered
TECH,2021-06-02,18:40:01,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Primary insider notification
TECH,2021-06-22,05:05:44,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Service (Mms) Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Service (Mms) Agreement With Storstockholms Lokaltrafik
TECH,2021-07-01,05:05:43,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services (Mms) Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Services (Mms) Agreement With Norwegian Healthcare Service Provider Innlandet Hospital Trust
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep appoints Brge Astrup as new CEO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Will step down with immediate effect and Techstep's CFO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep appoints Brge Astrup as new CEO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Will step down with immediate effect and Techstep's CFO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:32,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep Appoints Brge Astrup As New Ceo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Appoints Brge Astrup As New Ceo
TECH,2021-07-02,06:51:32,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Will step down with immediate effect and Techstep's CFO,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Appoints Brge Astrup As New Ceo
TECH,2021-07-14,12:49:18,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Publication of Prospectus
TECH,2021-07-14,12:49:18,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Publication of Prospectus
TECH,2021-07-14,12:49:25,03C304,Birdstep Technology ASA,98,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus
TECH,2021-07-14,12:49:25,03C304,Birdstep Technology ASA,98,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus
TECH,2021-08-12,11:30:58,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2021 results on Thursday 19 August 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2021 results
TECH,2021-08-12,11:30:58,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2021 results on Thursday 19 August 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2021 results
TECH,2021-08-12,11:30:58,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2021 results
TECH,2021-08-12,11:30:59,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2021 results on Thursday 19 August 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2021 Results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 325 million, up 36%",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.0,equity-actions,,Techstep raised NOK 100 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.0,equity-actions,,Techstep raised NOK 100 million,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:05:28,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 325 million, up 36%",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2021 Results
TECH,2021-08-19,05:05:28,03C304,Birdstep Technology ASA,99,0.0,equity-actions,,Techstep raised NOK 100 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2021 Results
TECH,2021-08-25,07:03:55,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2021-08-25,07:03:55,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2021-08-25,07:04:00,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Techstep today announces that CFO Marius Drefvelin has resigned,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,0.49,labor-issues,,Techstep will initiate a search for a new CFO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Techstep today announces that CFO Marius Drefvelin has resigned,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,0.49,labor-issues,,Techstep will initiate a search for a new CFO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-09-14,12:41:18,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep: Techstep Asa - Aligning New Management Team,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Aligning New Management Team With Software-Led Growth Strategy
TECH,2021-10-26,05:05:27,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services-Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Services-Agreement With The Olav Thon Group
TECH,2021-10-28,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 August 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2021 results
TECH,2021-10-28,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 August 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2021 results
TECH,2021-10-28,05:00:11,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2021 results
TECH,2021-10-28,05:05:27,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 August 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2021 Results
TECH,2021-10-28,06:38:22,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 November 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Corrected date. Invitation to presentation of Q3 2021 results
TECH,2021-10-28,06:38:22,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 November 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Corrected date. Invitation to presentation of Q3 2021 results
TECH,2021-10-28,06:38:22,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Corrected date. Invitation to presentation of Q3 2021 results
TECH,2021-10-28,06:38:23,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 November 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Corrected Date. Invitation To Presentation Of Q3 2021 Results
TECH,2021-11-04,06:00:08,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 290 million, up 36%",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2021 results
TECH,2021-11-04,06:00:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q3 2021 results
TECH,2021-11-04,06:05:29,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 290 million, up 36%",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2021 Results
TECH,2021-11-29,06:00:17,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep streamlines its customer offering by divesting non-strategic business units
TECH,2021-12-07,06:00:11,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Anita Huun appointed Chief Financial Officer
TECH,2021-12-14,11:03:48,03C304,Birdstep Technology ASA,100,0.39,products-services,,Dnb Signs Agreement For Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Dnb Signs Agreement For Techstep's Own Cloud-Based Mobility Software Solution
TECH,2021-12-14,11:03:48,03C304,Birdstep Technology ASA,100,0.52,products-services,,"Dnb, and Techstep will deliver new mobile devices",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Dnb Signs Agreement For Techstep's Own Cloud-Based Mobility Software Solution
TECH,2021-12-14,11:03:48,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Dnb Signs Agreement For Techstep's Own Cloud-Based Mobility Software Solution
TECH,2021-02-05,11:06:05,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2020 results on Friday 12 February 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2020 results
TECH,2021-02-05,11:06:05,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2020 results on Friday 12 February 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2020 results
TECH,2021-02-05,11:06:05,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2020 results
TECH,2021-02-05,11:06:07,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2020 results on Friday 12 February 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,Techstep: Techstep Asa: Invitation To Presentation Of Q4 2020 Results
TECH,2021-02-12,06:00:16,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Stable full-year 2020 revenues,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 and FY 2020 results
TECH,2021-02-12,06:00:16,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q4 and FY 2020 results
TECH,2021-02-12,06:05:45,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Stable full-year 2020 revenues,PRESS-RELEASE,Oslo Bors News,Techstep: Techstep Asa: Q4 And Fy 2020 Results
TECH,2021-03-19,14:29:17,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Annual Report 2020
TECH,2021-03-25,09:31:03,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Employee Share Purchase Program - resolution to increase the share capital
TECH,2021-03-25,09:34:18,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - notifiable transactions in connection with Employee Share Purchase Program
TECH,2021-03-26,06:00:09,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Optidev one of Sweden's Best Workplaces - again!
TECH,2021-03-26,06:00:09,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: As CEO,PRESS-RELEASE,Cision News,Techstep ASA: Optidev one of Sweden's Best Workplaces - again!
TECH,2021-03-26,06:05:47,03C304,Birdstep Technology ASA,99,0.53,labor-issues,,Birdstep Technology ASA: As CEO of Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Optidev One Of Sweden's Best Workplaces - Again!
TECH,2021-03-29,08:01:55,03C304,Birdstep Technology ASA,100,0.52,products-services,,Techstep ASA: Techstep to deliver MMS solution,PRESS-RELEASE,Cision News,"Techstep ASA: Techstep to deliver MMS solution with 1,000 managed devices to Vy in Sweden"
TECH,2021-03-29,08:01:55,03C304,Birdstep Technology ASA,100,0.52,products-services,,Techstep ASA: Techstep to deliver MMS solution,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep to deliver MMS solution with 1,000 managed devices to Vy in Sweden"
TECH,2021-03-29,08:01:55,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep to deliver MMS solution with 1,000 managed devices to Vy in Sweden"
TECH,2021-03-29,08:01:57,03C304,Birdstep Technology ASA,100,0.52,products-services,,Techstep: Techstep To Deliver Mms Solution,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep To Deliver Mms Solution With 1,000 Managed Devices To Vy In Sweden"
TECH,2021-04-06,05:00:10,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: The agreement with Svevia includes Platform Management, Advisory Services and support for 2,600 managed devices",PRESS-RELEASE,Cision News,Techstep ASA: Techstep signs Managed Mobility Service (MMS) agreement with infrastructure company Svevia
TECH,2021-04-06,05:00:10,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep signs Managed Mobility Service (MMS) agreement,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep signs Managed Mobility Service (MMS) agreement with infrastructure company Svevia
TECH,2021-04-06,05:00:10,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep signs Managed Mobility Service (MMS) agreement with infrastructure company Svevia
TECH,2021-04-06,05:05:40,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Birdstep Technology ASA: The agreement with Svevia includes Platform Management, Advisory Services and support for 2,600 managed devices",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Service (Mms) Agreement With Infrastructure Company Svevia
TECH,2021-04-07,08:17:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - share capital increase registered
TECH,2021-05-03,11:13:56,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2021 results on Monday 10 May 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2021 results
TECH,2021-05-03,11:13:56,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2021 results on Monday 10 May 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2021 results
TECH,2021-05-03,11:13:56,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2021 results
TECH,2021-05-03,11:13:57,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2021 results on Monday 10 May 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2021 Results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Cision News,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.58,acquisitions-mergers,completed,Techstep executes its M&A,PRESS-RELEASE,Cision News,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.38,credit,,Techstep has also secured an acquisition loan of NOK 34 million,PRESS-RELEASE,Cision News,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,"Techstep ASA (""Techstep""), has signed an agreement to",FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.58,acquisitions-mergers,completed,Techstep executes its M&A,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue was NOK 306 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.38,credit,,Techstep has also secured an acquisition loan of NOK 34 million,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,"Techstep ASA: Techstep acquires software company Famoc adding MMS capabilities, increasing ARR by 40% and announce fully underwritten private placement of NOK 100 million"
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep acquires software company,PRESS-RELEASE,Cision News,Techstep ASA: Techstep acquires software company -2-
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep acquires software company,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep acquires software company -2-
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue was NOK 306 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,-0.75,revenues,down,Birdstep Technology ASA: we did see slower sales,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.51,products-services,,Birdstep Technology ASA: We signed eight new MMS contracts,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep's Q1 2021 results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep's Q1 2021 results,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:00:04,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2021 results
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Acquires Software Company Famoc Adding Mms Capabilities, Increasing Arr By 40% And Announce Fully Underwritten Private Placement Of Nok 100 Million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.58,acquisitions-mergers,completed,Techstep executes its M&A,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Acquires Software Company Famoc Adding Mms Capabilities, Increasing Arr By 40% And Announce Fully Underwritten Private Placement Of Nok 100 Million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.38,credit,,Techstep has also secured an acquisition loan of NOK 34 million,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Acquires Software Company Famoc Adding Mms Capabilities, Increasing Arr By 40% And Announce Fully Underwritten Private Placement Of Nok 100 Million"
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep Acquires Software Company,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Acquires Software Company -2-
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,-0.75,revenues,down,Birdstep Technology ASA: we did see slower sales,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,0.51,products-services,,Birdstep Technology ASA: We signed eight new MMS contracts,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-10,05:05:45,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep's Q1 2021 results,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2021 Results
TECH,2021-05-12,09:16:52,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep To Provide Managed Mobility Services (Mms) Solution To Posten Norge
TECH,2021-05-20,20:07:52,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The Private Placement was successfully completed,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - Private placement of NOK 100 million successfully completed
TECH,2021-05-20,14:30:09,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The completion of the Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Fully underwritten private placement of NOK 100 million
TECH,2021-05-20,14:30:09,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Fully underwritten private placement of NOK 100 million
TECH,2021-05-20,14:30:11,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The completion of the Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Fully Underwritten Private Placement Of Nok 100 Million
TECH,2021-05-20,20:07:52,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - Private placement of NOK 100 million successfully completed
TECH,2021-05-20,20:07:52,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Private placement of NOK 100 million successfully completed
TECH,2021-05-21,13:04:18,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Primary insider notification
TECH,2021-05-31,07:32:28,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - share capital increase registered
TECH,2021-06-02,18:40:01,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The Company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Primary insider notification
TECH,2021-06-22,05:05:44,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Service (Mms) Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Service (Mms) Agreement With Storstockholms Lokaltrafik
TECH,2021-07-01,05:05:43,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services (Mms) Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Services (Mms) Agreement With Norwegian Healthcare Service Provider Innlandet Hospital Trust
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep appoints Brge Astrup as new CEO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Will step down with immediate effect and Techstep's CFO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep appoints Brge Astrup as new CEO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Will step down with immediate effect and Techstep's CFO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:30,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep appoints Brge Astrup as new CEO
TECH,2021-07-02,06:51:32,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep Appoints Brge Astrup As New Ceo,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Appoints Brge Astrup As New Ceo
TECH,2021-07-02,06:51:32,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Will step down with immediate effect and Techstep's CFO,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Appoints Brge Astrup As New Ceo
TECH,2021-07-14,12:49:18,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Publication of Prospectus
TECH,2021-07-14,12:49:18,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Publication of Prospectus
TECH,2021-07-14,12:49:25,03C304,Birdstep Technology ASA,98,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus
TECH,2021-07-14,12:49:25,03C304,Birdstep Technology ASA,98,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus
TECH,2021-08-12,11:30:58,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2021 results on Thursday 19 August 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2021 results
TECH,2021-08-12,11:30:58,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2021 results on Thursday 19 August 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2021 results
TECH,2021-08-12,11:30:58,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2021 results
TECH,2021-08-12,11:30:59,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2021 results on Thursday 19 August 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2021 Results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 325 million, up 36%",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.0,equity-actions,,Techstep raised NOK 100 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.0,equity-actions,,Techstep raised NOK 100 million,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:00:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 2021 results
TECH,2021-08-19,05:05:28,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 325 million, up 36%",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2021 Results
TECH,2021-08-19,05:05:28,03C304,Birdstep Technology ASA,99,0.0,equity-actions,,Techstep raised NOK 100 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 2021 Results
TECH,2021-08-25,07:03:55,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2021-08-25,07:03:55,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2021-08-25,07:04:00,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Techstep today announces that CFO Marius Drefvelin has resigned,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,0.49,labor-issues,,Techstep will initiate a search for a new CFO,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,-0.57,labor-issues,,Techstep today announces that CFO Marius Drefvelin has resigned,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-08-29,18:45:15,03C304,Birdstep Technology ASA,100,0.49,labor-issues,,Techstep will initiate a search for a new CFO,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - CFO resigns
TECH,2021-09-14,12:41:18,03C304,Birdstep Technology ASA,100,0.53,labor-issues,,Techstep: Techstep Asa - Aligning New Management Team,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Aligning New Management Team With Software-Led Growth Strategy
TECH,2021-10-26,05:05:27,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services-Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Services-Agreement With The Olav Thon Group
TECH,2021-10-28,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 August 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2021 results
TECH,2021-10-28,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 August 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2021 results
TECH,2021-10-28,05:00:11,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q3 2021 results
TECH,2021-10-28,05:05:27,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 August 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2021 Results
TECH,2021-10-28,06:38:22,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 November 2021 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Corrected date. Invitation to presentation of Q3 2021 results
TECH,2021-10-28,06:38:22,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 November 2021 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Corrected date. Invitation to presentation of Q3 2021 results
TECH,2021-10-28,06:38:22,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Corrected date. Invitation to presentation of Q3 2021 results
TECH,2021-10-28,06:38:23,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its third quarter 2021 results on Thursday 4 November 2021 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Corrected Date. Invitation To Presentation Of Q3 2021 Results
TECH,2021-11-04,06:00:08,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 290 million, up 36%",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2021 results
TECH,2021-11-04,06:00:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q3 2021 results
TECH,2021-11-04,06:05:29,03C304,Birdstep Technology ASA,99,0.5,revenues,up,"Birdstep Technology ASA: Revenue was NOK 290 million, up 36%",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2021 Results
TECH,2021-11-29,06:00:17,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep streamlines its customer offering by divesting non-strategic business units
TECH,2021-12-07,06:00:11,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Anita Huun appointed Chief Financial Officer
TECH,2021-12-14,11:03:48,03C304,Birdstep Technology ASA,100,0.39,products-services,,Dnb Signs Agreement For Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Dnb Signs Agreement For Techstep's Own Cloud-Based Mobility Software Solution
TECH,2021-12-14,11:03:48,03C304,Birdstep Technology ASA,100,0.52,products-services,,"Dnb, and Techstep will deliver new mobile devices",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Dnb Signs Agreement For Techstep's Own Cloud-Based Mobility Software Solution
TECH,2021-12-14,11:03:48,03C304,Birdstep Technology ASA,100,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Dnb Signs Agreement For Techstep's Own Cloud-Based Mobility Software Solution
TECH,2022-01-03,17:56:53,03C304,Birdstep Technology ASA,97,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Completion of transaction to divest non-core business unit
TECH,2022-01-12,10:00:15,03C304,Birdstep Technology ASA,99,0.49,partnerships,,"Birdstep Technology ASA: our leadership team with her experience from international brand, marketing, and product and service development",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Sheena Lim Appointed Chief Marketing Officer
TECH,2022-01-12,10:00:15,03C304,Birdstep Technology ASA,99,0.49,partnerships,,"Birdstep Technology ASA: our leadership team with her experience from international brand, marketing, and product and service development",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Sheena Lim Appointed Chief Marketing Officer
TECH,2022-02-07,06:00:08,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2021 results
TECH,2022-02-07,06:00:08,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2021 results
TECH,2022-02-07,06:00:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2021 results
TECH,2022-02-07,06:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2021 Results
TECH,2022-02-07,06:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2021 Results
TECH,2022-02-11,06:00:12,03C304,Birdstep Technology ASA,99,0.65,revenues,up,Birdstep Technology ASA: Revenue of NOK 384 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2021 results
TECH,2022-02-11,06:00:12,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: We closed 11 managed mobility services contracts,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2021 results
TECH,2022-02-11,06:00:12,03C304,Birdstep Technology ASA,99,0.47,equity-actions,,Birdstep Technology ASA: With the restructuring,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2021 results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.65,revenues,up,Birdstep Technology ASA: Revenue of NOK 384 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: We closed 11 managed mobility services contracts,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.47,equity-actions,,Birdstep Technology ASA: With the restructuring,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.65,revenues,up,Birdstep Technology ASA: Revenue of NOK 384 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: We closed 11 managed mobility services contracts,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.47,equity-actions,,Birdstep Technology ASA: With the restructuring,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-14,10:33:06,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep Asa Acquires Remaining Shares In Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa Acquires Remaining Shares In Techstep Finance As
TECH,2022-02-14,10:33:06,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep Asa Acquires Remaining Shares In Techstep,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa Acquires Remaining Shares In Techstep Finance As
TECH,2022-03-08,08:45:55,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services Agreement With Heidelbergcement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Services Agreement With Heidelbergcement
TECH,2022-03-08,08:45:55,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services Agreement With Heidelbergcement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Managed Mobility Services Agreement With Heidelbergcement
TECH,2022-03-31,14:45:30,03C304,Birdstep Technology ASA,99,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2022-03-31,14:45:30,03C304,Birdstep Technology ASA,99,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2022-03-31,14:45:35,03C304,Birdstep Technology ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2022-03-31,14:45:35,03C304,Birdstep Technology ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2022-04-04,05:05:26,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartdevice Agreement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Smartdevice Agreement For 1000 Users With Stendi
TECH,2022-04-04,05:05:26,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartdevice Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Smartdevice Agreement For 1000 Users With Stendi
TECH,2022-05-05,05:00:17,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2022 results
TECH,2022-05-05,05:00:17,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2022 results
TECH,2022-05-05,05:05:29,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2022 Results
TECH,2022-05-05,05:05:29,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2022 Results
TECH,2022-05-06,05:00:12,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Cision News,Techstep ASA: Techstep acquires cybersecurity SaaS company Crypho
TECH,2022-05-06,05:00:12,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep acquires cybersecurity SaaS company Crypho
TECH,2022-05-06,05:05:28,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Acquires Cybersecurity Saas Company Crypho
TECH,2022-05-06,05:05:28,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Acquires Cybersecurity Saas Company Crypho
TECH,2022-05-12,04:30:16,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue of NOK 346.2 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2022 results
TECH,2022-05-12,04:30:16,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: our quarterly result,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2022 results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue of NOK 346.2 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: our quarterly result,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue of NOK 346.2 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: our quarterly result,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-06-01,16:12:09,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep ASA - Completion of Crypho acquisition,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - Completion of Crypho acquisition
TECH,2022-06-01,16:12:09,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep ASA - Completion of Crypho acquisition,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Completion of Crypho acquisition
TECH,2022-06-01,16:12:10,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep Asa - Completion Of Crypho Acquisition,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Completion Of Crypho Acquisition
TECH,2022-06-01,16:12:10,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep Asa - Completion Of Crypho Acquisition,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Completion Of Crypho Acquisition
TECH,2022-06-15,05:30:15,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Techstep has signed an agreement with new customer, Nortel",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Smartdevice Agreement With Nortel For All Their Users
TECH,2022-06-15,05:30:15,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Techstep has signed an agreement with new customer, Nortel",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Smartdevice Agreement With Nortel For All Their Users
TECH,2022-08-12,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2022 financial results
TECH,2022-08-12,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2022 financial results
TECH,2022-08-12,05:05:24,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2022 Financial Results
TECH,2022-08-12,05:05:24,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2022 Financial Results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.62,acquisitions-mergers,,"Birdstep Technology ASA: Birdstep Technology ASA: Over the years we have acquired and combined multiple companies, resulting in many different",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: q2-and-h1-2022-results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: q2-and-h1-2022-results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.62,acquisitions-mergers,,"Birdstep Technology ASA: Birdstep Technology ASA: Over the years we have acquired and combined multiple companies, resulting in many different",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.62,acquisitions-mergers,,"Birdstep Technology ASA: Birdstep Technology ASA: Over the years we have acquired and combined multiple companies, resulting in many different",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The Private Placement was successfully completed,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-30,15:19:24,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2022-09-30,15:19:24,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2022-09-30,15:19:30,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-09-30,15:19:30,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-09-30,15:19:45,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-09-30,15:19:45,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-11-02,15:14:26,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-02,15:14:26,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-02,15:14:41,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-02,15:14:41,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-09,06:00:11,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2022 results
TECH,2022-11-09,06:00:11,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2022 results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-29,15:09:49,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Publication of prospectus and start of subscription period in the Subsequent Offering
TECH,2022-11-29,15:09:55,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2022-11-29,15:09:55,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2022-11-29,15:10:10,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2022-11-29,15:10:10,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2022-01-03,17:56:53,03C304,Birdstep Technology ASA,97,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Completion of transaction to divest non-core business unit
TECH,2022-01-12,10:00:15,03C304,Birdstep Technology ASA,99,0.49,partnerships,,"Birdstep Technology ASA: our leadership team with her experience from international brand, marketing, and product and service development",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Sheena Lim Appointed Chief Marketing Officer
TECH,2022-01-12,10:00:15,03C304,Birdstep Technology ASA,99,0.49,partnerships,,"Birdstep Technology ASA: our leadership team with her experience from international brand, marketing, and product and service development",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Sheena Lim Appointed Chief Marketing Officer
TECH,2022-02-07,06:00:08,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2021 results
TECH,2022-02-07,06:00:08,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2021 results
TECH,2022-02-07,06:00:08,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q4 2021 results
TECH,2022-02-07,06:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2021 Results
TECH,2022-02-07,06:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its fourth quarter 2021 results on Friday 11 February 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2021 Results
TECH,2022-02-11,06:00:12,03C304,Birdstep Technology ASA,99,0.65,revenues,up,Birdstep Technology ASA: Revenue of NOK 384 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2021 results
TECH,2022-02-11,06:00:12,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: We closed 11 managed mobility services contracts,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2021 results
TECH,2022-02-11,06:00:12,03C304,Birdstep Technology ASA,99,0.47,equity-actions,,Birdstep Technology ASA: With the restructuring,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2021 results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.65,revenues,up,Birdstep Technology ASA: Revenue of NOK 384 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: We closed 11 managed mobility services contracts,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.47,equity-actions,,Birdstep Technology ASA: With the restructuring,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.65,revenues,up,Birdstep Technology ASA: Revenue of NOK 384 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.39,products-services,,Birdstep Technology ASA: We closed 11 managed mobility services contracts,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-11,06:05:29,03C304,Birdstep Technology ASA,99,0.47,equity-actions,,Birdstep Technology ASA: With the restructuring,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2021 Results
TECH,2022-02-14,10:33:06,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep Asa Acquires Remaining Shares In Techstep,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa Acquires Remaining Shares In Techstep Finance As
TECH,2022-02-14,10:33:06,03C304,Birdstep Technology ASA,100,0.62,acquisitions-mergers,,Techstep Asa Acquires Remaining Shares In Techstep,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa Acquires Remaining Shares In Techstep Finance As
TECH,2022-03-08,08:45:55,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services Agreement With Heidelbergcement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Managed Mobility Services Agreement With Heidelbergcement
TECH,2022-03-08,08:45:55,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep Signs Managed Mobility Services Agreement With Heidelbergcement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Managed Mobility Services Agreement With Heidelbergcement
TECH,2022-03-31,14:45:30,03C304,Birdstep Technology ASA,99,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2022-03-31,14:45:30,03C304,Birdstep Technology ASA,99,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2022-03-31,14:45:35,03C304,Birdstep Technology ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2022-03-31,14:45:35,03C304,Birdstep Technology ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Thursday 21 April 2022 at 16:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2022-04-04,05:05:26,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartdevice Agreement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Smartdevice Agreement For 1000 Users With Stendi
TECH,2022-04-04,05:05:26,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartdevice Agreement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Smartdevice Agreement For 1000 Users With Stendi
TECH,2022-05-05,05:00:17,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2022 results
TECH,2022-05-05,05:00:17,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q1 2022 results
TECH,2022-05-05,05:05:29,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2022 Results
TECH,2022-05-05,05:05:29,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2022 financial results on Thursday 12 May 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2022 Results
TECH,2022-05-06,05:00:12,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Cision News,Techstep ASA: Techstep acquires cybersecurity SaaS company Crypho
TECH,2022-05-06,05:00:12,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep acquires cybersecurity SaaS company Crypho
TECH,2022-05-06,05:05:28,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Acquires Cybersecurity Saas Company Crypho
TECH,2022-05-06,05:05:28,03C304,Birdstep Technology ASA,99,0.39,products-services,,"Techstep ASA (""Techstep""), has signed an agreement to",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Acquires Cybersecurity Saas Company Crypho
TECH,2022-05-12,04:30:16,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue of NOK 346.2 million,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2022 results
TECH,2022-05-12,04:30:16,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: our quarterly result,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2022 results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue of NOK 346.2 million,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: our quarterly result,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,revenues,,Birdstep Technology ASA: Revenue of NOK 346.2 million,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-05-12,05:05:26,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: our quarterly result,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2022 Results
TECH,2022-06-01,16:12:09,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep ASA - Completion of Crypho acquisition,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA - Completion of Crypho acquisition
TECH,2022-06-01,16:12:09,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep ASA - Completion of Crypho acquisition,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA - Completion of Crypho acquisition
TECH,2022-06-01,16:12:10,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep Asa - Completion Of Crypho Acquisition,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Completion Of Crypho Acquisition
TECH,2022-06-01,16:12:10,03C304,Birdstep Technology ASA,100,0.57,acquisitions-mergers,completed,Techstep Asa - Completion Of Crypho Acquisition,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Completion Of Crypho Acquisition
TECH,2022-06-15,05:30:15,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Techstep has signed an agreement with new customer, Nortel",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Signs Smartdevice Agreement With Nortel For All Their Users
TECH,2022-06-15,05:30:15,03C304,Birdstep Technology ASA,100,0.39,products-services,,"Techstep has signed an agreement with new customer, Nortel",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Signs Smartdevice Agreement With Nortel For All Their Users
TECH,2022-08-12,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2022 financial results
TECH,2022-08-12,05:00:11,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Invitation to presentation of Q2 2022 financial results
TECH,2022-08-12,05:05:24,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2022 Financial Results
TECH,2022-08-12,05:05:24,03C304,Birdstep Technology ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2022 financial results on Friday 19 August 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2022 Financial Results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.62,acquisitions-mergers,,"Birdstep Technology ASA: Birdstep Technology ASA: Over the years we have acquired and combined multiple companies, resulting in many different",PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: q2-and-h1-2022-results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,earnings,,Birdstep Technology ASA: q2-and-h1-2022-results,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:00:14,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 and H1 2022 results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.62,acquisitions-mergers,,"Birdstep Technology ASA: Birdstep Technology ASA: Over the years we have acquired and combined multiple companies, resulting in many different",PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.0,revenues,,Techstep last twelve months revenues of NOK 1.3 billion,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-08-19,05:05:24,03C304,Birdstep Technology ASA,99,0.62,acquisitions-mergers,,"Birdstep Technology ASA: Birdstep Technology ASA: Over the years we have acquired and combined multiple companies, resulting in many different",PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2022 Results
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:47:54,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Financial update and Private placement of NOK 75-125 million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:00,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: The Private Placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-28,15:48:15,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa - Financial Update And Private Placement Of Nok 75-125 Million
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.4,equity-actions,completed,Birdstep Technology ASA: The Private Placement was successfully completed,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,PRESS-RELEASE,Cision News,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: the Company raising gross proceeds,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-29,21:00:10,03C304,Birdstep Technology ASA,99,0.58,indexes,,Birdstep Technology ASA: the Company that are already listed on Oslo Brs,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: TECHSTEP ASA - Private placement of NOK 103 million successfully completed
TECH,2022-09-30,15:19:24,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2022-09-30,15:19:24,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep ASA: Notice of Extraordinary General Meeting,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Extraordinary General Meeting
TECH,2022-09-30,15:19:30,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-09-30,15:19:30,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-09-30,15:19:45,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-09-30,15:19:45,03C304,Birdstep Technology ASA,100,0.0,investor-relations,,Techstep Asa: Notice Of Extraordinary General Meeting,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Extraordinary General Meeting
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:34,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.39,products-services,,Techstep: Techstep Signs Smartcontrol Agreement,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-10-10,12:04:49,03C304,Birdstep Technology ASA,100,0.52,products-services,,Birdstep Technology ASA: The solution was successfully deployed throughout July/August,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Signs Smartcontrol Agreement For 30,000 Devices With Hungarian Central Statistical Office (Hcso)"
TECH,2022-11-02,15:14:26,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-02,15:14:26,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-02,15:14:41,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-02,15:14:41,03C304,Birdstep Technology ASA,94,0.0,earnings,,Techstep ASA will release its third quarter 2022 financial results on Wednesday 9 November 2022 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q3 2022 Financial Results
TECH,2022-11-09,06:00:11,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2022 results
TECH,2022-11-09,06:00:11,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q3 2022 results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:26,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.64,earnings,up,Birdstep Technology ASA: Improved profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-09,06:05:40,03C304,Birdstep Technology ASA,99,0.49,equity-actions,,Birdstep Technology ASA: Successfully raised NOK 103 million in private placement,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q3 2022 Results
TECH,2022-11-29,15:09:49,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Publication of prospectus and start of subscription period in the Subsequent Offering
TECH,2022-11-29,15:09:55,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2022-11-29,15:09:55,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2022-11-29,15:10:10,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2022-11-29,15:10:10,03C304,Birdstep Technology ASA,99,0.59,equity-actions,,Birdstep Technology ASA: The Prospectus,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Publication Of Prospectus And Start Of Subscription Period In The Subsequent Offering
TECH,2025-02-07,14:38:58,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its fourth quarter 2024 results on Friday 14 February 2025 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2024 Financial Results
TECH,2025-02-07,14:38:58,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its fourth quarter 2024 results on Friday 14 February 2025 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2024 Financial Results
TECH,2025-02-12,06:30:18,03C304,Techstep ASA,100,0.44,products-services,,Techstep: Techstep Enter New Markets,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Enter New Markets With Loi For Delivering Techsteps's Lifecycle Platform
TECH,2025-02-12,06:30:18,03C304,Techstep ASA,100,0.44,products-services,,Techstep: Techstep Enter New Markets,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Enter New Markets With Loi For Delivering Techsteps's Lifecycle Platform
TECH,2025-02-14,06:00:13,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 6%,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2024 results
TECH,2025-02-14,06:00:13,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q4 2024 results
TECH,2025-02-14,06:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 6%,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2024 Results
TECH,2025-02-14,06:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 6%,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2024 Results
TECH,2025-05-02,07:50:15,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2025-05-02,07:50:15,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2025-05-02,07:50:16,03C304,Techstep ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2025-05-02,07:50:16,03C304,Techstep ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2025-05-09,08:38:58,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2025 results on Friday 16 May 2025 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2025 Financial Results
TECH,2025-05-09,08:38:58,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2025 results on Friday 16 May 2025 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2025 Financial Results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 7%,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed LOI with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.49,partnerships,,Techstep ASA: Partnership with devicenow and ice progressing according to,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep has signed an agreement with,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Extend Exclusive Frame Agreement To Deliver Mobile Devices, Software And Services To The Norwegian Health Sector"
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep has signed an agreement with,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Extend Exclusive Frame Agreement To Deliver Mobile Devices, Software And Services To The Norwegian Health Sector"
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 7%,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 7%,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-08-13,12:59:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2025 results on Wednesday 20 August 2025 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2025 Financial Results
TECH,2025-08-13,12:59:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2025 results on Wednesday 20 August 2025 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2025 Financial Results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 4%,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.49,partnerships,,Techstep ASA: Signed strategic partnership agreement with Telia in April,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Extending foothold in Swedish public sector with new agreements with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 4%,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 4%,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2025-02-07,14:38:58,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its fourth quarter 2024 results on Friday 14 February 2025 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2024 Financial Results
TECH,2025-02-07,14:38:58,03C304,Techstep ASA,98,0.0,earnings,,Techstep ASA will release its fourth quarter 2024 results on Friday 14 February 2025 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q4 2024 Financial Results
TECH,2025-02-12,06:30:18,03C304,Techstep ASA,100,0.44,products-services,,Techstep: Techstep Enter New Markets,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Enter New Markets With Loi For Delivering Techsteps's Lifecycle Platform
TECH,2025-02-12,06:30:18,03C304,Techstep ASA,100,0.44,products-services,,Techstep: Techstep Enter New Markets,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Enter New Markets With Loi For Delivering Techsteps's Lifecycle Platform
TECH,2025-02-14,06:00:13,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 6%,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q4 2024 results
TECH,2025-02-14,06:00:13,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q4 2024 results
TECH,2025-02-14,06:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 6%,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q4 2024 Results
TECH,2025-02-14,06:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 6%,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q4 2024 Results
TECH,2025-05-02,07:50:15,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2025-05-02,07:50:15,03C304,Techstep ASA,95,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Notice of Annual General Meeting
TECH,2025-05-02,07:50:16,03C304,Techstep ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2025-05-02,07:50:16,03C304,Techstep ASA,94,0.0,investor-relations,,Annual general meeting of Techstep ASA will be held on Tuesday 27 May 2025 at 15:00,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Notice Of Annual General Meeting
TECH,2025-05-09,08:38:58,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2025 results on Friday 16 May 2025 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2025 Financial Results
TECH,2025-05-09,08:38:58,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its first quarter 2025 results on Friday 16 May 2025 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q1 2025 Financial Results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 7%,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Signed LOI with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:00:15,03C304,Techstep ASA,99,0.49,partnerships,,Techstep ASA: Partnership with devicenow and ice progressing according to,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q1 2025 results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep has signed an agreement with,PRESS-RELEASE,Dow Jones Newswires,"TECHSTEP: Techstep Extend Exclusive Frame Agreement To Deliver Mobile Devices, Software And Services To The Norwegian Health Sector"
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.39,products-services,,Techstep has signed an agreement with,PRESS-RELEASE,Oslo Bors News,"TECHSTEP: Techstep Extend Exclusive Frame Agreement To Deliver Mobile Devices, Software And Services To The Norwegian Health Sector"
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 7%,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-05-16,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 7%,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q1 2025 Results
TECH,2025-08-13,12:59:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2025 results on Wednesday 20 August 2025 at 07:00 CET.,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2025 Financial Results
TECH,2025-08-13,12:59:24,03C304,Techstep ASA,99,0.0,earnings,,Techstep ASA will release its second quarter 2025 results on Wednesday 20 August 2025 at 07:00 CET.,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Invitation To Presentation Of Q2 2025 Financial Results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.57,equity-actions,listing,Techstep ASA: The company is listed on the Oslo Stock Exchange,FULL-ARTICLE,Dow Jones Newswires,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 4%,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.49,partnerships,,Techstep ASA: Signed strategic partnership agreement with Telia in April,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:00:17,03C304,Techstep ASA,99,0.39,products-services,,Techstep ASA: Extending foothold in Swedish public sector with new agreements with,PRESS-RELEASE,Cision News,Techstep ASA: Techstep ASA: Q2 and H1 2025 results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 4%,PRESS-RELEASE,Oslo Bors News,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.84,earnings,positive,Techstep ASA: Improving profitability,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2025-08-20,05:05:24,03C304,Techstep ASA,99,0.41,revenues,up,Techstep ASA: Recurring revenue annualised increased by 4%,PRESS-RELEASE,Dow Jones Newswires,TECHSTEP: Techstep Asa: Q2 And H1 2025 Results
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-01-20,20:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Directors of Anoto Group resolves on a directed rights issue and calls for an extraordinary general meeting with a proposal to approve the directed rights issue
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of new board member,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-02-15,12:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Approval of directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Anoto Group AB's extraordinary general meeting on February 15, 2021"
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-19,06:30:02,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Perry join Anoto as CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Venture capitalist from Silicon Valley with MIT background new CEO of Anoto
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-27,15:15:00,2E34B2,Anoto Group AB,99,-0.6,earnings,delayed,Anoto Group AB (publ) postpones the release of its Annual Report,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB (publ) postpones the release of its Annual Report 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report 2020 and corrects for a minor change in results 2020
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-01,06:00:02,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Invitation to Annual General Meeting in Anoto Group AB (publ)
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-06-30,12:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Bulletin from Annual General Meeting in Anoto Group AB on June 30, 2021"
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-10-26,06:45:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto establishes new agreement with Deutsche Telekom worth approximately 1.4 MUSD
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,-0.57,labor-issues,,Anoto Group AB: Although I left Anoto in April,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2021-12-17,07:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and is replaced by Joonhee Won
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB appoints new CEO
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB appoints new CEO
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto announces outcome of rights issue
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto announces outcome of rights issue
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB appoints new CEO
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB appoints new CEO
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto announces outcome of rights issue
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto announces outcome of rights issue
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB appoints new CEO
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB appoints new CEO
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto announces outcome of rights issue
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto announces outcome of rights issue
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB appoints new CEO
TECH,2024-01-26,15:45:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB appoints new CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB appoints new CEO
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-09,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Board members and Chairman of the Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2024-02-28,22:40:00,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-29,16:30:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto Group AB: Press Release: Mats Karlsson appointed as interim CEO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Mats Karlsson appointed as interim CEO of Anoto Group AB (publ)
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: The Group's results for 2023,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2023 and corrects for changes in the results as reported in the year-end report
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-12,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-26,20:45:00,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Decision to resign as board member of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Erik Fllstrm has decided to resign as board member of Anoto
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-06-27,17:45:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto has reappointed Hans Haywood as Group CFO,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a convertible investment agreement raising USD 1,500,000 and resolved on reappointment of Hans Haywood as Group CFO and Pedro Pinto as Group CTO"
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Marketing Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-09-11,15:30:00,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Appointed Chief Operating Officer of Anoto Group AB,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto is pleased to report two new recruits to the executive team
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: The new management team,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.52,products-services,,Anoto will launch its new product LivePen in November of 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.0,equity-actions,,"Anoto Group AB: Selling, general and administrative expenses",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto resolves on a SEK 15 million directed issue, a SEK 50 million rights issue and a set-off issue of SEK 21 million to strengthen the company's financial position and for the implementation of the company's business plan"
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Due to the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.53,labor-issues,,Anoto Group AB: New Board Member,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -2-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-10-25,06:15:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Complete information regarding the Rights Issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 15 million -3-
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-26,10:30:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: BULLETIN FROM THE EXTRAORDINARY GENERAL MEETING IN ANOTO GROUP AB (PUBL) ON 26 NOVEMBER 2024
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2024-11-29,22:00:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: The outcome of the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-11,07:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: The prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto extends the subscription period for the ongoing rights issue until 19 December 2024
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto announces outcome of rights issue
TECH,2024-12-30,00:00:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto announces outcome of rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto announces outcome of rights issue
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto Group AB: The Prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million directed issue and a SEK 20 million rights offering in order to strengthen financial position and in preparation for a large order from a customer of KAIT
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-04-05,06:45:00,2E34B2,Anoto Group AB,100,0.46,legal,,Anoto resolves on a SEK 20 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto resolves on a SEK 20 million -2-
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-04,11:45:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 4 May 2023
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes prospectus
TECH,2023-05-11,16:15:00,2E34B2,Anoto Group AB,100,0.59,equity-actions,,Anoto publishes prospectus,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes prospectus
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-24,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1.7 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1.7 million on a sale of 1.7 million shares of Knowledge AI to improve financial stability and prolongs the subscription period in the ongoing rights issue until and including 2 June 2023
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-05-29,06:30:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto raises additional USD 1 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto raises additional USD 1 million on a sale of 1 million shares of Knowledge AI to further improve financial strength
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-01,06:00:01,2E34B2,Anoto Group AB,99,0.59,equity-actions,,Anoto Group AB: Repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-06-09,06:15:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto has raised approximately SEK 70 million through a rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group announces outcome of the rights issue of 20.5 MSEK
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.0,equity-actions,,Anoto Group AB raises SEK 15.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-07-31,11:45:00,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: The convertible issue complements the rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB raises SEK 15.6 million through a directed issue of convertibles and warrants
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-08-07,11:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Rights issue of ordinary shares,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 7 August 2023
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-09-04,06:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,06:30:01,2E34B2,Anoto Group AB,99,-0.57,labor-issues,,"Anoto Group AB: the ""Company"") CEO, Joonhee Won, will step down from",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's CEO resigns and the Board of Directors will start a search process for a new CEO
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-09,10:00:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,Anoto Group AB: Election of Chairman of the Board,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Extraordinary General Meeting in Anoto Group AB (publ) on 9 October 2023
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,-0.51,labor-issues,,Anoto's Chair of the Board Jrgen Durban resigns,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-10,06:00:01,2E34B2,Anoto Group AB,100,0.47,labor-issues,,Anoto Group AB: The Board of Directors has appointed,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto's Chair of the Board Jrgen Durban resigns
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-13,10:00:00,2E34B2,Anoto Group AB,100,0.53,labor-issues,,Anoto appoints Hans Haywood as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto appoints Hans Haywood as interim CFO
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-10-24,05:45:00,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, and Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend Extraordinary General Meeting in Anoto Group AB (publ)
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,100,-0.6,labor-issues,,Anoto terminates Hans Heywood's assignment as interim CFO,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto terminates Hans Heywood's assignment as interim CFO
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the Board of Anoto
TECH,2023-11-02,07:00:01,2E34B2,Anoto Group AB,99,-0.51,labor-issues,,Own resignation from the board of Anoto,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the Board of Anoto
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-14,20:30:00,2E34B2,Anoto Group AB,99,0.0,investor-relations,,"Anoto Group AB: major shareholders in the Company, present",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto postpones Extraordinary General Meeting
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,07:00:01,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2023-11-28,18:15:00,2E34B2,Anoto Group AB,99,0.49,partnerships,,Anoto and Deutsche Telekom have collaborated to,PRESS-RELEASE,Dow Jones Newswires,"Press Release: CORRECTION: Missing MAR label in previous press release -- ""Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom"""
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-01-18,07:00:01,2E34B2,Anoto Group AB,100,0.46,equity-actions,,Anoto Group AB: Press Release: Anoto Group carries out a directed rights issue,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group carries out a directed rights issue of 7,500,000 new ordinary shares, through which the company will raise approximately MSEK 5.9"
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-04-05,06:30:01,2E34B2,Anoto Group AB,100,0.39,products-services,,Anoto and Samsung enter into development agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto and Samsung enter into development agreement regarding Anoto-developed pen for foldable OLED screens
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-05-30,08:30:01,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-06-28,10:40:00,2E34B2,Anoto Group AB,99,0.46,legal,,Anoto Group AB: Resolution to initiate legal proceedings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bulletin from the Annual General Meeting in Anoto Group AB (publ) on 28 June 2022
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-07-26,06:40:00,2E34B2,Anoto Group AB,99,0.51,products-services,increase,Order for KAIT to grow,PRESS-RELEASE,Dow Jones Newswires,Press Release: The Board of Anoto decides to find strategic options for Knowledge AI Inc. in order to raise growth capital
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2022-10-04,06:45:01,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: With regard to the directed rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto carries out a directed rights issue and the Board of Anoto resolves to call an Extraordinary General Meeting with a proposal for approval of another directed rights issue
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Annual Report for the year ended 31 December 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,0.0,revenues,,TechFinancials Inc.: No revenues in 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Pre-tax loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,-0.51,assets,close,TechFinancials Inc.: The Company closed all of its subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,0.0,dividends,,TechFinancials Inc.: Dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: Operating Loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2023
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,0.57,equity-actions,listing,TechFinancials Inc.: The Company is currently listed solely on the Aquis Stock Exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -2-
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: An impairment loss on,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -3-
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Loss) before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -6-
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,-0.67,earnings,down,TechFinancials Inc.: Loss) multiplied,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -6-
TECH,2024-06-27,14:03:58,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -6-
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Financial Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: The operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: the Company was US$ 0.090m (H1 2023: loss of,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024 -2-
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,-0.65,dividends,suspended,TechFinancials Inc.: No dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024 -2-
TECH,2024-09-27,10:00:02,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2024 -2-
TECH,2024-12-02,15:13:26,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Notice of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Notice of AGM
TECH,2024-12-23,10:30:01,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Result of AGM
TECH,2024-01-04,12:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-04,12:05:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-10,19:30:05,85DE00,Bio-Techne Corp.,92,0.22,equity-actions,increase,Bio-Techne Corp.: Increased Investment in the Biotechnology Industry,PRESS-RELEASE,PR Newswire,"Induced Pluripotent Stem Cells Global Market Report 2023-2028 - Key Market Drivers Include Use of iPSCs in Precision Medicine, Growing R&D in iPSCs and Rising Prevalence of Chronic Diseases"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 17c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 17c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 40c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 40c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $27.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $27.5M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $272.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $272.6M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Hold From Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Hold From Buy by Stifel
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by Stifel
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,-0.62,price-targets,downgrade,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens & Co.
TECH,2024-02-05,23:38:18,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH"
TECH,2024-02-23,08:09:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)"
TECH,2024-03-06,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-06,12:05:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,NEWS-FLASH,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-11,20:05:32,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 10,400 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 10,400 Of Bio-Techne Corp >TECH"
TECH,2024-03-12,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-12,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: Rising numbers of clinical trials,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-28,13:00:14,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,13:00:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,14:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Inc. and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services
TECH,2024-04-01,11:00:05,85DE00,Bio-Techne Corp.,99,0.4,products-services,,"Bio-Techne's Spatial Biology Division, was named winner of ""The Innovation Award",PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
TECH,2024-04-03,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-03,11:05:54,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-05,20:54:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Deutsche Bank
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,-0.48,price-targets,downgrade,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank
TECH,2024-04-23,11:00:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-23,11:02:37,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:05:33,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific>TECH
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:06:49,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director on the Company's Bd of Directors >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 31c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -3-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 48c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 48c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $49.1M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $49.1M >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $303.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $303.4M >TECH
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,14:21:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: the company reported third-quarter earnings per share,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Shares Rise 20% After 3Q EPS, Sales Beats"
TECH,2024-05-01,17:52:36,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: The company reported adjusted earnings for its third quarter,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here's Why. -- Barrons.com
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.61,products-services,increase,"Demand for Exosome Diagnostics, Therapeutics and Research Tools: Global Markets expected to grow",PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: Which application type market is growing,PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-07,11:21:53,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-08,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-08,11:13:38,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-14,20:12:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-16,20:19:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 4,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Buy by Citigroup
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $85.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $85.00/Share by Citigroup
TECH,2024-05-23,07:07:22,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)"
TECH,2024-05-23,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-23,11:06:10,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-24,15:14:00,85DE00,Bio-Techne Corp.,99,0.22,equity-actions,increase,Bio-Techne Corp.: Increasing Investment in Biomedical Research,PRESS-RELEASE,Business Wire,"Exosome Diagnostics, Therapeutics and Research Tools Global Market Research 2024-2028: Commercial Opportunities and Trends, Patent Analysis and Sustainability Trends, Competitive Landscape - ResearchAndMarkets.com"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,98,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,97,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Business Wire,"Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-31,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-05-31,11:03:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-07-10,20:36:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-25,20:32:21,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 10,718 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 10,718 Of Bio-Techne Corp >TECH"
TECH,2024-07-29,11:00:04,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:00:05,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:03:40,85DE00,Bio-Techne Corp.,100,0.22,acquisitions-mergers,,Bio-Techne To Invest in Spear Bio >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Invest in Spear Bio >TECH
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-08-02,20:23:32,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH"
TECH,2024-08-06,20:25:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 16,924 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 16,924 Of Bio-Techne Corp >TECH"
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 25c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 25c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 49c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 49c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $40.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $40.6M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $306.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $306.1M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -5-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2024-08-08,12:11:18,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-08-08,12:11:19,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird
TECH,2024-08-08,20:02:08,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-08-08,20:15:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-12,20:09:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-19,21:28:54,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Bohnen Acquires 34 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Bohnen Acquires 34 Of Bio-Techne Corp >TECH
TECH,2024-08-23,07:05:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)"
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-09-03,20:10:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH"
TECH,2024-09-13,21:30:05,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: The Exosome diagnostics market is also growing,PRESS-RELEASE,PR Newswire,Exosome Therapeutics Market to Grow by USD 234.7 -2-
TECH,2024-09-16,11:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,11:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,14:41:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing Deals,PRESS-RELEASE,Business Wire,The Global Exosome Market 2024: Two Exosome-based -2-
TECH,2024-09-16,20:19:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH"
TECH,2024-09-18,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-18,11:07:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-10-09,12:00:19,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces ""The Simple Way to Advance Protein Research"" Virtual Event Series"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 21c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 21c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 42c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $33.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $33.6M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $289.5M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $289.5M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.62,price-targets,upgrade,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank
TECH,2024-11-05,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,21:34:28,85DE00,Bio-Techne Corp.,98,0.0,labor-issues,,Bio-Techne Corp.: the Company's 2020 Equity Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Bio-Techne Files 8K - Director, Officer or Compensation Filing >TECH"
TECH,2024-11-05,21:52:17,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,684 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,684 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:52:53,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:53:22,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH"
TECH,2024-11-06,12:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-06,12:05:41,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-11,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-14,12:20:59,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:02:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Announces Strategic Partnership With ALZpath to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Strategic Partnership With ALZpath to Accelerate Breakthroughs in Neurodegenerative Disease Research and Treatment >TECH
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-23,08:04:19,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,PR Newswire,"Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-12-10,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-10,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:04:21,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-01-04,12:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-04,12:05:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-10,19:30:05,85DE00,Bio-Techne Corp.,92,0.22,equity-actions,increase,Bio-Techne Corp.: Increased Investment in the Biotechnology Industry,PRESS-RELEASE,PR Newswire,"Induced Pluripotent Stem Cells Global Market Report 2023-2028 - Key Market Drivers Include Use of iPSCs in Precision Medicine, Growing R&D in iPSCs and Rising Prevalence of Chronic Diseases"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 17c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 17c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 40c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 40c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $27.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $27.5M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $272.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $272.6M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Hold From Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Hold From Buy by Stifel
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by Stifel
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,-0.62,price-targets,downgrade,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens & Co.
TECH,2024-02-05,23:38:18,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH"
TECH,2024-02-23,08:09:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)"
TECH,2024-03-06,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-06,12:05:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,NEWS-FLASH,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-11,20:05:32,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 10,400 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 10,400 Of Bio-Techne Corp >TECH"
TECH,2024-03-12,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-12,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: Rising numbers of clinical trials,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-28,13:00:14,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,13:00:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,14:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Inc. and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services
TECH,2024-04-01,11:00:05,85DE00,Bio-Techne Corp.,99,0.4,products-services,,"Bio-Techne's Spatial Biology Division, was named winner of ""The Innovation Award",PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
TECH,2024-04-03,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-03,11:05:54,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-05,20:54:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Deutsche Bank
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,-0.48,price-targets,downgrade,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank
TECH,2024-04-23,11:00:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-23,11:02:37,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:05:33,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific>TECH
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:06:49,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director on the Company's Bd of Directors >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 31c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -3-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 48c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 48c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $49.1M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $49.1M >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $303.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $303.4M >TECH
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,14:21:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: the company reported third-quarter earnings per share,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Shares Rise 20% After 3Q EPS, Sales Beats"
TECH,2024-05-01,17:52:36,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: The company reported adjusted earnings for its third quarter,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here's Why. -- Barrons.com
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.61,products-services,increase,"Demand for Exosome Diagnostics, Therapeutics and Research Tools: Global Markets expected to grow",PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: Which application type market is growing,PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-07,11:21:53,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-08,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-08,11:13:38,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-14,20:12:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-16,20:19:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 4,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Buy by Citigroup
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $85.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $85.00/Share by Citigroup
TECH,2024-05-23,07:07:22,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)"
TECH,2024-05-23,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-23,11:06:10,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-24,15:14:00,85DE00,Bio-Techne Corp.,99,0.22,equity-actions,increase,Bio-Techne Corp.: Increasing Investment in Biomedical Research,PRESS-RELEASE,Business Wire,"Exosome Diagnostics, Therapeutics and Research Tools Global Market Research 2024-2028: Commercial Opportunities and Trends, Patent Analysis and Sustainability Trends, Competitive Landscape - ResearchAndMarkets.com"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,98,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,97,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Business Wire,"Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-31,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-05-31,11:03:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-07-10,20:36:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-25,20:32:21,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 10,718 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 10,718 Of Bio-Techne Corp >TECH"
TECH,2024-07-29,11:00:04,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:00:05,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:03:40,85DE00,Bio-Techne Corp.,100,0.22,acquisitions-mergers,,Bio-Techne To Invest in Spear Bio >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Invest in Spear Bio >TECH
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-08-02,20:23:32,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH"
TECH,2024-08-06,20:25:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 16,924 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 16,924 Of Bio-Techne Corp >TECH"
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 25c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 25c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 49c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 49c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $40.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $40.6M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $306.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $306.1M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -5-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2024-08-08,12:11:18,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-08-08,12:11:19,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird
TECH,2024-08-08,20:02:08,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-08-08,20:15:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-12,20:09:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-19,21:28:54,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Bohnen Acquires 34 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Bohnen Acquires 34 Of Bio-Techne Corp >TECH
TECH,2024-08-23,07:05:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)"
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-09-03,20:10:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH"
TECH,2024-09-13,21:30:05,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: The Exosome diagnostics market is also growing,PRESS-RELEASE,PR Newswire,Exosome Therapeutics Market to Grow by USD 234.7 -2-
TECH,2024-09-16,11:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,11:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,14:41:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing Deals,PRESS-RELEASE,Business Wire,The Global Exosome Market 2024: Two Exosome-based -2-
TECH,2024-09-16,20:19:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH"
TECH,2024-09-18,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-18,11:07:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-10-09,12:00:19,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces ""The Simple Way to Advance Protein Research"" Virtual Event Series"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 21c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 21c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 42c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $33.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $33.6M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $289.5M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $289.5M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.62,price-targets,upgrade,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank
TECH,2024-11-05,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,21:34:28,85DE00,Bio-Techne Corp.,98,0.0,labor-issues,,Bio-Techne Corp.: the Company's 2020 Equity Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Bio-Techne Files 8K - Director, Officer or Compensation Filing >TECH"
TECH,2024-11-05,21:52:17,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,684 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,684 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:52:53,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:53:22,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH"
TECH,2024-11-06,12:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-06,12:05:41,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-11,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-14,12:20:59,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:02:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Announces Strategic Partnership With ALZpath to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Strategic Partnership With ALZpath to Accelerate Breakthroughs in Neurodegenerative Disease Research and Treatment >TECH
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-23,08:04:19,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,PR Newswire,"Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-12-10,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-10,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:04:21,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-01-04,12:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-04,12:05:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-10,19:30:05,85DE00,Bio-Techne Corp.,92,0.22,equity-actions,increase,Bio-Techne Corp.: Increased Investment in the Biotechnology Industry,PRESS-RELEASE,PR Newswire,"Induced Pluripotent Stem Cells Global Market Report 2023-2028 - Key Market Drivers Include Use of iPSCs in Precision Medicine, Growing R&D in iPSCs and Rising Prevalence of Chronic Diseases"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 17c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 17c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 40c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 40c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $27.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $27.5M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $272.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $272.6M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Hold From Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Hold From Buy by Stifel
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by Stifel
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,-0.62,price-targets,downgrade,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens & Co.
TECH,2024-02-05,23:38:18,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH"
TECH,2024-02-23,08:09:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)"
TECH,2024-03-06,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-06,12:05:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,NEWS-FLASH,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-11,20:05:32,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 10,400 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 10,400 Of Bio-Techne Corp >TECH"
TECH,2024-03-12,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-12,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: Rising numbers of clinical trials,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-28,13:00:14,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,13:00:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,14:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Inc. and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services
TECH,2024-04-01,11:00:05,85DE00,Bio-Techne Corp.,99,0.4,products-services,,"Bio-Techne's Spatial Biology Division, was named winner of ""The Innovation Award",PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
TECH,2024-04-03,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-03,11:05:54,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-05,20:54:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Deutsche Bank
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,-0.48,price-targets,downgrade,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank
TECH,2024-04-23,11:00:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-23,11:02:37,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:05:33,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific>TECH
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:06:49,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director on the Company's Bd of Directors >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 31c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -3-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 48c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 48c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $49.1M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $49.1M >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $303.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $303.4M >TECH
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,14:21:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: the company reported third-quarter earnings per share,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Shares Rise 20% After 3Q EPS, Sales Beats"
TECH,2024-05-01,17:52:36,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: The company reported adjusted earnings for its third quarter,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here's Why. -- Barrons.com
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.61,products-services,increase,"Demand for Exosome Diagnostics, Therapeutics and Research Tools: Global Markets expected to grow",PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: Which application type market is growing,PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-07,11:21:53,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-08,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-08,11:13:38,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-14,20:12:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-16,20:19:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 4,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Buy by Citigroup
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $85.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $85.00/Share by Citigroup
TECH,2024-05-23,07:07:22,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)"
TECH,2024-05-23,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-23,11:06:10,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-24,15:14:00,85DE00,Bio-Techne Corp.,99,0.22,equity-actions,increase,Bio-Techne Corp.: Increasing Investment in Biomedical Research,PRESS-RELEASE,Business Wire,"Exosome Diagnostics, Therapeutics and Research Tools Global Market Research 2024-2028: Commercial Opportunities and Trends, Patent Analysis and Sustainability Trends, Competitive Landscape - ResearchAndMarkets.com"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,98,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,97,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Business Wire,"Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-31,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-05-31,11:03:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-07-10,20:36:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-25,20:32:21,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 10,718 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 10,718 Of Bio-Techne Corp >TECH"
TECH,2024-07-29,11:00:04,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:00:05,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:03:40,85DE00,Bio-Techne Corp.,100,0.22,acquisitions-mergers,,Bio-Techne To Invest in Spear Bio >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Invest in Spear Bio >TECH
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-08-02,20:23:32,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH"
TECH,2024-08-06,20:25:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 16,924 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 16,924 Of Bio-Techne Corp >TECH"
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 25c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 25c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 49c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 49c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $40.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $40.6M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $306.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $306.1M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -5-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2024-08-08,12:11:18,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-08-08,12:11:19,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird
TECH,2024-08-08,20:02:08,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-08-08,20:15:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-12,20:09:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-19,21:28:54,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Bohnen Acquires 34 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Bohnen Acquires 34 Of Bio-Techne Corp >TECH
TECH,2024-08-23,07:05:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)"
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-09-03,20:10:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH"
TECH,2024-09-13,21:30:05,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: The Exosome diagnostics market is also growing,PRESS-RELEASE,PR Newswire,Exosome Therapeutics Market to Grow by USD 234.7 -2-
TECH,2024-09-16,11:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,11:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,14:41:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing Deals,PRESS-RELEASE,Business Wire,The Global Exosome Market 2024: Two Exosome-based -2-
TECH,2024-09-16,20:19:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH"
TECH,2024-09-18,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-18,11:07:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-10-09,12:00:19,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces ""The Simple Way to Advance Protein Research"" Virtual Event Series"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 21c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 21c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 42c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $33.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $33.6M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $289.5M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $289.5M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.62,price-targets,upgrade,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank
TECH,2024-11-05,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,21:34:28,85DE00,Bio-Techne Corp.,98,0.0,labor-issues,,Bio-Techne Corp.: the Company's 2020 Equity Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Bio-Techne Files 8K - Director, Officer or Compensation Filing >TECH"
TECH,2024-11-05,21:52:17,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,684 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,684 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:52:53,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:53:22,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH"
TECH,2024-11-06,12:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-06,12:05:41,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-11,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-14,12:20:59,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:02:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Announces Strategic Partnership With ALZpath to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Strategic Partnership With ALZpath to Accelerate Breakthroughs in Neurodegenerative Disease Research and Treatment >TECH
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-23,08:04:19,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,PR Newswire,"Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-12-10,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-10,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:04:21,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-01-04,12:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-04,12:05:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-10,19:30:05,85DE00,Bio-Techne Corp.,92,0.22,equity-actions,increase,Bio-Techne Corp.: Increased Investment in the Biotechnology Industry,PRESS-RELEASE,PR Newswire,"Induced Pluripotent Stem Cells Global Market Report 2023-2028 - Key Market Drivers Include Use of iPSCs in Precision Medicine, Growing R&D in iPSCs and Rising Prevalence of Chronic Diseases"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 17c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 17c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 40c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 40c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $27.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $27.5M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $272.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $272.6M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Hold From Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Hold From Buy by Stifel
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by Stifel
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,-0.62,price-targets,downgrade,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens & Co.
TECH,2024-02-05,23:38:18,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH"
TECH,2024-02-23,08:09:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)"
TECH,2024-03-06,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-06,12:05:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,NEWS-FLASH,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-11,20:05:32,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 10,400 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 10,400 Of Bio-Techne Corp >TECH"
TECH,2024-03-12,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-12,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: Rising numbers of clinical trials,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-28,13:00:14,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,13:00:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,14:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Inc. and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services
TECH,2024-04-01,11:00:05,85DE00,Bio-Techne Corp.,99,0.4,products-services,,"Bio-Techne's Spatial Biology Division, was named winner of ""The Innovation Award",PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
TECH,2024-04-03,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-03,11:05:54,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-05,20:54:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Deutsche Bank
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,-0.48,price-targets,downgrade,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank
TECH,2024-04-23,11:00:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-23,11:02:37,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:05:33,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific>TECH
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:06:49,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director on the Company's Bd of Directors >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 31c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -3-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 48c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 48c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $49.1M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $49.1M >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $303.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $303.4M >TECH
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,14:21:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: the company reported third-quarter earnings per share,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Shares Rise 20% After 3Q EPS, Sales Beats"
TECH,2024-05-01,17:52:36,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: The company reported adjusted earnings for its third quarter,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here's Why. -- Barrons.com
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.61,products-services,increase,"Demand for Exosome Diagnostics, Therapeutics and Research Tools: Global Markets expected to grow",PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: Which application type market is growing,PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-07,11:21:53,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-08,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-08,11:13:38,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-14,20:12:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-16,20:19:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 4,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Buy by Citigroup
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $85.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $85.00/Share by Citigroup
TECH,2024-05-23,07:07:22,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)"
TECH,2024-05-23,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-23,11:06:10,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-24,15:14:00,85DE00,Bio-Techne Corp.,99,0.22,equity-actions,increase,Bio-Techne Corp.: Increasing Investment in Biomedical Research,PRESS-RELEASE,Business Wire,"Exosome Diagnostics, Therapeutics and Research Tools Global Market Research 2024-2028: Commercial Opportunities and Trends, Patent Analysis and Sustainability Trends, Competitive Landscape - ResearchAndMarkets.com"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,98,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,97,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Business Wire,"Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-31,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-05-31,11:03:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-07-10,20:36:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-25,20:32:21,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 10,718 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 10,718 Of Bio-Techne Corp >TECH"
TECH,2024-07-29,11:00:04,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:00:05,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:03:40,85DE00,Bio-Techne Corp.,100,0.22,acquisitions-mergers,,Bio-Techne To Invest in Spear Bio >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Invest in Spear Bio >TECH
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-08-02,20:23:32,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH"
TECH,2024-08-06,20:25:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 16,924 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 16,924 Of Bio-Techne Corp >TECH"
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 25c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 25c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 49c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 49c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $40.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $40.6M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $306.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $306.1M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -5-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2024-08-08,12:11:18,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-08-08,12:11:19,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird
TECH,2024-08-08,20:02:08,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-08-08,20:15:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-12,20:09:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-19,21:28:54,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Bohnen Acquires 34 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Bohnen Acquires 34 Of Bio-Techne Corp >TECH
TECH,2024-08-23,07:05:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)"
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-09-03,20:10:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH"
TECH,2024-09-13,21:30:05,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: The Exosome diagnostics market is also growing,PRESS-RELEASE,PR Newswire,Exosome Therapeutics Market to Grow by USD 234.7 -2-
TECH,2024-09-16,11:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,11:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,14:41:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing Deals,PRESS-RELEASE,Business Wire,The Global Exosome Market 2024: Two Exosome-based -2-
TECH,2024-09-16,20:19:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH"
TECH,2024-09-18,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-18,11:07:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-10-09,12:00:19,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces ""The Simple Way to Advance Protein Research"" Virtual Event Series"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 21c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 21c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 42c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $33.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $33.6M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $289.5M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $289.5M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.62,price-targets,upgrade,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank
TECH,2024-11-05,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,21:34:28,85DE00,Bio-Techne Corp.,98,0.0,labor-issues,,Bio-Techne Corp.: the Company's 2020 Equity Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Bio-Techne Files 8K - Director, Officer or Compensation Filing >TECH"
TECH,2024-11-05,21:52:17,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,684 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,684 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:52:53,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:53:22,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH"
TECH,2024-11-06,12:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-06,12:05:41,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-11,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-14,12:20:59,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:02:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Announces Strategic Partnership With ALZpath to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Strategic Partnership With ALZpath to Accelerate Breakthroughs in Neurodegenerative Disease Research and Treatment >TECH
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-23,08:04:19,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,PR Newswire,"Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-12-10,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-10,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:04:21,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-01-04,12:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-04,12:05:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-10,19:30:05,85DE00,Bio-Techne Corp.,92,0.22,equity-actions,increase,Bio-Techne Corp.: Increased Investment in the Biotechnology Industry,PRESS-RELEASE,PR Newswire,"Induced Pluripotent Stem Cells Global Market Report 2023-2028 - Key Market Drivers Include Use of iPSCs in Precision Medicine, Growing R&D in iPSCs and Rising Prevalence of Chronic Diseases"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 17c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 17c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 40c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 40c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $27.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $27.5M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $272.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $272.6M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Hold From Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Hold From Buy by Stifel
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by Stifel
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,-0.62,price-targets,downgrade,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens & Co.
TECH,2024-02-05,23:38:18,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH"
TECH,2024-02-23,08:09:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)"
TECH,2024-03-06,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-06,12:05:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,NEWS-FLASH,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-11,20:05:32,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 10,400 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 10,400 Of Bio-Techne Corp >TECH"
TECH,2024-03-12,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-12,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: Rising numbers of clinical trials,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-28,13:00:14,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,13:00:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,14:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Inc. and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services
TECH,2024-04-01,11:00:05,85DE00,Bio-Techne Corp.,99,0.4,products-services,,"Bio-Techne's Spatial Biology Division, was named winner of ""The Innovation Award",PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
TECH,2024-04-03,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-03,11:05:54,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-05,20:54:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Deutsche Bank
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,-0.48,price-targets,downgrade,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank
TECH,2024-04-23,11:00:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-23,11:02:37,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:05:33,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific>TECH
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:06:49,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director on the Company's Bd of Directors >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 31c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -3-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 48c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 48c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $49.1M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $49.1M >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $303.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $303.4M >TECH
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,14:21:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: the company reported third-quarter earnings per share,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Shares Rise 20% After 3Q EPS, Sales Beats"
TECH,2024-05-01,17:52:36,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: The company reported adjusted earnings for its third quarter,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here's Why. -- Barrons.com
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.61,products-services,increase,"Demand for Exosome Diagnostics, Therapeutics and Research Tools: Global Markets expected to grow",PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: Which application type market is growing,PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-07,11:21:53,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-08,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-08,11:13:38,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-14,20:12:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-16,20:19:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 4,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Buy by Citigroup
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $85.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $85.00/Share by Citigroup
TECH,2024-05-23,07:07:22,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)"
TECH,2024-05-23,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-23,11:06:10,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-24,15:14:00,85DE00,Bio-Techne Corp.,99,0.22,equity-actions,increase,Bio-Techne Corp.: Increasing Investment in Biomedical Research,PRESS-RELEASE,Business Wire,"Exosome Diagnostics, Therapeutics and Research Tools Global Market Research 2024-2028: Commercial Opportunities and Trends, Patent Analysis and Sustainability Trends, Competitive Landscape - ResearchAndMarkets.com"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,98,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,97,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Business Wire,"Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-31,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-05-31,11:03:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-07-10,20:36:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-25,20:32:21,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 10,718 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 10,718 Of Bio-Techne Corp >TECH"
TECH,2024-07-29,11:00:04,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:00:05,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:03:40,85DE00,Bio-Techne Corp.,100,0.22,acquisitions-mergers,,Bio-Techne To Invest in Spear Bio >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Invest in Spear Bio >TECH
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-08-02,20:23:32,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH"
TECH,2024-08-06,20:25:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 16,924 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 16,924 Of Bio-Techne Corp >TECH"
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 25c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 25c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 49c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 49c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $40.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $40.6M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $306.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $306.1M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -5-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2024-08-08,12:11:18,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-08-08,12:11:19,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird
TECH,2024-08-08,20:02:08,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-08-08,20:15:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-12,20:09:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-19,21:28:54,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Bohnen Acquires 34 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Bohnen Acquires 34 Of Bio-Techne Corp >TECH
TECH,2024-08-23,07:05:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)"
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-09-03,20:10:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH"
TECH,2024-09-13,21:30:05,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: The Exosome diagnostics market is also growing,PRESS-RELEASE,PR Newswire,Exosome Therapeutics Market to Grow by USD 234.7 -2-
TECH,2024-09-16,11:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,11:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,14:41:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing Deals,PRESS-RELEASE,Business Wire,The Global Exosome Market 2024: Two Exosome-based -2-
TECH,2024-09-16,20:19:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH"
TECH,2024-09-18,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-18,11:07:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-10-09,12:00:19,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces ""The Simple Way to Advance Protein Research"" Virtual Event Series"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 21c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 21c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 42c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $33.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $33.6M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $289.5M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $289.5M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.62,price-targets,upgrade,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank
TECH,2024-11-05,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,21:34:28,85DE00,Bio-Techne Corp.,98,0.0,labor-issues,,Bio-Techne Corp.: the Company's 2020 Equity Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Bio-Techne Files 8K - Director, Officer or Compensation Filing >TECH"
TECH,2024-11-05,21:52:17,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,684 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,684 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:52:53,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:53:22,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH"
TECH,2024-11-06,12:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-06,12:05:41,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-11,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-14,12:20:59,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:02:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Announces Strategic Partnership With ALZpath to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Strategic Partnership With ALZpath to Accelerate Breakthroughs in Neurodegenerative Disease Research and Treatment >TECH
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-23,08:04:19,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,PR Newswire,"Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-12-10,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-10,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:04:21,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-01-04,12:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-04,12:05:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne's strategic partnership with Fresenius Kabi and Wilson Wolf for integrated immune cell therapy manufacturing,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING TOOLS AT PHACILITATE ADVANCED THERAPIES WEEK 2024
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-05,12:00:04,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT"
TECH,2024-01-10,19:30:05,85DE00,Bio-Techne Corp.,92,0.22,equity-actions,increase,Bio-Techne Corp.: Increased Investment in the Biotechnology Industry,PRESS-RELEASE,PR Newswire,"Induced Pluripotent Stem Cells Global Market Report 2023-2028 - Key Market Drivers Include Use of iPSCs in Precision Medicine, Growing R&D in iPSCs and Rising Prevalence of Chronic Diseases"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:00:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-01-16,12:01:53,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO ANNOUNCE SECOND QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 17c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 17c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 40c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 40c >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $27.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $27.5M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $272.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $272.6M >TECH
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Second quarter organic revenue declined by 2%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.3,earnings,down,Bio-Techne Corp.: Adjusted EPS of $0.40 compared to $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Corp.: Appointment of Matthew F. McManus to President,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2024 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,-0.24,revenues,down,Bio-Techne Corp.: Organic revenue declined 2% compared to the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 5% for the second quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.17 $ 0.32 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,730,753 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 272,598 $ 271,581 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-01,11:30:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Hold From Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Hold From Buy by Stifel
TECH,2024-02-02,11:50:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by Stifel
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-02-02,15:35:30,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $85.00 by RBC Capital
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2024-02-02,17:41:21,85DE00,Bio-Techne Corp.,100,-0.62,price-targets,downgrade,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $87.00/Share From $92.00 by Stephens & Co.
TECH,2024-02-05,23:38:18,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Surrenders 1,111 Of Bio-Techne Corp >TECH"
TECH,2024-02-23,08:09:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2023 (TECH)"
TECH,2024-03-06,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-06,12:05:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE,NEWS-FLASH,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2024-03-11,20:05:32,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 10,400 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 10,400 Of Bio-Techne Corp >TECH"
TECH,2024-03-12,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-12,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-22,11:00:05,85DE00,Bio-Techne Corp.,100,0.57,products-services,granted,Bio-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-26,21:15:04,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: Rising numbers of clinical trials,PRESS-RELEASE,PR Newswire,"Global Exosome Market Size, Forecast, Trials and Trends Insights - Surging Number of Scientific Papers Investigating Exosomes and their Applications"
TECH,2024-03-28,13:00:14,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,13:00:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
TECH,2024-03-28,14:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Inc. and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Nikon Instruments Inc. and Bio-Techne announce partnership to expand access to innovative spatial biology services
TECH,2024-04-01,11:00:05,85DE00,Bio-Techne Corp.,99,0.4,products-services,,"Bio-Techne's Spatial Biology Division, was named winner of ""The Innovation Award",PRESS-RELEASE,PR Newswire,BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
TECH,2024-04-03,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-03,11:05:54,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
TECH,2024-04-05,20:54:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,512 Of Bio-Techne Corp >TECH"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-10,11:00:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Deutsche Bank
TECH,2024-04-18,12:21:56,85DE00,Bio-Techne Corp.,100,-0.48,price-targets,downgrade,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $82.00/Share From $85.00 by Deutsche Bank
TECH,2024-04-23,11:00:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-23,11:02:37,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:00:03,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
TECH,2024-04-29,11:05:33,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Reaches Distribution Agreement With Thermo Fisher Scientific>TECH
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:00:04,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
TECH,2024-04-30,11:06:49,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Judith Klimovsky to Serve as an Independent Director on the Company's Bd of Directors >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 31c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -2-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -3-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 -4-
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 48c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 48c >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $49.1M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $49.1M >TECH
TECH,2024-05-01,10:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $303.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $303.4M >TECH
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 3% to $303.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.48 compared to $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 1, 2024 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 10% for the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.31 $ 0.45 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,721,170 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 303,428 $ 294,146 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:14,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,10:30:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-05-01,14:21:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: the company reported third-quarter earnings per share,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Shares Rise 20% After 3Q EPS, Sales Beats"
TECH,2024-05-01,17:52:36,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: The company reported adjusted earnings for its third quarter,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Here's Why. -- Barrons.com
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-05-02,11:02:17,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $81.00/Share From $73.00 by Baird
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.61,products-services,increase,"Demand for Exosome Diagnostics, Therapeutics and Research Tools: Global Markets expected to grow",PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,09:22:03,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: Which application type market is growing,PRESS-RELEASE,PR Newswire,Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)
TECH,2024-05-07,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-07,11:21:53,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,Bio-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
TECH,2024-05-08,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-08,11:13:38,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
TECH,2024-05-14,20:12:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-16,20:19:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 4,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Buy by Citigroup
TECH,2024-05-22,12:48:31,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $85.00/Share by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $85.00/Share by Citigroup
TECH,2024-05-23,07:07:22,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2024 (TECH)"
TECH,2024-05-23,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-23,11:06:10,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
TECH,2024-05-24,15:14:00,85DE00,Bio-Techne Corp.,99,0.22,equity-actions,increase,Bio-Techne Corp.: Increasing Investment in Biomedical Research,PRESS-RELEASE,Business Wire,"Exosome Diagnostics, Therapeutics and Research Tools Global Market Research 2024-2028: Commercial Opportunities and Trends, Patent Analysis and Sustainability Trends, Competitive Landscape - ResearchAndMarkets.com"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,98,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-30,20:05:01,85DE00,Bio-Techne Corp.,97,0.58,indexes,,Bio-Techne Corp.: the company to join the S&P 500,PRESS-RELEASE,Business Wire,"Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors"
TECH,2024-05-31,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-05-31,11:03:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
TECH,2024-07-10,20:36:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 6,000 Of Bio-Techne Corp >TECH"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS"
TECH,2024-07-25,20:32:21,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 10,718 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 10,718 Of Bio-Techne Corp >TECH"
TECH,2024-07-29,11:00:04,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:00:05,85DE00,Bio-Techne Corp.,99,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO
TECH,2024-07-29,11:03:40,85DE00,Bio-Techne Corp.,100,0.22,acquisitions-mergers,,Bio-Techne To Invest in Spear Bio >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Invest in Spear Bio >TECH
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: The upcoming introduction of the Leo System,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-07-31,11:00:33,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
TECH,2024-08-02,20:23:32,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,521 Of Bio-Techne Corp >TECH"
TECH,2024-08-06,20:25:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 16,924 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 16,924 Of Bio-Techne Corp >TECH"
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 25c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 25c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -2-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -3-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 49c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 49c >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $40.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $40.6M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -4-
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $306.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $306.1M >TECH
TECH,2024-08-07,10:30:12,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 -5-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 2% to $306.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $1.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,-0.23,earnings,down,Bio-Techne Corp.: Delivered adjusted EPS of $0.49 compared to $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year adjusted EPS was $1.77,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Kelderman added, ""Our differentiated financial performance throughout fiscal 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 7, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2024 increased 2% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.65,acquisitions-mergers,,"The prior year, the acquisition of Lunaphore",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 9% for the fourth quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.26 $ 0.48 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,703,867 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 306,098 $ 301,320",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2024-08-07,10:30:13,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2024-08-08,12:11:18,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-08-08,12:11:19,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $82.00/Share From $81.00 by Baird
TECH,2024-08-08,20:02:08,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2024-08-08,20:15:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-12,20:09:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 16,000 Of Bio-Techne Corp >TECH"
TECH,2024-08-19,21:28:54,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Bohnen Acquires 34 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Bohnen Acquires 34 Of Bio-Techne Corp >TECH
TECH,2024-08-23,07:05:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2024 (TECH)"
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-08-26,11:03:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2024-09-03,20:10:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 1,492 Of Bio-Techne Corp >TECH"
TECH,2024-09-13,21:30:05,85DE00,Bio-Techne Corp.,99,0.55,products-services,gain,Bio-Techne Corp.: The Exosome diagnostics market is also growing,PRESS-RELEASE,PR Newswire,Exosome Therapeutics Market to Grow by USD 234.7 -2-
TECH,2024-09-16,11:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,11:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex(R) Manufacture of CAR-T and TCR Therapies
TECH,2024-09-16,14:41:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing Deals,PRESS-RELEASE,Business Wire,The Global Exosome Market 2024: Two Exosome-based -2-
TECH,2024-09-16,20:19:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 4,126 Of Bio-Techne Corp >TECH"
TECH,2024-09-18,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-18,11:07:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.57,equity-actions,listing,Bio-TECHNE TO PRESENT AT NEUROSCIENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-24,11:07:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Lunaphore PARTNERS WITH DISCOVERY LIFE SCIENCES TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: This new service,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-09-26,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH
TECH,2024-10-09,12:00:19,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces ""The Simple Way to Advance Protein Research"" Virtual Event Series"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS"
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 21c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 21c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 42c >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $33.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $33.6M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $289.5M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $289.5M >TECH
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -2-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -3-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 -4-
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $289.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 30, 2024",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 14% for the first quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.21 $ 0.32,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,736,017 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 289,458 $ 276,935",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-30,10:30:16,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2024-10-31,12:01:36,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $84.00/Share From $82.00 by Baird
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2024-10-31,19:26:47,85DE00,Bio-Techne Corp.,100,0.62,price-targets,upgrade,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $88.00/Share From $83.00 by Scotiabank
TECH,2024-11-05,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: LUNAPHORE COMET(TM) PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH
TECH,2024-11-05,21:34:28,85DE00,Bio-Techne Corp.,98,0.0,labor-issues,,Bio-Techne Corp.: the Company's 2020 Equity Incentive Plan,RNS-SEC8K,Dow Jones Newswires,"Bio-Techne Files 8K - Director, Officer or Compensation Filing >TECH"
TECH,2024-11-05,21:52:17,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,684 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,684 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:52:53,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 6,642 Of Bio-Techne Corp >TECH"
TECH,2024-11-05,21:53:22,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Surrenders 2,430 Of Bio-Techne Corp >TECH"
TECH,2024-11-06,12:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-06,12:05:41,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-08,12:19:55,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
TECH,2024-11-11,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,PR Newswire,UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-11,22:47:57,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne, in partnership with Wilson Wolf, is creating products such as media",PRESS-RELEASE,Dow Jones Newswires,Press Release: UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS
TECH,2024-11-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-14,12:20:59,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
TECH,2024-11-18,12:02:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Announces Strategic Partnership With ALZpath to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Strategic Partnership With ALZpath to Accelerate Breakthroughs in Neurodegenerative Disease Research and Treatment >TECH
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-20,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES
TECH,2024-11-23,08:04:19,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2024 (TECH)"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,PR Newswire,"Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-25,14:02:03,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,"Bio-Techne Corp.: BelHealth Investment Partners, based in Fort Lauderdale",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne"
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-11-27,12:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
TECH,2024-12-10,12:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-10,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne Corp.: Bio-Techne Corp.: Partnering with global brands, the company provides high-quality solutions in",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY
TECH,2024-12-12,12:04:21,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Announces Distribution Agreement With Medsantek in Turkey
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-19,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2024-12-20,12:03:32,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,0.0,revenues,,TechFinancials Inc.: Revenues of US$1.3 million,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,0.59,earnings,positive,TechFinancials Inc.: Pre-tax profit,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,0.61,earnings,positive,TechFinancials Inc.: Basic earnings per share ('EPS') US$0.01,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,0.22,acquisitions-mergers,,TechFinancials Inc.: the Company purchased additional shares of Cedex from a third party for a total,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,-0.43,products-services,terminated,TechFinancials Inc.: the Company terminated all its agreements with the Company's,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,0.0,dividends,,TechFinancials Inc.: Dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,0.61,earnings,positive,"TechFinancials Inc.: Gross profit 1,222",PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Operating Income,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and AGM Update
TECH,2021-07-30,10:05:06,72B305,TechFinancials Inc.,95,-0.65,earnings,negative,TechFinancials Inc.: Profit (Loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report & Accounts and -2-
TECH,2021-09-28,14:00:00,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2021
TECH,2021-09-28,14:00:00,72B305,TechFinancials Inc.,99,0.61,earnings,positive,TechFinancials Inc.: Gross profit - 535,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2021
TECH,2021-09-28,14:00:00,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: The operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2021
TECH,2021-09-28,14:00:00,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: the Company was US$0.10m (H1 2020: loss of,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2021
TECH,2021-09-28,14:00:00,72B305,TechFinancials Inc.,99,-0.67,earnings,down,TechFinancials Inc.: Gain (Loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June 2021
TECH,2021-09-28,14:00:00,72B305,TechFinancials Inc.,97,0.0,dividends,,TechFinancials Inc.: No dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June -3-
TECH,2021-09-28,14:00:00,72B305,TechFinancials Inc.,97,0.0,earnings,,TechFinancials Inc.: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report to 30 June -3-
TECH,2021-10-04,13:53:02,72B305,TechFinancials Inc.,99,-0.44,assets,sale,TechFinancials Inc.: Sale of subsidiary,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Sale of Subsidiary
TECH,2021-10-22,06:00:12,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Notice of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Notice of AGM
TECH,2021-11-29,14:40:50,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Result of AGM
TECH,2021-01-12,23:02:39,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-13,22:21:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-19,22:44:43,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 20,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-20,21:44:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 20,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-22,08:25:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)"
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.15,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.15 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -2-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -3-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.62,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.62 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $46.3M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $46.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $224.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $224.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2021-02-02,19:58:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-02-03,12:27:15,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Craig-Hallum
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup
TECH,2021-02-09,22:26:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 32,933 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 32,933 Of Bio-Techne Corp >TECH"
TECH,2021-02-09,23:33:13,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 823 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 823 Of Bio-Techne Corp >TECH
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,21:27:14,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 6,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 6,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-10,22:53:49,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,21:11:35,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-16,21:32:52,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:49:28,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 10,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:52:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-18,21:41:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH"
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Hold by Stifel
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $435.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $435.00/Share by Stifel
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,PR Newswire,Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:01:18,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics Sign License Agreement,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne's TcBuster for the Development of Luminary's CAR-T Cell Therapies
TECH,2021-02-23,12:35:18,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to buy from hold at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to buy from hold at Stifel Nicolaus
TECH,2021-03-01,12:00:03,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Laboratory Announces Reimbursement Contract With Humana,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,PR Newswire,Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne To Acquire Asuragen >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Acquire Asuragen >TECH
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:58,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne to Acquire Asuragen For Initial Consideration of $215, Plus Contingent Considerations"
TECH,2021-03-03,22:12:29,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen For,NEWS-FLASH,Dow Jones Newswires,"Correct: Bio-Techne to Acquire Asuragen For Initial Consideration of $215M, Plus Contingent Considerations"
TECH,2021-03-03,22:15:38,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne Corp. on Wednesday said it agreed to acquire Asuragen Inc.,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. Agrees to Acquire Asuragen
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Equal-Weight by Stephens & Co.
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens & Co.
TECH,2021-03-26,11:00:05,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-03-26,11:02:49,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,PR Newswire,"Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH"
TECH,2021-04-06,20:01:02,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:09:38,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Asuragen for $215 M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-13,10:21:13,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne stock price target raised to $460 from $410,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $460 from $410 at Benchmark
TECH,2021-04-22,07:32:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)"
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:03:26,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne, 908 Devices to Collaborate on",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne, 908 Devices to Collaborate on Extended Workflow Solution for Protein Characterization >TECH"
TECH,2021-05-04,11:05:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,NEWS-FLASH,Dow Jones Newswires,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,21:08:41,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -3-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.12,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.12 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $1.79,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $1.79 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $45.8M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $45.8M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $243.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $243.6M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -3-
TECH,2021-05-09,18:14:55,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,PR Newswire,Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:04:56,85DE00,Bio-Techne Corp.,100,0.41,products-services,start,Bio-Techne: Plans to Conduct Diagnostic Clinical Trials,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Plans to Conduct Diagnostic Clinical Trials in India, With the Aim of Filing for Regulatory Approval Using Ella as a Diagnostic Device for Ophthalmic Applications >TECH"
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-26,21:17:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH
TECH,2021-05-27,20:27:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH"
TECH,2021-05-27,20:28:46,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 845 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 845 Of Bio-Techne Corp >TECH
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,PR Newswire,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,19:36:03,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 9,942 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-09,20:49:39,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,942 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-11,21:01:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 811 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 811 Of Bio-Techne Corp >TECH
TECH,2021-06-15,19:30:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 19,979 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 19,979 Of Bio-Techne Corp >TECH"
TECH,2021-06-16,23:24:06,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 7,481 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 7,481 Of Bio-Techne Corp >TECH"
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Argus Research
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research
TECH,2021-06-21,20:38:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 12,498 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 12,498 Of Bio-Techne Corp >TECH"
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Of collaborating with Bio-Techne to,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:04:42,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio: Expanded Collaboration for,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Catamaran Bio: Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-28,11:03:15,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening of New Ireland Facility,NEWS-FLASH,Dow Jones Newswires,Bio-techne Announces Opening of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,PR Newswire,Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.64,price-targets,upgrade,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,18:08:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-14,20:58:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-20,10:54:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing deals,PRESS-RELEASE,Business Wire,"Exosome Technologies Market Research Report 2021 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2031 - ResearchAndMarkets.com"
TECH,2021-07-22,07:39:02,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)"
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -3-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 37c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 37c >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $1.87,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $1.87 >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $15M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $15M >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $259M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $259M >TECH
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-07,16:12:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-08-10,18:11:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 697 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,VP Furlow Acquires 697 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:22:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:23:33,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:24:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH"
TECH,2021-08-13,20:04:52,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Ceo Kummeth Acquires 921 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CEO Kummeth Acquires 921 Of Bio-Techne Corp >TECH
TECH,2021-08-23,20:17:26,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 3,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 3,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,18:32:30,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,21:23:23,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne to Join S&P 500,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Join S&P 500 >TECH
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,PR Newswire,"Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:12:39,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Corp. to Join S&P 500 Aug. 30,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. to Join S&P 500 Aug. 30
TECH,2021-08-25,20:43:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-25,21:14:01,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:05:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 5,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:41:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,20:51:00,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 5,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,20:51:10,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 1,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:03:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:17:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 6,871 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,20:59:50,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 6,871 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:01:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:02:04,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH"
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-09,20:28:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Steer Sells 8,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Steer Sells 8,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Sector Weight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Sector Weight by Keybanc
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $600.00/Share by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $600.00/Share by Keybanc
TECH,2021-09-15,10:17:26,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital
TECH,2021-09-24,20:32:45,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 822 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 822 Of Bio-Techne Corp >TECH
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-22,07:53:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)"
TECH,2021-10-29,15:21:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-11-01,20:38:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Cfo Hippel Sells 762 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CFO Hippel Sells 762 Of Bio-Techne Corp >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $1.69,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $1.69 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.83 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $69.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $69.6M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $257.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $257.7M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:32:31,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2021-11-02,18:56:59,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call Transcript >TECH
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,21:31:18,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,022 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,022 Of Bio-Techne Corp >TECH"
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-16,00:45:38,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-16,21:53:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 27,159 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,20:38:46,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH"
TECH,2021-11-24,01:03:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 500 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 500 Of Bio-Techne Corp >TECH
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:04:02,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:05:24,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne: William a. Geist Has Been Appointed Pres,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: William a. Geist Has Been Appointed Pres, Protein Sciences Segment >TECH"
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-01-12,23:02:39,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-13,22:21:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-19,22:44:43,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 20,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-20,21:44:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 20,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-22,08:25:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)"
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.15,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.15 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -2-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -3-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.62,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.62 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $46.3M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $46.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $224.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $224.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2021-02-02,19:58:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-02-03,12:27:15,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Craig-Hallum
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup
TECH,2021-02-09,22:26:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 32,933 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 32,933 Of Bio-Techne Corp >TECH"
TECH,2021-02-09,23:33:13,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 823 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 823 Of Bio-Techne Corp >TECH
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,21:27:14,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 6,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 6,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-10,22:53:49,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,21:11:35,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-16,21:32:52,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:49:28,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 10,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:52:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-18,21:41:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH"
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Hold by Stifel
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $435.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $435.00/Share by Stifel
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,PR Newswire,Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:01:18,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics Sign License Agreement,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne's TcBuster for the Development of Luminary's CAR-T Cell Therapies
TECH,2021-02-23,12:35:18,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to buy from hold at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to buy from hold at Stifel Nicolaus
TECH,2021-03-01,12:00:03,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Laboratory Announces Reimbursement Contract With Humana,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,PR Newswire,Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne To Acquire Asuragen >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Acquire Asuragen >TECH
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:58,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne to Acquire Asuragen For Initial Consideration of $215, Plus Contingent Considerations"
TECH,2021-03-03,22:12:29,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen For,NEWS-FLASH,Dow Jones Newswires,"Correct: Bio-Techne to Acquire Asuragen For Initial Consideration of $215M, Plus Contingent Considerations"
TECH,2021-03-03,22:15:38,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne Corp. on Wednesday said it agreed to acquire Asuragen Inc.,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. Agrees to Acquire Asuragen
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Equal-Weight by Stephens & Co.
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens & Co.
TECH,2021-03-26,11:00:05,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-03-26,11:02:49,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,PR Newswire,"Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH"
TECH,2021-04-06,20:01:02,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:09:38,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Asuragen for $215 M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-13,10:21:13,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne stock price target raised to $460 from $410,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $460 from $410 at Benchmark
TECH,2021-04-22,07:32:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)"
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:03:26,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne, 908 Devices to Collaborate on",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne, 908 Devices to Collaborate on Extended Workflow Solution for Protein Characterization >TECH"
TECH,2021-05-04,11:05:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,NEWS-FLASH,Dow Jones Newswires,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,21:08:41,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -3-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.12,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.12 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $1.79,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $1.79 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $45.8M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $45.8M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $243.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $243.6M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -3-
TECH,2021-05-09,18:14:55,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,PR Newswire,Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:04:56,85DE00,Bio-Techne Corp.,100,0.41,products-services,start,Bio-Techne: Plans to Conduct Diagnostic Clinical Trials,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Plans to Conduct Diagnostic Clinical Trials in India, With the Aim of Filing for Regulatory Approval Using Ella as a Diagnostic Device for Ophthalmic Applications >TECH"
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-26,21:17:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH
TECH,2021-05-27,20:27:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH"
TECH,2021-05-27,20:28:46,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 845 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 845 Of Bio-Techne Corp >TECH
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,PR Newswire,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,19:36:03,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 9,942 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-09,20:49:39,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,942 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-11,21:01:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 811 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 811 Of Bio-Techne Corp >TECH
TECH,2021-06-15,19:30:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 19,979 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 19,979 Of Bio-Techne Corp >TECH"
TECH,2021-06-16,23:24:06,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 7,481 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 7,481 Of Bio-Techne Corp >TECH"
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Argus Research
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research
TECH,2021-06-21,20:38:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 12,498 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 12,498 Of Bio-Techne Corp >TECH"
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Of collaborating with Bio-Techne to,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:04:42,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio: Expanded Collaboration for,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Catamaran Bio: Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-28,11:03:15,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening of New Ireland Facility,NEWS-FLASH,Dow Jones Newswires,Bio-techne Announces Opening of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,PR Newswire,Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.64,price-targets,upgrade,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,18:08:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-14,20:58:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-20,10:54:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing deals,PRESS-RELEASE,Business Wire,"Exosome Technologies Market Research Report 2021 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2031 - ResearchAndMarkets.com"
TECH,2021-07-22,07:39:02,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)"
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -3-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 37c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 37c >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $1.87,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $1.87 >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $15M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $15M >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $259M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $259M >TECH
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-07,16:12:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-08-10,18:11:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 697 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,VP Furlow Acquires 697 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:22:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:23:33,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:24:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH"
TECH,2021-08-13,20:04:52,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Ceo Kummeth Acquires 921 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CEO Kummeth Acquires 921 Of Bio-Techne Corp >TECH
TECH,2021-08-23,20:17:26,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 3,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 3,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,18:32:30,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,21:23:23,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne to Join S&P 500,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Join S&P 500 >TECH
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,PR Newswire,"Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:12:39,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Corp. to Join S&P 500 Aug. 30,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. to Join S&P 500 Aug. 30
TECH,2021-08-25,20:43:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-25,21:14:01,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:05:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 5,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:41:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,20:51:00,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 5,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,20:51:10,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 1,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:03:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:17:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 6,871 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,20:59:50,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 6,871 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:01:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:02:04,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH"
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-09,20:28:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Steer Sells 8,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Steer Sells 8,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Sector Weight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Sector Weight by Keybanc
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $600.00/Share by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $600.00/Share by Keybanc
TECH,2021-09-15,10:17:26,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital
TECH,2021-09-24,20:32:45,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 822 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 822 Of Bio-Techne Corp >TECH
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-22,07:53:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)"
TECH,2021-10-29,15:21:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-11-01,20:38:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Cfo Hippel Sells 762 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CFO Hippel Sells 762 Of Bio-Techne Corp >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $1.69,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $1.69 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.83 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $69.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $69.6M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $257.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $257.7M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:32:31,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2021-11-02,18:56:59,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call Transcript >TECH
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,21:31:18,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,022 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,022 Of Bio-Techne Corp >TECH"
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-16,00:45:38,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-16,21:53:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 27,159 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,20:38:46,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH"
TECH,2021-11-24,01:03:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 500 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 500 Of Bio-Techne Corp >TECH
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:04:02,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:05:24,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne: William a. Geist Has Been Appointed Pres,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: William a. Geist Has Been Appointed Pres, Protein Sciences Segment >TECH"
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-01-12,23:02:39,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-13,22:21:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-19,22:44:43,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 20,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-20,21:44:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 20,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-22,08:25:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)"
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.15,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.15 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -2-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -3-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.62,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.62 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $46.3M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $46.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $224.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $224.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2021-02-02,19:58:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-02-03,12:27:15,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Craig-Hallum
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup
TECH,2021-02-09,22:26:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 32,933 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 32,933 Of Bio-Techne Corp >TECH"
TECH,2021-02-09,23:33:13,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 823 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 823 Of Bio-Techne Corp >TECH
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,21:27:14,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 6,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 6,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-10,22:53:49,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,21:11:35,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-16,21:32:52,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:49:28,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 10,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:52:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-18,21:41:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH"
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Hold by Stifel
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $435.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $435.00/Share by Stifel
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,PR Newswire,Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:01:18,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics Sign License Agreement,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne's TcBuster for the Development of Luminary's CAR-T Cell Therapies
TECH,2021-02-23,12:35:18,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to buy from hold at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to buy from hold at Stifel Nicolaus
TECH,2021-03-01,12:00:03,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Laboratory Announces Reimbursement Contract With Humana,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,PR Newswire,Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne To Acquire Asuragen >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Acquire Asuragen >TECH
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:58,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne to Acquire Asuragen For Initial Consideration of $215, Plus Contingent Considerations"
TECH,2021-03-03,22:12:29,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen For,NEWS-FLASH,Dow Jones Newswires,"Correct: Bio-Techne to Acquire Asuragen For Initial Consideration of $215M, Plus Contingent Considerations"
TECH,2021-03-03,22:15:38,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne Corp. on Wednesday said it agreed to acquire Asuragen Inc.,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. Agrees to Acquire Asuragen
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Equal-Weight by Stephens & Co.
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens & Co.
TECH,2021-03-26,11:00:05,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-03-26,11:02:49,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,PR Newswire,"Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH"
TECH,2021-04-06,20:01:02,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:09:38,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Asuragen for $215 M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-13,10:21:13,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne stock price target raised to $460 from $410,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $460 from $410 at Benchmark
TECH,2021-04-22,07:32:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)"
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:03:26,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne, 908 Devices to Collaborate on",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne, 908 Devices to Collaborate on Extended Workflow Solution for Protein Characterization >TECH"
TECH,2021-05-04,11:05:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,NEWS-FLASH,Dow Jones Newswires,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,21:08:41,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -3-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.12,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.12 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $1.79,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $1.79 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $45.8M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $45.8M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $243.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $243.6M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -3-
TECH,2021-05-09,18:14:55,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,PR Newswire,Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:04:56,85DE00,Bio-Techne Corp.,100,0.41,products-services,start,Bio-Techne: Plans to Conduct Diagnostic Clinical Trials,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Plans to Conduct Diagnostic Clinical Trials in India, With the Aim of Filing for Regulatory Approval Using Ella as a Diagnostic Device for Ophthalmic Applications >TECH"
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-26,21:17:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH
TECH,2021-05-27,20:27:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH"
TECH,2021-05-27,20:28:46,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 845 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 845 Of Bio-Techne Corp >TECH
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,PR Newswire,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,19:36:03,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 9,942 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-09,20:49:39,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,942 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-11,21:01:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 811 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 811 Of Bio-Techne Corp >TECH
TECH,2021-06-15,19:30:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 19,979 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 19,979 Of Bio-Techne Corp >TECH"
TECH,2021-06-16,23:24:06,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 7,481 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 7,481 Of Bio-Techne Corp >TECH"
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Argus Research
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research
TECH,2021-06-21,20:38:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 12,498 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 12,498 Of Bio-Techne Corp >TECH"
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Of collaborating with Bio-Techne to,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:04:42,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio: Expanded Collaboration for,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Catamaran Bio: Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-28,11:03:15,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening of New Ireland Facility,NEWS-FLASH,Dow Jones Newswires,Bio-techne Announces Opening of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,PR Newswire,Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.64,price-targets,upgrade,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,18:08:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-14,20:58:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-20,10:54:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing deals,PRESS-RELEASE,Business Wire,"Exosome Technologies Market Research Report 2021 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2031 - ResearchAndMarkets.com"
TECH,2021-07-22,07:39:02,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)"
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -3-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 37c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 37c >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $1.87,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $1.87 >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $15M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $15M >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $259M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $259M >TECH
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-07,16:12:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-08-10,18:11:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 697 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,VP Furlow Acquires 697 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:22:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:23:33,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:24:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH"
TECH,2021-08-13,20:04:52,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Ceo Kummeth Acquires 921 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CEO Kummeth Acquires 921 Of Bio-Techne Corp >TECH
TECH,2021-08-23,20:17:26,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 3,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 3,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,18:32:30,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,21:23:23,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne to Join S&P 500,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Join S&P 500 >TECH
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,PR Newswire,"Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:12:39,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Corp. to Join S&P 500 Aug. 30,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. to Join S&P 500 Aug. 30
TECH,2021-08-25,20:43:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-25,21:14:01,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:05:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 5,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:41:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,20:51:00,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 5,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,20:51:10,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 1,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:03:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:17:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 6,871 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,20:59:50,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 6,871 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:01:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:02:04,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH"
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-09,20:28:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Steer Sells 8,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Steer Sells 8,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Sector Weight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Sector Weight by Keybanc
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $600.00/Share by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $600.00/Share by Keybanc
TECH,2021-09-15,10:17:26,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital
TECH,2021-09-24,20:32:45,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 822 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 822 Of Bio-Techne Corp >TECH
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-22,07:53:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)"
TECH,2021-10-29,15:21:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-11-01,20:38:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Cfo Hippel Sells 762 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CFO Hippel Sells 762 Of Bio-Techne Corp >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $1.69,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $1.69 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.83 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $69.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $69.6M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $257.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $257.7M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:32:31,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2021-11-02,18:56:59,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call Transcript >TECH
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,21:31:18,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,022 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,022 Of Bio-Techne Corp >TECH"
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-16,00:45:38,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-16,21:53:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 27,159 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,20:38:46,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH"
TECH,2021-11-24,01:03:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 500 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 500 Of Bio-Techne Corp >TECH
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:04:02,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:05:24,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne: William a. Geist Has Been Appointed Pres,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: William a. Geist Has Been Appointed Pres, Protein Sciences Segment >TECH"
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-01-12,23:02:39,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-13,22:21:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-19,22:44:43,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 20,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-20,21:44:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 20,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-22,08:25:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)"
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.15,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.15 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -2-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -3-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.62,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.62 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $46.3M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $46.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $224.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $224.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2021-02-02,19:58:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-02-03,12:27:15,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Craig-Hallum
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup
TECH,2021-02-09,22:26:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 32,933 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 32,933 Of Bio-Techne Corp >TECH"
TECH,2021-02-09,23:33:13,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 823 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 823 Of Bio-Techne Corp >TECH
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,21:27:14,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 6,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 6,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-10,22:53:49,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,21:11:35,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-16,21:32:52,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:49:28,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 10,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:52:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-18,21:41:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH"
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Hold by Stifel
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $435.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $435.00/Share by Stifel
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,PR Newswire,Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:01:18,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics Sign License Agreement,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne's TcBuster for the Development of Luminary's CAR-T Cell Therapies
TECH,2021-02-23,12:35:18,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to buy from hold at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to buy from hold at Stifel Nicolaus
TECH,2021-03-01,12:00:03,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Laboratory Announces Reimbursement Contract With Humana,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,PR Newswire,Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne To Acquire Asuragen >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Acquire Asuragen >TECH
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:58,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne to Acquire Asuragen For Initial Consideration of $215, Plus Contingent Considerations"
TECH,2021-03-03,22:12:29,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen For,NEWS-FLASH,Dow Jones Newswires,"Correct: Bio-Techne to Acquire Asuragen For Initial Consideration of $215M, Plus Contingent Considerations"
TECH,2021-03-03,22:15:38,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne Corp. on Wednesday said it agreed to acquire Asuragen Inc.,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. Agrees to Acquire Asuragen
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Equal-Weight by Stephens & Co.
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens & Co.
TECH,2021-03-26,11:00:05,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-03-26,11:02:49,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,PR Newswire,"Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH"
TECH,2021-04-06,20:01:02,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:09:38,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Asuragen for $215 M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-13,10:21:13,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne stock price target raised to $460 from $410,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $460 from $410 at Benchmark
TECH,2021-04-22,07:32:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)"
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:03:26,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne, 908 Devices to Collaborate on",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne, 908 Devices to Collaborate on Extended Workflow Solution for Protein Characterization >TECH"
TECH,2021-05-04,11:05:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,NEWS-FLASH,Dow Jones Newswires,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,21:08:41,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -3-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.12,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.12 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $1.79,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $1.79 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $45.8M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $45.8M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $243.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $243.6M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -3-
TECH,2021-05-09,18:14:55,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,PR Newswire,Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:04:56,85DE00,Bio-Techne Corp.,100,0.41,products-services,start,Bio-Techne: Plans to Conduct Diagnostic Clinical Trials,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Plans to Conduct Diagnostic Clinical Trials in India, With the Aim of Filing for Regulatory Approval Using Ella as a Diagnostic Device for Ophthalmic Applications >TECH"
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-26,21:17:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH
TECH,2021-05-27,20:27:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH"
TECH,2021-05-27,20:28:46,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 845 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 845 Of Bio-Techne Corp >TECH
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,PR Newswire,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,19:36:03,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 9,942 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-09,20:49:39,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,942 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-11,21:01:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 811 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 811 Of Bio-Techne Corp >TECH
TECH,2021-06-15,19:30:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 19,979 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 19,979 Of Bio-Techne Corp >TECH"
TECH,2021-06-16,23:24:06,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 7,481 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 7,481 Of Bio-Techne Corp >TECH"
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Argus Research
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research
TECH,2021-06-21,20:38:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 12,498 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 12,498 Of Bio-Techne Corp >TECH"
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Of collaborating with Bio-Techne to,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:04:42,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio: Expanded Collaboration for,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Catamaran Bio: Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-28,11:03:15,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening of New Ireland Facility,NEWS-FLASH,Dow Jones Newswires,Bio-techne Announces Opening of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,PR Newswire,Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.64,price-targets,upgrade,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,18:08:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-14,20:58:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-20,10:54:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing deals,PRESS-RELEASE,Business Wire,"Exosome Technologies Market Research Report 2021 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2031 - ResearchAndMarkets.com"
TECH,2021-07-22,07:39:02,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)"
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -3-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 37c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 37c >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $1.87,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $1.87 >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $15M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $15M >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $259M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $259M >TECH
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-07,16:12:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-08-10,18:11:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 697 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,VP Furlow Acquires 697 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:22:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:23:33,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:24:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH"
TECH,2021-08-13,20:04:52,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Ceo Kummeth Acquires 921 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CEO Kummeth Acquires 921 Of Bio-Techne Corp >TECH
TECH,2021-08-23,20:17:26,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 3,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 3,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,18:32:30,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,21:23:23,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne to Join S&P 500,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Join S&P 500 >TECH
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,PR Newswire,"Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:12:39,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Corp. to Join S&P 500 Aug. 30,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. to Join S&P 500 Aug. 30
TECH,2021-08-25,20:43:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-25,21:14:01,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:05:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 5,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:41:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,20:51:00,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 5,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,20:51:10,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 1,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:03:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:17:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 6,871 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,20:59:50,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 6,871 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:01:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:02:04,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH"
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-09,20:28:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Steer Sells 8,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Steer Sells 8,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Sector Weight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Sector Weight by Keybanc
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $600.00/Share by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $600.00/Share by Keybanc
TECH,2021-09-15,10:17:26,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital
TECH,2021-09-24,20:32:45,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 822 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 822 Of Bio-Techne Corp >TECH
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-22,07:53:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)"
TECH,2021-10-29,15:21:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-11-01,20:38:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Cfo Hippel Sells 762 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CFO Hippel Sells 762 Of Bio-Techne Corp >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $1.69,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $1.69 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.83 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $69.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $69.6M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $257.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $257.7M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:32:31,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2021-11-02,18:56:59,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call Transcript >TECH
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,21:31:18,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,022 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,022 Of Bio-Techne Corp >TECH"
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-16,00:45:38,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-16,21:53:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 27,159 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,20:38:46,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH"
TECH,2021-11-24,01:03:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 500 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 500 Of Bio-Techne Corp >TECH
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:04:02,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:05:24,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne: William a. Geist Has Been Appointed Pres,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: William a. Geist Has Been Appointed Pres, Protein Sciences Segment >TECH"
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-01-12,23:02:39,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-13,22:21:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-19,22:44:43,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 20,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-20,21:44:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 20,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-22,08:25:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)"
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.15,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.15 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -2-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -3-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.62,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.62 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $46.3M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $46.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $224.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $224.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2021-02-02,19:58:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-02-03,12:27:15,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Craig-Hallum
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup
TECH,2021-02-09,22:26:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 32,933 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 32,933 Of Bio-Techne Corp >TECH"
TECH,2021-02-09,23:33:13,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 823 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 823 Of Bio-Techne Corp >TECH
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,21:27:14,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 6,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 6,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-10,22:53:49,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,21:11:35,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-16,21:32:52,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:49:28,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 10,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:52:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-18,21:41:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH"
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Hold by Stifel
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $435.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $435.00/Share by Stifel
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,PR Newswire,Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:01:18,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics Sign License Agreement,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne's TcBuster for the Development of Luminary's CAR-T Cell Therapies
TECH,2021-02-23,12:35:18,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to buy from hold at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to buy from hold at Stifel Nicolaus
TECH,2021-03-01,12:00:03,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Laboratory Announces Reimbursement Contract With Humana,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,PR Newswire,Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne To Acquire Asuragen >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Acquire Asuragen >TECH
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:58,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne to Acquire Asuragen For Initial Consideration of $215, Plus Contingent Considerations"
TECH,2021-03-03,22:12:29,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen For,NEWS-FLASH,Dow Jones Newswires,"Correct: Bio-Techne to Acquire Asuragen For Initial Consideration of $215M, Plus Contingent Considerations"
TECH,2021-03-03,22:15:38,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne Corp. on Wednesday said it agreed to acquire Asuragen Inc.,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. Agrees to Acquire Asuragen
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Equal-Weight by Stephens & Co.
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens & Co.
TECH,2021-03-26,11:00:05,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-03-26,11:02:49,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,PR Newswire,"Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH"
TECH,2021-04-06,20:01:02,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:09:38,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Asuragen for $215 M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-13,10:21:13,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne stock price target raised to $460 from $410,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $460 from $410 at Benchmark
TECH,2021-04-22,07:32:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)"
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:03:26,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne, 908 Devices to Collaborate on",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne, 908 Devices to Collaborate on Extended Workflow Solution for Protein Characterization >TECH"
TECH,2021-05-04,11:05:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,NEWS-FLASH,Dow Jones Newswires,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,21:08:41,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -3-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.12,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.12 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $1.79,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $1.79 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $45.8M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $45.8M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $243.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $243.6M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -3-
TECH,2021-05-09,18:14:55,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,PR Newswire,Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:04:56,85DE00,Bio-Techne Corp.,100,0.41,products-services,start,Bio-Techne: Plans to Conduct Diagnostic Clinical Trials,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Plans to Conduct Diagnostic Clinical Trials in India, With the Aim of Filing for Regulatory Approval Using Ella as a Diagnostic Device for Ophthalmic Applications >TECH"
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-26,21:17:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH
TECH,2021-05-27,20:27:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH"
TECH,2021-05-27,20:28:46,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 845 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 845 Of Bio-Techne Corp >TECH
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,PR Newswire,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,19:36:03,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 9,942 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-09,20:49:39,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,942 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-11,21:01:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 811 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 811 Of Bio-Techne Corp >TECH
TECH,2021-06-15,19:30:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 19,979 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 19,979 Of Bio-Techne Corp >TECH"
TECH,2021-06-16,23:24:06,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 7,481 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 7,481 Of Bio-Techne Corp >TECH"
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Argus Research
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research
TECH,2021-06-21,20:38:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 12,498 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 12,498 Of Bio-Techne Corp >TECH"
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Of collaborating with Bio-Techne to,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:04:42,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio: Expanded Collaboration for,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Catamaran Bio: Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-28,11:03:15,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening of New Ireland Facility,NEWS-FLASH,Dow Jones Newswires,Bio-techne Announces Opening of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,PR Newswire,Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.64,price-targets,upgrade,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,18:08:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-14,20:58:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-20,10:54:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing deals,PRESS-RELEASE,Business Wire,"Exosome Technologies Market Research Report 2021 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2031 - ResearchAndMarkets.com"
TECH,2021-07-22,07:39:02,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)"
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -3-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 37c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 37c >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $1.87,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $1.87 >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $15M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $15M >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $259M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $259M >TECH
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-07,16:12:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-08-10,18:11:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 697 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,VP Furlow Acquires 697 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:22:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:23:33,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:24:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH"
TECH,2021-08-13,20:04:52,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Ceo Kummeth Acquires 921 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CEO Kummeth Acquires 921 Of Bio-Techne Corp >TECH
TECH,2021-08-23,20:17:26,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 3,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 3,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,18:32:30,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,21:23:23,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne to Join S&P 500,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Join S&P 500 >TECH
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,PR Newswire,"Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:12:39,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Corp. to Join S&P 500 Aug. 30,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. to Join S&P 500 Aug. 30
TECH,2021-08-25,20:43:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-25,21:14:01,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:05:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 5,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:41:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,20:51:00,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 5,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,20:51:10,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 1,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:03:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:17:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 6,871 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,20:59:50,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 6,871 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:01:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:02:04,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH"
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-09,20:28:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Steer Sells 8,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Steer Sells 8,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Sector Weight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Sector Weight by Keybanc
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $600.00/Share by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $600.00/Share by Keybanc
TECH,2021-09-15,10:17:26,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital
TECH,2021-09-24,20:32:45,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 822 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 822 Of Bio-Techne Corp >TECH
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-22,07:53:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)"
TECH,2021-10-29,15:21:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-11-01,20:38:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Cfo Hippel Sells 762 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CFO Hippel Sells 762 Of Bio-Techne Corp >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $1.69,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $1.69 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.83 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $69.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $69.6M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $257.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $257.7M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:32:31,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2021-11-02,18:56:59,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call Transcript >TECH
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,21:31:18,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,022 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,022 Of Bio-Techne Corp >TECH"
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-16,00:45:38,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-16,21:53:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 27,159 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,20:38:46,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH"
TECH,2021-11-24,01:03:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 500 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 500 Of Bio-Techne Corp >TECH
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:04:02,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:05:24,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne: William a. Geist Has Been Appointed Pres,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: William a. Geist Has Been Appointed Pres, Protein Sciences Segment >TECH"
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-01-12,23:02:39,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-13,22:21:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On February 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-14,12:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second Quarter 2021 Financial Results"
TECH,2021-01-19,22:44:43,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 20,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-20,21:44:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 20,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 20,000 Of Bio-Techne Corp >TECH"
TECH,2021-01-22,08:25:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2020 (TECH)"
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-01-28,12:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Be partnering with Bio-Techne at,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Strategic Investment In Eminence
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.15,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.15 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -2-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2021 -3-
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.62,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.62 >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $46.3M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $46.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $224.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $224.3M >TECH
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the second quarter ended December 31, 2020",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 21% to $224.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.7%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.62,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.44,products-services,,Bio-Techne Corp.: Our expanded digital platform,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: GAAP EPS decreased to $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.52,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2021 increased 37.9% to $51.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2021 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2021 Results
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2021-02-02,11:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2021-02-02,19:58:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Charles Kummeth on Q2 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-02-03,12:27:15,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $400 from $310 at Stifel Nicolaus
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Craig-Hallum
TECH,2021-02-03,17:00:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $440.00/Share From $352.00 by Craig-Hallum
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2021-02-03,18:40:57,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $400.00/Share From $310.00 by Citigroup
TECH,2021-02-09,22:26:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 32,933 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 32,933 Of Bio-Techne Corp >TECH"
TECH,2021-02-09,23:33:13,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 823 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 823 Of Bio-Techne Corp >TECH
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,12:00:22,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference
TECH,2021-02-10,21:27:14,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 6,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 6,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-10,22:53:49,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 823 Of Bio-Techne Corp >TECH
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:00:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,12:01:39,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT Virtual Conference"
TECH,2021-02-16,21:11:35,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-16,21:32:52,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:49:28,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 10,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-17,21:52:58,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-02-18,21:41:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 12,572 Of Bio-Techne Corp >TECH"
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Hold by Stifel
TECH,2021-02-23,11:11:45,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $435.00/Share by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $435.00/Share by Stifel
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,PR Newswire,Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics sign license agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Luminary Therapeutics sign license agreement for use of Bio-Techne's TcBuster(TM) for the development of Luminary's CAR-T cell therapies
TECH,2021-02-23,12:01:18,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne and Luminary Therapeutics Sign License Agreement,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Luminary Therapeutics Sign License Agreement for Use of Bio-Techne's TcBuster for the Development of Luminary's CAR-T Cell Therapies
TECH,2021-02-23,12:35:18,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to buy from hold at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to buy from hold at Stifel Nicolaus
TECH,2021-03-01,12:00:03,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Laboratory Announces Reimbursement Contract With Humana,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Barclays Global Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-02,12:56:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Barclays Global Healthcare Conference
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,PR Newswire,Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne To Acquire Asuragen >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne To Acquire Asuragen >TECH
TECH,2021-03-03,21:45:03,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Acquire Asuragen
TECH,2021-03-03,21:45:58,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne to Acquire Asuragen For Initial Consideration of $215, Plus Contingent Considerations"
TECH,2021-03-03,22:12:29,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne to Acquire Asuragen For,NEWS-FLASH,Dow Jones Newswires,"Correct: Bio-Techne to Acquire Asuragen For Initial Consideration of $215M, Plus Contingent Considerations"
TECH,2021-03-03,22:15:38,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-Techne Corp. on Wednesday said it agreed to acquire Asuragen Inc.,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. Agrees to Acquire Asuragen
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Equal-Weight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Equal-Weight by Stephens & Co.
TECH,2021-03-08,15:02:47,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $425.00/Share From $380.00 by Stephens & Co.
TECH,2021-03-26,11:00:05,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-03-26,11:02:49,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne also partnered with Kantaro Biosciences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On May 6, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results"
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,PR Newswire,"Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:01:01,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Completes Acquisition Of Asuragen, Inc. >TECH"
TECH,2021-04-06,20:01:02,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corporation (NASDAQ: TECH) today announced it has completed the acquisition of Asuragen, Inc.",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Completes Acquisition of Asuragen, Inc."
TECH,2021-04-06,20:09:38,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Asuragen for $215 M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Asuragen for $215 M in Cash Plus Up to $105 M Upon Reaching Milestones >TECH
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-08,11:00:17,85DE00,Bio-Techne Corp.,99,0.44,products-services,,Bio-Techne Corp.: This latest addition to the Simple Western product family,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Release of Abby Automated Western System for Simple Western and Introduces Stellar Modules for Jess
TECH,2021-04-13,10:21:13,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne stock price target raised to $460 from $410,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target raised to $460 from $410 at Benchmark
TECH,2021-04-22,07:32:12,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2021 (TECH)"
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: 908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and 908 Devices Announce Joint Collaboration,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:00:17,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and 908 Devices Announce Joint Collaboration
TECH,2021-05-04,11:03:26,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,"Bio-Techne, 908 Devices to Collaborate on",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne, 908 Devices to Collaborate on Extended Workflow Solution for Protein Characterization >TECH"
TECH,2021-05-04,11:05:58,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,908 Devices and Bio-Techne Announce Joint Collaboration,NEWS-FLASH,Dow Jones Newswires,908 Devices and Bio-Techne Announce Joint Collaboration
TECH,2021-05-04,21:08:41,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 811 Of Bio-Techne Corp >TECH
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Third Quarter Fiscal 2021 -3-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.12,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.12 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $1.79,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $1.79 >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $45.8M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $45.8M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $243.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $243.6M >TECH
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Third Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 25% to $243.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.12 versus $0.92,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 40.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.51,products-services,increase,Bio-Techne Corp.: increasing demand for our portfolio of life science tools,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.56,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2021 increased 43.6% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.79,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 6, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter Fiscal 2021 Results
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -2-
TECH,2021-05-06,10:30:08,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Third Quarter -3-
TECH,2021-05-09,18:14:55,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,PR Newswire,Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: This collaboration with Narayana Nethralaya potentially expands Ella's capabilities as a,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for Ophthalmic Disorder Diagnostic Applications
TECH,2021-05-18,11:04:56,85DE00,Bio-Techne Corp.,100,0.41,products-services,start,Bio-Techne: Plans to Conduct Diagnostic Clinical Trials,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Plans to Conduct Diagnostic Clinical Trials in India, With the Aim of Filing for Regulatory Approval Using Ella as a Diagnostic Device for Ophthalmic Applications >TECH"
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Jefferies Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Jefferies Virtual Healthcare Conference
TECH,2021-05-26,21:17:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,Officer Kelderman Registers 845 Of Bio-Techne Corp >TECH
TECH,2021-05-27,20:27:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 15,544 Of Bio-Techne Corp >TECH"
TECH,2021-05-27,20:28:46,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 845 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 845 Of Bio-Techne Corp >TECH
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,PR Newswire,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology Consortium
TECH,2021-06-08,19:36:03,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 9,942 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-09,20:49:39,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,942 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,942 Of Bio-Techne Corp >TECH"
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-10,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy Manufacturing Capabilities
TECH,2021-06-11,21:01:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 811 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 811 Of Bio-Techne Corp >TECH
TECH,2021-06-15,19:30:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 19,979 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 19,979 Of Bio-Techne Corp >TECH"
TECH,2021-06-16,23:24:06,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 7,481 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 7,481 Of Bio-Techne Corp >TECH"
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Argus Research
TECH,2021-06-18,12:18:03,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $490.00/Share From $440.00 by Argus Research
TECH,2021-06-21,20:38:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 12,498 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Sells 12,498 Of Bio-Techne Corp >TECH"
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Of collaborating with Bio-Techne to,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Business Wire,Catamaran Bio and Bio-Techne Announce Expanded Collaboration for CAR--NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio Announce Expanded Collaboration for,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-24,11:04:42,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Catamaran Bio: Expanded Collaboration for,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Catamaran Bio: Expanded Collaboration for CAR-NK Cell Manufacturing Technologies
TECH,2021-06-28,11:03:15,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening of New Ireland Facility,NEWS-FLASH,Dow Jones Newswires,Bio-techne Announces Opening of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,PR Newswire,Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-28,11:00:10,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-techne Announces Opening Of New Ireland Facility,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-techne Announces Opening Of New Ireland Facility
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2021-06-29,10:46:44,85DE00,Bio-Techne Corp.,100,0.64,price-targets,upgrade,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $480.00/Share From $450.00 by SVB Leerink
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On August 5, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter 2021 Financial Results"
TECH,2021-07-13,18:08:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-14,20:58:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-07-20,10:54:00,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corp.: Licensing deals,PRESS-RELEASE,Business Wire,"Exosome Technologies Market Research Report 2021 - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2031 - ResearchAndMarkets.com"
TECH,2021-07-22,07:39:02,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2021 (TECH)"
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-07-28,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,PR Newswire,Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-03,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $739 million in net sales in fiscal 2020,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces 2021 Investor Day and Webcast
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -2-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2021 -3-
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 37c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 37c >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $1.87,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $1.87 >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $15M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $15M >TECH
TECH,2021-08-05,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $259M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $259M >TECH
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2021 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.52,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 47% to $259.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $3.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.87,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.6,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $6.75 vs $4.55 in the prior year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,revenues,up,Bio-Techne Corp.: Adjusted Operating Margin increased to 38.5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.72,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2021 increased 74.5% to $68.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.44,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2021 increased 26% to $931.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.62,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2021 increased 51% to $237.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2021 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2021 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 5th, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2021 Results
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-05,10:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-08-07,16:12:43,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2021 Results -- Earnings Call Transcript >TECH
TECH,2021-08-10,18:11:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Acquires 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:21:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 697 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,VP Furlow Acquires 697 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:22:39,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Acquires 822 Of Bio-Techne Corp >TECH
TECH,2021-08-10,22:23:33,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-10,22:24:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 4,443 Of Bio-Techne Corp >TECH"
TECH,2021-08-13,20:04:52,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Ceo Kummeth Acquires 921 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CEO Kummeth Acquires 921 Of Bio-Techne Corp >TECH
TECH,2021-08-23,20:17:26,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 3,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 3,538 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,18:32:30,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-24,21:23:23,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne to Join S&P 500,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Join S&P 500 >TECH
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,PR Newswire,"Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:03:57,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Set to Join S&P 500,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600"
TECH,2021-08-24,22:12:39,85DE00,Bio-Techne Corp.,100,0.58,indexes,,Bio-Techne Corp. to Join S&P 500 Aug. 30,FULL-ARTICLE,Dow Jones Newswires,Bio-Techne Corp. to Join S&P 500 Aug. 30
TECH,2021-08-25,20:43:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Chmn Baumgartner Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-08-25,21:14:01,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 4,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Nusse Sells 4,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:05:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 5,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-01,20:41:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 1,638 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference
TECH,2021-09-02,20:51:00,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 5,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 5,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-02,20:51:10,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 1,538 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 1,538 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:03:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-03,18:17:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 6,871 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,20:59:50,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 6,871 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"VP Furlow Sells 6,871 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:01:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 10,000 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-07,21:02:04,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 31,487 Of Bio-Techne Corp >TECH"
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-08,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis
TECH,2021-09-09,20:28:05,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Steer Sells 8,000 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Steer Sells 8,000 Of Bio-Techne Corp >TECH"
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Overweight From Sector Weight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Overweight From Sector Weight by Keybanc
TECH,2021-09-15,08:40:06,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $600.00/Share by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $600.00/Share by Keybanc
TECH,2021-09-15,10:17:26,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne upgraded to overweight from sector weight at KeyBanc Capital
TECH,2021-09-24,20:32:45,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 822 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 822 Of Bio-Techne Corp >TECH
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne To Host Conference Call On November 2, 2021",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-11,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne To Host Conference Call On November 2, 2021 To Announce First Quarter 2022 Financial Results"
TECH,2021-10-22,07:53:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2021 (TECH)"
TECH,2021-10-29,15:21:31,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Cfo Hippel Registers 10,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CFO Hippel Registers 10,000 Of Bio-Techne Corp >TECH"
TECH,2021-11-01,20:38:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Cfo Hippel Sells 762 Of Bio-Techne Corp >TECH,TABULAR-MATERIAL,Dow Jones Newswires,CFO Hippel Sells 762 Of Bio-Techne Corp >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $1.69,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $1.69 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.83,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.83 >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $69.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $69.6M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $257.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $257.7M >TECH
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -2-
TECH,2021-11-02,10:30:10,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases First Quarter Fiscal 2022 -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases First Quarter Fiscal 2022 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 26% to $257.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.82,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.69 versus $0.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP operating income for the first quarter of fiscal 2022 increased 28.8% to $63.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.83,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.46,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2022 net sales were $197.2 million, an increase of 28%",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 2, 2021 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter Fiscal 2022 Results
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER ENDED 9/30/21 9/30/20 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -2-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,98,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases First Quarter -3-
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2021-11-02,10:32:31,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2021-11-02,18:56:59,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q1 2022 Results -- Earnings Call Transcript >TECH
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,11:00:30,85DE00,Bio-Techne Corp.,99,0.46,equity-actions,,Bio-Techne invested approximately $50 million to build,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility
TECH,2021-11-03,21:31:18,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Cfo Hippel Sells 9,022 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CFO Hippel Sells 9,022 Of Bio-Techne Corp >TECH"
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,20:01:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-04,21:39:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:00:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-09,12:08:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference
TECH,2021-11-16,00:45:38,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Eansor Registers 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-16,21:53:59,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Officer Eansor Sells 27,159 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Eansor Sells 27,159 Of Bio-Techne Corp >TECH"
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-Techne Corp.: Chuck Kummeth, President and Chief Executive Officer will present at the Stephens Annual Investment Conference",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,12:03:45,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne To Present At Upcoming Investor Conferences
TECH,2021-11-22,20:38:46,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Officer Kelderman Registers 5,511 Of Bio-Techne Corp >TECH"
TECH,2021-11-24,01:03:24,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Officer Kelderman Sells 500 Of Bio-Techne Corp,TABULAR-MATERIAL,Dow Jones Newswires,Officer Kelderman Sells 500 Of Bio-Techne Corp >TECH
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:00:08,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne and Fresenius Kabi announced the formation of the ScaleReady(TM) joint venture,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT
TECH,2021-12-14,12:04:02,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Enters Into Option Agreement With Wilson Wolf Corp >TECH
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:00:06,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES SEGMENT"
TECH,2021-12-21,12:05:24,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne: William a. Geist Has Been Appointed Pres,NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: William a. Geist Has Been Appointed Pres, Protein Sciences Segment >TECH"
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2021-12-27,12:00:02,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,0.0,revenues,,TechFinancials Inc.: No Revenues in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Pre-tax loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,0.22,acquisitions-mergers,,"TechFinancials Inc.: the Company acquired shares in few transactions, of listed companies in the LSE",PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,-0.51,assets,close,TechFinancials Inc.: The Company decided to close all its subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,0.61,earnings,positive,"TechFinancials Inc.: Gross profit - 1,222",PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,0.46,equity-actions,,TechFinancials Inc.: The Company has invested in London,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Operating Income,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Profit (Loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 December 2021
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,91,0.0,equity-actions,,TechFinancials Inc.: Total comprehensive income (expense) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 -2-
TECH,2022-07-01,06:00:39,72B305,TechFinancials Inc.,91,-0.65,earnings,negative,TechFinancials Inc.: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Unaudited Results to 31 -2-
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,100,0.0,earnings,,Techfinancials Inc. Audited Results to 31 December 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 December 2021
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,100,0.0,revenues,,TechFinancials Inc.: No Revenues in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 December 2021
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,100,-0.62,earnings,negative,TechFinancials Inc.: Pre-tax loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 December 2021
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,100,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 December 2021
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,100,-0.51,assets,close,TechFinancials Inc.: The Company decided to close all its subsidiaries,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 December 2021
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,100,0.61,earnings,positive,TechFinancials Inc.: Gross profit - 584,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 December 2021
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,100,-0.63,earnings,negative,TechFinancials Inc.: Operating (Loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 December 2021
TECH,2022-07-29,15:35:18,72B305,TechFinancials Inc.,93,0.0,equity-actions,,TechFinancials Inc.: Total comprehensive income (expense) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Audited Results to 31 -2-
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2022
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Financial Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2022
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: The operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2022
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,0.0,equity-actions,,TechFinancials Inc.: Financial expenses for the period were US$ 0.089m,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2022
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: the Company was US$ 0.16m (H1 2021: loss of,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2022
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six -2-
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,0.0,dividends,,TechFinancials Inc.: No dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six -2-
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six -2-
TECH,2022-09-30,06:00:26,72B305,TechFinancials Inc.,92,-0.65,earnings,negative,TechFinancials Inc.: Loss per share - diluted,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six -3-
TECH,2022-11-14,07:00:13,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Notice of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Notice of AGM
TECH,2022-12-09,12:08:25,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Result of AGM
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:03:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow With Industry-Leading Speed and Resolution
TECH,2022-01-07,21:01:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,marketing,,Bio-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-22,09:11:57,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)"
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.94,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.94 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.88 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 -2-
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $80.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $80.2M >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $269.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $269.3M >TECH
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne to Repurchase Up to $400M of Common Stk,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Repurchase Up to $400M of Common Stk >TECH
TECH,2022-02-01,19:49:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-01,21:36:24,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH"
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.72,price-targets,upgrade,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink
TECH,2022-02-05,09:13:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-10,21:32:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH"
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-15,20:51:07,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 9,503 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 9,503 Of Bio-Techne Corp >TECH"
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:04:31,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne: In Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: In Agreement With Thermo Fisher Scientific to Exclusively Complete Development of and Commercialize the ExoTRU Kidney Transplant Rejection Test Developed by Exosome Diagnostics >TECH
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.37,equity-actions,increase,The increasing interest in exosome,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,High demand for exosome research products & services,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-23,07:04:46,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)"
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.98,analyst-ratings,negative,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.7,price-targets,downgrade,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.48,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.48 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $2.14,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $2.14 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -3-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $60.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $60.7M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $290.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $290.4M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2022-05-04,16:20:48,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc
TECH,2022-05-05,10:00:08,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-11,20:53:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-06-08,18:32:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-06-08,18:35:29,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 5,104 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:06:38,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 5,104 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:08:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 1,600 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 1,600 Of Bio-Techne Corp >TECH"
TECH,2022-06-22,15:11:00,85DE00,Bio-Techne Corp.,94,0.49,partnerships,,Bio-Techne Corp.: The collaboration with QuaCell will further reduce costs by 75%,PRESS-RELEASE,Business Wire,Global Fetal Bovine Serum Market Report 2022: Market to Surpass $1.25+ Billion in 2026 - Increase in R&D Towards Development of Novel Biopharmaceuticals - ResearchAndMarkets.com
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-08,21:20:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-23,07:22:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)"
TECH,2022-07-25,15:24:00,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Some of these factors considered for analysis are financial performance over the last 3 years,PRESS-RELEASE,Business Wire,"Global $1.24 Bn Fetal Bovine Serum Markets, 2022-2027: Untapped Potential of Emerging Markets & Increase in R&D Activities Towards the Introduction of New Biopharmaceuticals - ResearchAndMarkets.com"
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-08-01,22:12:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH"
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -4-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS $1.51 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $2.05 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $61.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $61.5M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $288.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $288.2M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,-0.52,price-targets,downgrade,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens & Co.
TECH,2022-08-07,04:01:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-08-09,22:58:37,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:01:43,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:03:10,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Furlow Acquires 1,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Acquires 1,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:04:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH"
TECH,2022-08-10,22:10:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 563 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Furlow Acquires 563 Of Bio-Techne Corp >TECH
TECH,2022-08-12,19:20:36,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-12,20:04:43,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 2,504 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Higgins Sells 2,504 Of Bio-Techne Corp >TECH"
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Underweight by Wells Fargo
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.42,price-targets,downgrade,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo
TECH,2022-08-18,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-24,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Credit Suisse
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse
TECH,2022-08-25,21:40:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-08,11:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,PR Newswire,BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-08,11:05:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-26,11:00:02,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,PR Newswire,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:01:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:03:43,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-23,07:03:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)"
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $2.21,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $2.21 >TECH
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.78,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.78 >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $89.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $89.6M >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $269.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $269.7M >TECH
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES CASH DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,-0.76,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink
TECH,2022-11-02,11:43:44,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-14,12:18:00,85DE00,Bio-Techne Corp.,91,0.0,products-services,,Bio-Techne Corp.: Development of new technologies,PRESS-RELEASE,Business Wire,Global Cell Expansion Market Report 2022: Increasing R&D Activities Fueling Growth - ResearchAndMarkets.com
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:06:19,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:06:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies Partner to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,14:59:46,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.01,analyst-ratings,neutral,Bio-Techne Initiated at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Sector Perform by RBC Capital
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital
TECH,2022-12-09,20:24:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 15,700 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 15,700 Of Bio-Techne Corp >TECH"
TECH,2022-12-09,21:03:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Vp Furlow Registers 800 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,VP Furlow Registers 800 Of Bio-Techne Corp >TECH
TECH,2022-12-09,21:49:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 8,250 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Sells 8,250 Of Bio-Techne Corp >TECH"
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by Deutsche Bank
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:03:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow With Industry-Leading Speed and Resolution
TECH,2022-01-07,21:01:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,marketing,,Bio-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-22,09:11:57,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)"
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.94,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.94 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.88 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 -2-
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $80.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $80.2M >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $269.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $269.3M >TECH
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne to Repurchase Up to $400M of Common Stk,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Repurchase Up to $400M of Common Stk >TECH
TECH,2022-02-01,19:49:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-01,21:36:24,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH"
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.72,price-targets,upgrade,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink
TECH,2022-02-05,09:13:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-10,21:32:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH"
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-15,20:51:07,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 9,503 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 9,503 Of Bio-Techne Corp >TECH"
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:04:31,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne: In Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: In Agreement With Thermo Fisher Scientific to Exclusively Complete Development of and Commercialize the ExoTRU Kidney Transplant Rejection Test Developed by Exosome Diagnostics >TECH
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.37,equity-actions,increase,The increasing interest in exosome,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,High demand for exosome research products & services,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-23,07:04:46,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)"
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.98,analyst-ratings,negative,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.7,price-targets,downgrade,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.48,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.48 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $2.14,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $2.14 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -3-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $60.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $60.7M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $290.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $290.4M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2022-05-04,16:20:48,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc
TECH,2022-05-05,10:00:08,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-11,20:53:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-06-08,18:32:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-06-08,18:35:29,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 5,104 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:06:38,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 5,104 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:08:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 1,600 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 1,600 Of Bio-Techne Corp >TECH"
TECH,2022-06-22,15:11:00,85DE00,Bio-Techne Corp.,94,0.49,partnerships,,Bio-Techne Corp.: The collaboration with QuaCell will further reduce costs by 75%,PRESS-RELEASE,Business Wire,Global Fetal Bovine Serum Market Report 2022: Market to Surpass $1.25+ Billion in 2026 - Increase in R&D Towards Development of Novel Biopharmaceuticals - ResearchAndMarkets.com
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-08,21:20:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-23,07:22:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)"
TECH,2022-07-25,15:24:00,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Some of these factors considered for analysis are financial performance over the last 3 years,PRESS-RELEASE,Business Wire,"Global $1.24 Bn Fetal Bovine Serum Markets, 2022-2027: Untapped Potential of Emerging Markets & Increase in R&D Activities Towards the Introduction of New Biopharmaceuticals - ResearchAndMarkets.com"
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-08-01,22:12:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH"
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -4-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS $1.51 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $2.05 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $61.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $61.5M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $288.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $288.2M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,-0.52,price-targets,downgrade,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens & Co.
TECH,2022-08-07,04:01:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-08-09,22:58:37,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:01:43,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:03:10,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Furlow Acquires 1,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Acquires 1,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:04:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH"
TECH,2022-08-10,22:10:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 563 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Furlow Acquires 563 Of Bio-Techne Corp >TECH
TECH,2022-08-12,19:20:36,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-12,20:04:43,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 2,504 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Higgins Sells 2,504 Of Bio-Techne Corp >TECH"
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Underweight by Wells Fargo
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.42,price-targets,downgrade,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo
TECH,2022-08-18,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-24,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Credit Suisse
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse
TECH,2022-08-25,21:40:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-08,11:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,PR Newswire,BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-08,11:05:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-26,11:00:02,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,PR Newswire,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:01:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:03:43,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-23,07:03:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)"
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $2.21,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $2.21 >TECH
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.78,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.78 >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $89.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $89.6M >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $269.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $269.7M >TECH
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES CASH DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,-0.76,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink
TECH,2022-11-02,11:43:44,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-14,12:18:00,85DE00,Bio-Techne Corp.,91,0.0,products-services,,Bio-Techne Corp.: Development of new technologies,PRESS-RELEASE,Business Wire,Global Cell Expansion Market Report 2022: Increasing R&D Activities Fueling Growth - ResearchAndMarkets.com
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:06:19,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:06:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies Partner to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,14:59:46,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.01,analyst-ratings,neutral,Bio-Techne Initiated at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Sector Perform by RBC Capital
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital
TECH,2022-12-09,20:24:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 15,700 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 15,700 Of Bio-Techne Corp >TECH"
TECH,2022-12-09,21:03:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Vp Furlow Registers 800 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,VP Furlow Registers 800 Of Bio-Techne Corp >TECH
TECH,2022-12-09,21:49:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 8,250 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Sells 8,250 Of Bio-Techne Corp >TECH"
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by Deutsche Bank
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:03:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow With Industry-Leading Speed and Resolution
TECH,2022-01-07,21:01:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,marketing,,Bio-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-22,09:11:57,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)"
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.94,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.94 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.88 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 -2-
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $80.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $80.2M >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $269.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $269.3M >TECH
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne to Repurchase Up to $400M of Common Stk,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Repurchase Up to $400M of Common Stk >TECH
TECH,2022-02-01,19:49:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-01,21:36:24,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH"
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.72,price-targets,upgrade,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink
TECH,2022-02-05,09:13:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-10,21:32:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH"
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-15,20:51:07,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 9,503 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 9,503 Of Bio-Techne Corp >TECH"
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:04:31,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne: In Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: In Agreement With Thermo Fisher Scientific to Exclusively Complete Development of and Commercialize the ExoTRU Kidney Transplant Rejection Test Developed by Exosome Diagnostics >TECH
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.37,equity-actions,increase,The increasing interest in exosome,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,High demand for exosome research products & services,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-23,07:04:46,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)"
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.98,analyst-ratings,negative,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.7,price-targets,downgrade,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.48,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.48 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $2.14,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $2.14 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -3-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $60.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $60.7M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $290.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $290.4M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2022-05-04,16:20:48,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc
TECH,2022-05-05,10:00:08,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-11,20:53:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-06-08,18:32:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-06-08,18:35:29,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 5,104 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:06:38,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 5,104 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:08:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 1,600 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 1,600 Of Bio-Techne Corp >TECH"
TECH,2022-06-22,15:11:00,85DE00,Bio-Techne Corp.,94,0.49,partnerships,,Bio-Techne Corp.: The collaboration with QuaCell will further reduce costs by 75%,PRESS-RELEASE,Business Wire,Global Fetal Bovine Serum Market Report 2022: Market to Surpass $1.25+ Billion in 2026 - Increase in R&D Towards Development of Novel Biopharmaceuticals - ResearchAndMarkets.com
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-08,21:20:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-23,07:22:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)"
TECH,2022-07-25,15:24:00,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Some of these factors considered for analysis are financial performance over the last 3 years,PRESS-RELEASE,Business Wire,"Global $1.24 Bn Fetal Bovine Serum Markets, 2022-2027: Untapped Potential of Emerging Markets & Increase in R&D Activities Towards the Introduction of New Biopharmaceuticals - ResearchAndMarkets.com"
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-08-01,22:12:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH"
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -4-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS $1.51 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $2.05 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $61.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $61.5M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $288.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $288.2M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,-0.52,price-targets,downgrade,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens & Co.
TECH,2022-08-07,04:01:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-08-09,22:58:37,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:01:43,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:03:10,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Furlow Acquires 1,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Acquires 1,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:04:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH"
TECH,2022-08-10,22:10:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 563 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Furlow Acquires 563 Of Bio-Techne Corp >TECH
TECH,2022-08-12,19:20:36,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-12,20:04:43,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 2,504 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Higgins Sells 2,504 Of Bio-Techne Corp >TECH"
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Underweight by Wells Fargo
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.42,price-targets,downgrade,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo
TECH,2022-08-18,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-24,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Credit Suisse
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse
TECH,2022-08-25,21:40:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-08,11:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,PR Newswire,BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-08,11:05:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-26,11:00:02,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,PR Newswire,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:01:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:03:43,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-23,07:03:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)"
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $2.21,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $2.21 >TECH
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.78,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.78 >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $89.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $89.6M >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $269.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $269.7M >TECH
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES CASH DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,-0.76,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink
TECH,2022-11-02,11:43:44,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-14,12:18:00,85DE00,Bio-Techne Corp.,91,0.0,products-services,,Bio-Techne Corp.: Development of new technologies,PRESS-RELEASE,Business Wire,Global Cell Expansion Market Report 2022: Increasing R&D Activities Fueling Growth - ResearchAndMarkets.com
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:06:19,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:06:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies Partner to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,14:59:46,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.01,analyst-ratings,neutral,Bio-Techne Initiated at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Sector Perform by RBC Capital
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital
TECH,2022-12-09,20:24:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 15,700 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 15,700 Of Bio-Techne Corp >TECH"
TECH,2022-12-09,21:03:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Vp Furlow Registers 800 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,VP Furlow Registers 800 Of Bio-Techne Corp >TECH
TECH,2022-12-09,21:49:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 8,250 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Sells 8,250 Of Bio-Techne Corp >TECH"
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by Deutsche Bank
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:03:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow With Industry-Leading Speed and Resolution
TECH,2022-01-07,21:01:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,marketing,,Bio-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-22,09:11:57,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)"
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.94,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.94 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.88 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 -2-
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $80.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $80.2M >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $269.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $269.3M >TECH
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne to Repurchase Up to $400M of Common Stk,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Repurchase Up to $400M of Common Stk >TECH
TECH,2022-02-01,19:49:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-01,21:36:24,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH"
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.72,price-targets,upgrade,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink
TECH,2022-02-05,09:13:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-10,21:32:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH"
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-15,20:51:07,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 9,503 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 9,503 Of Bio-Techne Corp >TECH"
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:04:31,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne: In Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: In Agreement With Thermo Fisher Scientific to Exclusively Complete Development of and Commercialize the ExoTRU Kidney Transplant Rejection Test Developed by Exosome Diagnostics >TECH
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.37,equity-actions,increase,The increasing interest in exosome,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,High demand for exosome research products & services,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-23,07:04:46,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)"
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.98,analyst-ratings,negative,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.7,price-targets,downgrade,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.48,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.48 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $2.14,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $2.14 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -3-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $60.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $60.7M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $290.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $290.4M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2022-05-04,16:20:48,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc
TECH,2022-05-05,10:00:08,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-11,20:53:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-06-08,18:32:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-06-08,18:35:29,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 5,104 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:06:38,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 5,104 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:08:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 1,600 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 1,600 Of Bio-Techne Corp >TECH"
TECH,2022-06-22,15:11:00,85DE00,Bio-Techne Corp.,94,0.49,partnerships,,Bio-Techne Corp.: The collaboration with QuaCell will further reduce costs by 75%,PRESS-RELEASE,Business Wire,Global Fetal Bovine Serum Market Report 2022: Market to Surpass $1.25+ Billion in 2026 - Increase in R&D Towards Development of Novel Biopharmaceuticals - ResearchAndMarkets.com
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-08,21:20:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-23,07:22:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)"
TECH,2022-07-25,15:24:00,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Some of these factors considered for analysis are financial performance over the last 3 years,PRESS-RELEASE,Business Wire,"Global $1.24 Bn Fetal Bovine Serum Markets, 2022-2027: Untapped Potential of Emerging Markets & Increase in R&D Activities Towards the Introduction of New Biopharmaceuticals - ResearchAndMarkets.com"
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-08-01,22:12:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH"
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -4-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS $1.51 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $2.05 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $61.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $61.5M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $288.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $288.2M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,-0.52,price-targets,downgrade,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens & Co.
TECH,2022-08-07,04:01:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-08-09,22:58:37,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:01:43,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:03:10,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Furlow Acquires 1,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Acquires 1,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:04:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH"
TECH,2022-08-10,22:10:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 563 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Furlow Acquires 563 Of Bio-Techne Corp >TECH
TECH,2022-08-12,19:20:36,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-12,20:04:43,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 2,504 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Higgins Sells 2,504 Of Bio-Techne Corp >TECH"
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Underweight by Wells Fargo
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.42,price-targets,downgrade,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo
TECH,2022-08-18,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-24,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Credit Suisse
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse
TECH,2022-08-25,21:40:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-08,11:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,PR Newswire,BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-08,11:05:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-26,11:00:02,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,PR Newswire,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:01:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:03:43,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-23,07:03:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)"
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $2.21,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $2.21 >TECH
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.78,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.78 >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $89.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $89.6M >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $269.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $269.7M >TECH
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES CASH DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,-0.76,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink
TECH,2022-11-02,11:43:44,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-14,12:18:00,85DE00,Bio-Techne Corp.,91,0.0,products-services,,Bio-Techne Corp.: Development of new technologies,PRESS-RELEASE,Business Wire,Global Cell Expansion Market Report 2022: Increasing R&D Activities Fueling Growth - ResearchAndMarkets.com
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:06:19,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:06:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies Partner to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,14:59:46,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.01,analyst-ratings,neutral,Bio-Techne Initiated at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Sector Perform by RBC Capital
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital
TECH,2022-12-09,20:24:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 15,700 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 15,700 Of Bio-Techne Corp >TECH"
TECH,2022-12-09,21:03:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Vp Furlow Registers 800 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,VP Furlow Registers 800 Of Bio-Techne Corp >TECH
TECH,2022-12-09,21:49:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 8,250 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Sells 8,250 Of Bio-Techne Corp >TECH"
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by Deutsche Bank
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:03:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow With Industry-Leading Speed and Resolution
TECH,2022-01-07,21:01:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,marketing,,Bio-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-22,09:11:57,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)"
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.94,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.94 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.88 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 -2-
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $80.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $80.2M >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $269.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $269.3M >TECH
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne to Repurchase Up to $400M of Common Stk,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Repurchase Up to $400M of Common Stk >TECH
TECH,2022-02-01,19:49:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-01,21:36:24,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH"
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.72,price-targets,upgrade,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink
TECH,2022-02-05,09:13:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-10,21:32:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH"
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-15,20:51:07,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 9,503 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 9,503 Of Bio-Techne Corp >TECH"
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:04:31,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne: In Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: In Agreement With Thermo Fisher Scientific to Exclusively Complete Development of and Commercialize the ExoTRU Kidney Transplant Rejection Test Developed by Exosome Diagnostics >TECH
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.37,equity-actions,increase,The increasing interest in exosome,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,High demand for exosome research products & services,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-23,07:04:46,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)"
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.98,analyst-ratings,negative,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.7,price-targets,downgrade,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.48,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.48 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $2.14,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $2.14 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -3-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $60.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $60.7M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $290.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $290.4M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2022-05-04,16:20:48,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc
TECH,2022-05-05,10:00:08,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-11,20:53:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-06-08,18:32:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-06-08,18:35:29,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 5,104 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:06:38,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 5,104 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:08:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 1,600 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 1,600 Of Bio-Techne Corp >TECH"
TECH,2022-06-22,15:11:00,85DE00,Bio-Techne Corp.,94,0.49,partnerships,,Bio-Techne Corp.: The collaboration with QuaCell will further reduce costs by 75%,PRESS-RELEASE,Business Wire,Global Fetal Bovine Serum Market Report 2022: Market to Surpass $1.25+ Billion in 2026 - Increase in R&D Towards Development of Novel Biopharmaceuticals - ResearchAndMarkets.com
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-08,21:20:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-23,07:22:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)"
TECH,2022-07-25,15:24:00,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Some of these factors considered for analysis are financial performance over the last 3 years,PRESS-RELEASE,Business Wire,"Global $1.24 Bn Fetal Bovine Serum Markets, 2022-2027: Untapped Potential of Emerging Markets & Increase in R&D Activities Towards the Introduction of New Biopharmaceuticals - ResearchAndMarkets.com"
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-08-01,22:12:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH"
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -4-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS $1.51 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $2.05 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $61.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $61.5M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $288.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $288.2M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,-0.52,price-targets,downgrade,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens & Co.
TECH,2022-08-07,04:01:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-08-09,22:58:37,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:01:43,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:03:10,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Furlow Acquires 1,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Acquires 1,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:04:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH"
TECH,2022-08-10,22:10:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 563 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Furlow Acquires 563 Of Bio-Techne Corp >TECH
TECH,2022-08-12,19:20:36,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-12,20:04:43,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 2,504 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Higgins Sells 2,504 Of Bio-Techne Corp >TECH"
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Underweight by Wells Fargo
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.42,price-targets,downgrade,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo
TECH,2022-08-18,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-24,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Credit Suisse
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse
TECH,2022-08-25,21:40:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-08,11:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,PR Newswire,BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-08,11:05:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-26,11:00:02,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,PR Newswire,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:01:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:03:43,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-23,07:03:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)"
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $2.21,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $2.21 >TECH
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.78,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.78 >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $89.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $89.6M >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $269.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $269.7M >TECH
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES CASH DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,-0.76,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink
TECH,2022-11-02,11:43:44,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-14,12:18:00,85DE00,Bio-Techne Corp.,91,0.0,products-services,,Bio-Techne Corp.: Development of new technologies,PRESS-RELEASE,Business Wire,Global Cell Expansion Market Report 2022: Increasing R&D Activities Fueling Growth - ResearchAndMarkets.com
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:06:19,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:06:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies Partner to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,14:59:46,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.01,analyst-ratings,neutral,Bio-Techne Initiated at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Sector Perform by RBC Capital
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital
TECH,2022-12-09,20:24:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 15,700 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 15,700 Of Bio-Techne Corp >TECH"
TECH,2022-12-09,21:03:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Vp Furlow Registers 800 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,VP Furlow Registers 800 Of Bio-Techne Corp >TECH
TECH,2022-12-09,21:49:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 8,250 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Sells 8,250 Of Bio-Techne Corp >TECH"
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by Deutsche Bank
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-03,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,GlobeNewswire,Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Akoya Biosciences and Bio-Techne Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Akoya Biosciences and Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution
TECH,2022-01-05,12:03:44,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Akoya Biosciences Partner to Deliver,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial Multiomics Workflow With Industry-Leading Speed and Resolution
TECH,2022-01-07,21:01:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,marketing,,Bio-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-07,21:01:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-17,13:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-01-22,09:11:57,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2021 (TECH)"
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:03,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS $1.94,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS $1.94 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS $1.88,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS $1.88 >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 -2-
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $80.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $80.2M >TECH
TECH,2022-02-01,11:30:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $269.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $269.3M >TECH
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2021",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 20% to $269.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.7,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.94 versus $1.15,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.94,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.42,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2022 increased 22.3% to $62.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $1.88,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 1, 2022 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2022 RESULTS
TECH,2022-02-01,11:30:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend of 32,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Declares Dividend of 32c >TECH
TECH,2022-02-01,11:31:51,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne to Repurchase Up to $400M of Common Stk,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Repurchase Up to $400M of Common Stk >TECH
TECH,2022-02-01,19:49:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-01,21:36:24,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"CEO Kummeth Acquires 1,737 Of Bio-Techne Corp >TECH"
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-02-02,10:44:34,85DE00,Bio-Techne Corp.,100,0.72,price-targets,upgrade,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $575.00/Share From $530.00 by SVB Leerink
TECH,2022-02-05,09:13:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q2 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-02-10,21:32:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH",TABULAR-MATERIAL,Dow Jones Newswires,"Officer Kelderman Acquires 1,989 Of Bio-Techne Corp >TECH"
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-11,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 11th ANNUAL SVB LEERINK GLOBAL HEALTHCARE CONFERENCE
TECH,2022-02-15,20:51:07,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 9,503 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 9,503 Of Bio-Techne Corp >TECH"
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced an agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:00:24,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,To partnering with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES EXCLUSIVE DEVELOPMENT AND LICENSE AGREEMENT WITH THERMO FISHER SCIENTIFIC FOR ExoTRU(R) KIDNEY TRANSPLANT REJECTION ASSAY
TECH,2022-02-22,12:04:31,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne: In Agreement With Thermo Fisher Scientific,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: In Agreement With Thermo Fisher Scientific to Exclusively Complete Development of and Commercialize the ExoTRU Kidney Transplant Rejection Test Developed by Exosome Diagnostics >TECH
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-22,21:01:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2022 VIRTUAL HEALTHCARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-02-28,12:07:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 42ND ANNUAL HEALTH CARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-09,12:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-03-17,11:06:46,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.37,equity-actions,increase,The increasing interest in exosome,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-05,12:30:13,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,High demand for exosome research products & services,PRESS-RELEASE,PR Newswire,Exosome Research Market worth $661 million by 2026 - Exclusive Report by MarketsandMarkets(TM)
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-12,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE AND CYGNUS TECHNOLOGIES, PART OF MARAVAI LIFESCIENCES, INTRODUCE NEW SIMPLE PLEX HEK 293 HCP 3G IMMUNOASSAY"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-13,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-04-23,07:04:46,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2022 (TECH)"
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.98,analyst-ratings,negative,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Underweight From Equal-Weight by Wells Fargo
TECH,2022-04-25,11:15:27,85DE00,Bio-Techne Corp.,100,-0.7,price-targets,downgrade,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $370.00/Share From $400.00 by Wells Fargo
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-02,11:06:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS $1.48,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS $1.48 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS $2.14,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS $2.14 >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 -3-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $60.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $60.7M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $290.4M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $290.4M >TECH
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 19% to $290.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.48 versus $1.12,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: Announced exclusive agreement with Thermo Fisher Scientific,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP operating income for the third quarter of fiscal 2022 increased 31.8% to $90.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2022-05-04,10:30:11,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2022-05-04,16:20:48,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q3 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2022-05-05,09:19:59,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $600.00 by Keybanc
TECH,2022-05-05,10:00:08,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $500 from $600 at KeyBanc Capital
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:00:24,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-10,11:03:06,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Returns to partner with Exosome Diagnostics and Bio-Techne as,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS
TECH,2022-05-11,20:53:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Chmn Baumgartner Buys 300 Of Bio-Techne Corp >TECH
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Excited to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-12,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria(R) Bladder Cancer Test
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-05-19,11:03:27,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
TECH,2022-06-08,18:32:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-06-08,18:35:29,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 5,104 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:06:38,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 5,104 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 5,104 Of Bio-Techne Corp >TECH"
TECH,2022-06-09,21:08:31,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 1,600 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Sells 1,600 Of Bio-Techne Corp >TECH"
TECH,2022-06-22,15:11:00,85DE00,Bio-Techne Corp.,94,0.49,partnerships,,Bio-Techne Corp.: The collaboration with QuaCell will further reduce costs by 75%,PRESS-RELEASE,Business Wire,Global Fetal Bovine Serum Market Report 2022: Market to Surpass $1.25+ Billion in 2026 - Increase in R&D Towards Development of Novel Biopharmaceuticals - ResearchAndMarkets.com
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-05,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION
TECH,2022-07-08,21:20:30,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,065 Of Bio-Techne Corp >TECH"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-14,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $931 million in net sales in fiscal 2021,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 4, 2022, TO ANNOUNCE FOURTH QUARTER 2022 FINANCIAL RESULTS"
TECH,2022-07-23,07:22:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2022 (TECH)"
TECH,2022-07-25,15:24:00,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Some of these factors considered for analysis are financial performance over the last 3 years,PRESS-RELEASE,Business Wire,"Global $1.24 Bn Fetal Bovine Serum Markets, 2022-2027: Untapped Potential of Emerging Markets & Increase in R&D Activities Towards the Introduction of New Biopharmaceuticals - ResearchAndMarkets.com"
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-07-28,11:00:05,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corporation (NASDAQ: TECH) today announced the signing of an exclusive licensing agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LICENSING AGREEMENT AND PARTNERSHIP WITH UNIVERSITY OF DUNDEE
TECH,2022-08-01,22:12:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 17,639 Of Bio-Techne Corp >TECH"
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:19,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE ANNOUNCES CEO TRANSITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,-0.43,labor-issues,,Bio-Techne's Board of Directors upon his retirement.,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:20,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne grew its revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES CEO TRANSITION PLAN
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 -4-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS $1.51,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS $1.51 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS $2.05,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS $2.05 >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $61.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $61.5M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $288.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $288.2M >TECH
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 11% to $288.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.86,earnings,up,Bio-Techne Corp.: GAAP EPS was $1.51 versus $0.37,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted earnings per share (EPS) of $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Fourth quarter adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,"Bio-Techne Corp.: Adjusted operating income for full year 2022 was $421.3 million ($296.6 million reported), an increase of 16%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $1.51,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2022 increased 17% to $80.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.64,earnings,up,Bio-Techne Corp.: Adjusted EPS increased to $2.05,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2022 increased 19% to $1,105.6 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2022 increased 25.0% to $296.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2022 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2022 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2022 RESULTS
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 4, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted earnings,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: QUARTER YEAR ENDED ENDED 6/30/2022 6/30/2021 6/30/2022 6/30/2021 Net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2022-08-04,10:30:21,85DE00,Bio-Techne Corp.,94,0.59,equity-actions,,Bio-Techne Corp.: Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-08-05,12:00:25,85DE00,Bio-Techne Corp.,100,-0.52,price-targets,downgrade,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $480.00/Share From $500.00 by Stephens & Co.
TECH,2022-08-07,04:01:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Corporation CEO Chuck Kummeth on Q4 2022 Results -- Earnings Call Transcript >TECH
TECH,2022-08-09,22:58:37,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:01:43,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 5,380 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:03:10,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Furlow Acquires 1,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Acquires 1,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-09,23:04:44,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 1,149 Of Bio-Techne Corp >TECH"
TECH,2022-08-10,22:10:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Vp Furlow Acquires 563 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,VP Furlow Acquires 563 Of Bio-Techne Corp >TECH
TECH,2022-08-12,19:20:36,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Higgins Registers 3,000 Of Bio-Techne Corp >TECH"
TECH,2022-08-12,20:04:43,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Higgins Sells 2,504 Of Bio-Techne Corp",TABULAR-MATERIAL,Dow Jones Newswires,"Dir Higgins Sells 2,504 Of Bio-Techne Corp >TECH"
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Underweight by Wells Fargo
TECH,2022-08-16,11:48:14,85DE00,Bio-Techne Corp.,100,-0.42,price-targets,downgrade,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $360.00/Share From $370.00 by Wells Fargo
TECH,2022-08-18,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-18,11:00:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES RELEASE OF QUANTIST LUMINEX(R) DATA ANALYSIS SOFTWARE
TECH,2022-08-24,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INCLUDED IN THE FORBES BEST-IN-STATE EMPLOYERS 2022 LIST
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Credit Suisse
TECH,2022-08-25,09:32:59,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $465.00/Share by Credit Suisse
TECH,2022-08-25,21:40:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Officer Kelderman Acquires 663 Of Bio-Techne Corp >TECH
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-29,11:00:42,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2022 WELLS FARGO HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-08-30,11:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE MORGAN STANLEY 20th ANNUAL GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,dividends,,Bio-Techne Corp.: The stock dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-01,11:00:34,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO SEEK APPROVAL TO IMPLEMENT FOUR-FOR-ONE STOCK SPLIT
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-06,11:14:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BAIRD 2022 GLOBAL HEALTHCARE CONFERENCE
TECH,2022-09-08,11:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,PR Newswire,BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-08,11:05:10,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Corp.: New tools for,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE PRESENTS INITIAL DATA ON SJGREN'S SYNDROME MONITORING ASSAY
TECH,2022-09-26,11:00:02,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,PR Newswire,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:01:04,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-09-26,11:03:43,85DE00,Bio-Techne Corp.,100,-0.53,legal,,Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Files Patent Infringement Lawsuit Against Molecular Instruments
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: Developed in partnership with Roche, Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-06,11:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES AUTOMATED MULTI-OMIC RNASCOPE ASSAYS FOR SPATIAL VISUALIZATION OF RNA AND PROTEIN BIOMARKERS IN FFPE TISSUES
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-10,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON NOVEMBER 1, 2022, TO ANNOUNCE FIRST QUARTER 2023 FINANCIAL RESULTS"
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: our partnership with BioTechne through,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-11,11:00:53,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-12,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY
TECH,2022-10-23,07:03:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2022 (TECH)"
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS $2.21,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS $2.21 >TECH
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:08,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS $1.78,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS $1.78 >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -2-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $89.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $89.6M >TECH
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -3-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 -4-
TECH,2022-11-01,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $269.7M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $269.7M >TECH
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES CASH DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 5% to $269.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.48,earnings,up,Bio-Techne Corp.: GAAP EPS was $2.21 versus $1.69,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Current year adjusted earnings per share (EPS) of $1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $2.21,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2023 net sales were $199.9 million, an increase of 1%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, November 1, 2022 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2023 RESULTS
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 2.28 $ 1.78,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,350,721 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 269,655 $ 257,719",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:42,85DE00,Bio-Techne Corp.,95,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-Techne Corp.: Trading will begin on a stock split,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-01,10:30:52,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES CASH DIVIDEND AND STOCK DIVIDEND
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2022-11-02,08:52:00,85DE00,Bio-Techne Corp.,100,-0.76,price-targets,downgrade,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $500.00/Share From $550.00 by SVB Leerink
TECH,2022-11-02,11:43:44,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $415 from $500 at Stifel Nicolaus
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:00:40,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-03,11:29:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE CREDIT SUISSE 31ST ANNUAL HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-08,12:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STIFEL 2022 HEALTHCARE CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-10,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE STEPHENS ANNUAL INVESTMENT CONFERENCE
TECH,2022-11-14,12:18:00,85DE00,Bio-Techne Corp.,91,0.0,products-services,,Bio-Techne Corp.: Development of new technologies,PRESS-RELEASE,Business Wire,Global Cell Expansion Market Report 2022: Increasing R&D Activities Fueling Growth - ResearchAndMarkets.com
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:00:05,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES OPENING OF NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-15,12:06:19,85DE00,Bio-Techne Corp.,100,0.41,assets,open,Bio-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE ANNOUNCES OPENING of NEW IMMUNOASSAY MANUFACTURING FACILITY
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-11-28,12:07:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE FIFTH ANNUAL EVERCORE ISI HealthCONx CONFERENCE
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:00:21,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies partner to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:01:34,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
TECH,2022-12-01,12:06:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and Oxford Nanopore Technologies Partner to,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and Oxford Nanopore Technologies Partner to Bring Innovative Reproductive Health and Carrier Screening Solutions to the Market
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.52,products-services,,"Bio-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS"
TECH,2022-12-05,14:59:46,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Stephens,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Stephens & Co.
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.01,analyst-ratings,neutral,Bio-Techne Initiated at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Sector Perform by RBC Capital
TECH,2022-12-07,09:57:16,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $89.00/Share by RBC Capital
TECH,2022-12-09,20:24:26,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Vp Furlow Registers 15,700 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"VP Furlow Registers 15,700 Of Bio-Techne Corp >TECH"
TECH,2022-12-09,21:03:37,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,Vp Furlow Registers 800 Of Bio-Techne Corp >TECH,RNS-SEC144,Dow Jones Newswires,VP Furlow Registers 800 Of Bio-Techne Corp >TECH
TECH,2022-12-09,21:49:17,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Vp Furlow Sells 8,250 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"VP Furlow Sells 8,250 Of Bio-Techne Corp >TECH"
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2022-12-12,12:40:24,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $81.25 by Citigroup
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by Deutsche Bank
TECH,2022-12-14,10:13:44,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $100.00/Share by Deutsche Bank
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2022-12-21,12:04:49,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 41st ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-06-30,09:31:45,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Annual Report for the year ended 31 December 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Final Results to 31 December 2022
TECH,2023-06-30,09:31:45,72B305,TechFinancials Inc.,99,0.0,revenues,,TechFinancials Inc.: No Revenues in 2022,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Final Results to 31 December 2022
TECH,2023-06-30,09:31:45,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Pre-tax loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Final Results to 31 December 2022
TECH,2023-06-30,09:31:45,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Final Results to 31 December 2022
TECH,2023-06-30,09:31:45,72B305,TechFinancials Inc.,99,-0.51,assets,close,TechFinancials Inc.: The Company closed most of its subsidiaries in 2021,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Final Results to 31 December 2022
TECH,2023-06-30,09:31:45,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: Operating Loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Final Results to 31 December 2022
TECH,2023-06-30,09:31:45,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Loss) for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Final Results to 31 December 2022
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June 2023
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Financial Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June 2023
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: The operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June 2023
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: the Company was US$ 0.073m (H1 2022: loss of,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June 2023
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June 2023
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Total comprehensive loss for the year,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June -2-
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,0.0,dividends,,TechFinancials Inc.: No dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June -2-
TECH,2023-09-29,06:00:28,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Results to 30 June -2-
TECH,2023-11-24,14:18:09,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Notice of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Notice of AGM
TECH,2023-12-18,14:32:50,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Result of AGM
TECH,2023-01-06,21:39:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH"
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.62,analyst-ratings,positive,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-22,09:17:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)"
TECH,2023-01-26,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-26,12:09:49,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-31,12:00:13,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:00:17,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:02:58,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel Effective March 3 >TECH"
TECH,2023-01-31,12:03:24,85DE00,Bio-Techne Corp.,100,-0.49,labor-issues,,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring From the Co >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 31c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -3-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 47c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $50M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $50M >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $271.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $271.6M >TECH
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,-0.72,price-targets,downgrade,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink
TECH,2023-02-03,11:54:27,85DE00,Bio-Techne Corp.,100,-0.94,price-targets,downgrade,Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus
TECH,2023-02-03,13:04:55,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,-0.22,price-targets,downgrade,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital
TECH,2023-02-07,17:26:38,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-07,17:29:08,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:07:27,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-15,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-03-15,11:00:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:03:01,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE COMPLETES INVESTMENT in WILSON WOLF MANUFACTURING
TECH,2023-04-05,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-05,11:00:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-13,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-13,11:03:55,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-17,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-17,11:06:48,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-21,20:04:09,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH
TECH,2023-04-22,07:36:41,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)"
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,20:52:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH"
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 43c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 43c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 53c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $70.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $70.2M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $294.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $294.1M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird
TECH,2023-05-04,13:58:39,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-05-04,13:58:40,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital
TECH,2023-05-10,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-10,11:01:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-16,11:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-16,11:01:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-06-01,11:00:06,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-01,11:01:34,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-06,18:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 50,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 50,000 Of Bio-Techne Corp >TECH"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: 9.9 Clinical Trials,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,20:11:16,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Ceo Kummeth Sells 322 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,CEO Kummeth Sells 322 Of Bio-Techne Corp >TECH
TECH,2023-06-19,15:44:36,85DE00,Bio-Techne Corp.,92,0.46,equity-actions,,Bio-Techne company invested up to US$ 50 million in,PRESS-RELEASE,PR Newswire,"Protein Expression, Purification and Isolation Technology Global Market Report 2023: Increase in Investment in Pharmaceutical and Biotechnological R&D"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-TECHNE TO ACQUIRE LUNAPHORE >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE TO ACQUIRE LUNAPHORE >TECH
TECH,2023-07-05,22:39:57,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH"
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:03:37,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-21,20:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 80,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-07-25,21:29:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 80,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 47c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 55c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 55c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $75.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $75.5M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $301.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $301.3M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -5-
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,21:30:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,541 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,541 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:45,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH"
TECH,2023-08-11,20:20:25,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH"
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-17,20:19:56,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH"
TECH,2023-08-19,07:19:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)"
TECH,2023-08-24,11:00:57,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,13:41:07,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by William Blair,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by William Blair
TECH,2023-08-28,20:20:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH"
TECH,2023-08-30,20:18:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-01,20:08:09,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 8,939 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-19,06:00:26,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cizzle Biotechnology Holdings PLC Completion of Evaluation Programme with Bio-Techne
TECH,2023-09-19,06:00:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-19,06:00:52,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-25,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-09-25,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:24:44,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Names Kelderman to Succeed Kummeth as President,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Names Kelderman to Succeed Kummeth as President, CEO"
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 31c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 41c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 41c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $51M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $51M >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $276.9M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $276.9M >TECH
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc
TECH,2023-11-01,16:26:00,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-11-01,16:26:01,85DE00,Bio-Techne Corp.,100,-0.4,price-targets,downgrade,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Stifel
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,-0.86,price-targets,downgrade,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Citigroup
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-19,08:43:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)"
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by UBS
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $80.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $80.00/Share by UBS
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,21:07:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 14,323 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 14,323 Of Bio-Techne Corp >TECH"
TECH,2023-01-06,21:39:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH"
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.62,analyst-ratings,positive,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-22,09:17:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)"
TECH,2023-01-26,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-26,12:09:49,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-31,12:00:13,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:00:17,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:02:58,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel Effective March 3 >TECH"
TECH,2023-01-31,12:03:24,85DE00,Bio-Techne Corp.,100,-0.49,labor-issues,,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring From the Co >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 31c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -3-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 47c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $50M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $50M >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $271.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $271.6M >TECH
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,-0.72,price-targets,downgrade,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink
TECH,2023-02-03,11:54:27,85DE00,Bio-Techne Corp.,100,-0.94,price-targets,downgrade,Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus
TECH,2023-02-03,13:04:55,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,-0.22,price-targets,downgrade,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital
TECH,2023-02-07,17:26:38,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-07,17:29:08,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:07:27,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-15,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-03-15,11:00:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:03:01,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE COMPLETES INVESTMENT in WILSON WOLF MANUFACTURING
TECH,2023-04-05,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-05,11:00:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-13,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-13,11:03:55,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-17,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-17,11:06:48,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-21,20:04:09,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH
TECH,2023-04-22,07:36:41,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)"
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,20:52:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH"
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 43c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 43c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 53c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $70.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $70.2M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $294.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $294.1M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird
TECH,2023-05-04,13:58:39,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-05-04,13:58:40,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital
TECH,2023-05-10,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-10,11:01:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-16,11:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-16,11:01:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-06-01,11:00:06,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-01,11:01:34,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-06,18:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 50,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 50,000 Of Bio-Techne Corp >TECH"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: 9.9 Clinical Trials,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,20:11:16,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Ceo Kummeth Sells 322 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,CEO Kummeth Sells 322 Of Bio-Techne Corp >TECH
TECH,2023-06-19,15:44:36,85DE00,Bio-Techne Corp.,92,0.46,equity-actions,,Bio-Techne company invested up to US$ 50 million in,PRESS-RELEASE,PR Newswire,"Protein Expression, Purification and Isolation Technology Global Market Report 2023: Increase in Investment in Pharmaceutical and Biotechnological R&D"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-TECHNE TO ACQUIRE LUNAPHORE >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE TO ACQUIRE LUNAPHORE >TECH
TECH,2023-07-05,22:39:57,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH"
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:03:37,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-21,20:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 80,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-07-25,21:29:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 80,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 47c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 55c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 55c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $75.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $75.5M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $301.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $301.3M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -5-
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,21:30:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,541 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,541 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:45,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH"
TECH,2023-08-11,20:20:25,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH"
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-17,20:19:56,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH"
TECH,2023-08-19,07:19:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)"
TECH,2023-08-24,11:00:57,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,13:41:07,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by William Blair,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by William Blair
TECH,2023-08-28,20:20:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH"
TECH,2023-08-30,20:18:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-01,20:08:09,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 8,939 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-19,06:00:26,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cizzle Biotechnology Holdings PLC Completion of Evaluation Programme with Bio-Techne
TECH,2023-09-19,06:00:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-19,06:00:52,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-25,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-09-25,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:24:44,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Names Kelderman to Succeed Kummeth as President,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Names Kelderman to Succeed Kummeth as President, CEO"
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 31c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 41c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 41c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $51M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $51M >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $276.9M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $276.9M >TECH
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc
TECH,2023-11-01,16:26:00,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-11-01,16:26:01,85DE00,Bio-Techne Corp.,100,-0.4,price-targets,downgrade,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Stifel
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,-0.86,price-targets,downgrade,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Citigroup
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-19,08:43:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)"
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by UBS
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $80.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $80.00/Share by UBS
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,21:07:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 14,323 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 14,323 Of Bio-Techne Corp >TECH"
TECH,2023-01-06,21:39:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH"
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.62,analyst-ratings,positive,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-22,09:17:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)"
TECH,2023-01-26,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-26,12:09:49,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-31,12:00:13,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:00:17,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:02:58,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel Effective March 3 >TECH"
TECH,2023-01-31,12:03:24,85DE00,Bio-Techne Corp.,100,-0.49,labor-issues,,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring From the Co >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 31c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -3-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 47c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $50M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $50M >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $271.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $271.6M >TECH
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,-0.72,price-targets,downgrade,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink
TECH,2023-02-03,11:54:27,85DE00,Bio-Techne Corp.,100,-0.94,price-targets,downgrade,Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus
TECH,2023-02-03,13:04:55,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,-0.22,price-targets,downgrade,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital
TECH,2023-02-07,17:26:38,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-07,17:29:08,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:07:27,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-15,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-03-15,11:00:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:03:01,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE COMPLETES INVESTMENT in WILSON WOLF MANUFACTURING
TECH,2023-04-05,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-05,11:00:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-13,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-13,11:03:55,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-17,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-17,11:06:48,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-21,20:04:09,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH
TECH,2023-04-22,07:36:41,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)"
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,20:52:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH"
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 43c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 43c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 53c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $70.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $70.2M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $294.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $294.1M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird
TECH,2023-05-04,13:58:39,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-05-04,13:58:40,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital
TECH,2023-05-10,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-10,11:01:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-16,11:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-16,11:01:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-06-01,11:00:06,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-01,11:01:34,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-06,18:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 50,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 50,000 Of Bio-Techne Corp >TECH"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: 9.9 Clinical Trials,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,20:11:16,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Ceo Kummeth Sells 322 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,CEO Kummeth Sells 322 Of Bio-Techne Corp >TECH
TECH,2023-06-19,15:44:36,85DE00,Bio-Techne Corp.,92,0.46,equity-actions,,Bio-Techne company invested up to US$ 50 million in,PRESS-RELEASE,PR Newswire,"Protein Expression, Purification and Isolation Technology Global Market Report 2023: Increase in Investment in Pharmaceutical and Biotechnological R&D"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-TECHNE TO ACQUIRE LUNAPHORE >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE TO ACQUIRE LUNAPHORE >TECH
TECH,2023-07-05,22:39:57,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH"
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:03:37,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-21,20:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 80,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-07-25,21:29:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 80,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 47c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 55c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 55c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $75.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $75.5M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $301.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $301.3M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -5-
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,21:30:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,541 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,541 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:45,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH"
TECH,2023-08-11,20:20:25,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH"
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-17,20:19:56,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH"
TECH,2023-08-19,07:19:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)"
TECH,2023-08-24,11:00:57,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,13:41:07,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by William Blair,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by William Blair
TECH,2023-08-28,20:20:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH"
TECH,2023-08-30,20:18:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-01,20:08:09,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 8,939 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-19,06:00:26,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cizzle Biotechnology Holdings PLC Completion of Evaluation Programme with Bio-Techne
TECH,2023-09-19,06:00:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-19,06:00:52,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-25,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-09-25,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:24:44,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Names Kelderman to Succeed Kummeth as President,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Names Kelderman to Succeed Kummeth as President, CEO"
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 31c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 41c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 41c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $51M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $51M >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $276.9M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $276.9M >TECH
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc
TECH,2023-11-01,16:26:00,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-11-01,16:26:01,85DE00,Bio-Techne Corp.,100,-0.4,price-targets,downgrade,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Stifel
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,-0.86,price-targets,downgrade,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Citigroup
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-19,08:43:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)"
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by UBS
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $80.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $80.00/Share by UBS
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,21:07:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 14,323 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 14,323 Of Bio-Techne Corp >TECH"
TECH,2023-01-06,21:39:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH"
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.62,analyst-ratings,positive,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-22,09:17:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)"
TECH,2023-01-26,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-26,12:09:49,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-31,12:00:13,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:00:17,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:02:58,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel Effective March 3 >TECH"
TECH,2023-01-31,12:03:24,85DE00,Bio-Techne Corp.,100,-0.49,labor-issues,,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring From the Co >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 31c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -3-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 47c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $50M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $50M >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $271.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $271.6M >TECH
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,-0.72,price-targets,downgrade,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink
TECH,2023-02-03,11:54:27,85DE00,Bio-Techne Corp.,100,-0.94,price-targets,downgrade,Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus
TECH,2023-02-03,13:04:55,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,-0.22,price-targets,downgrade,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital
TECH,2023-02-07,17:26:38,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-07,17:29:08,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:07:27,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-15,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-03-15,11:00:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:03:01,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE COMPLETES INVESTMENT in WILSON WOLF MANUFACTURING
TECH,2023-04-05,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-05,11:00:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-13,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-13,11:03:55,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-17,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-17,11:06:48,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-21,20:04:09,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH
TECH,2023-04-22,07:36:41,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)"
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,20:52:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH"
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 43c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 43c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 53c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $70.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $70.2M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $294.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $294.1M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird
TECH,2023-05-04,13:58:39,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-05-04,13:58:40,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital
TECH,2023-05-10,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-10,11:01:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-16,11:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-16,11:01:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-06-01,11:00:06,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-01,11:01:34,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-06,18:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 50,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 50,000 Of Bio-Techne Corp >TECH"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: 9.9 Clinical Trials,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,20:11:16,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Ceo Kummeth Sells 322 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,CEO Kummeth Sells 322 Of Bio-Techne Corp >TECH
TECH,2023-06-19,15:44:36,85DE00,Bio-Techne Corp.,92,0.46,equity-actions,,Bio-Techne company invested up to US$ 50 million in,PRESS-RELEASE,PR Newswire,"Protein Expression, Purification and Isolation Technology Global Market Report 2023: Increase in Investment in Pharmaceutical and Biotechnological R&D"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-TECHNE TO ACQUIRE LUNAPHORE >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE TO ACQUIRE LUNAPHORE >TECH
TECH,2023-07-05,22:39:57,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH"
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:03:37,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-21,20:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 80,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-07-25,21:29:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 80,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 47c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 55c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 55c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $75.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $75.5M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $301.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $301.3M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -5-
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,21:30:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,541 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,541 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:45,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH"
TECH,2023-08-11,20:20:25,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH"
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-17,20:19:56,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH"
TECH,2023-08-19,07:19:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)"
TECH,2023-08-24,11:00:57,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,13:41:07,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by William Blair,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by William Blair
TECH,2023-08-28,20:20:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH"
TECH,2023-08-30,20:18:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-01,20:08:09,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 8,939 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-19,06:00:26,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cizzle Biotechnology Holdings PLC Completion of Evaluation Programme with Bio-Techne
TECH,2023-09-19,06:00:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-19,06:00:52,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-25,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-09-25,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:24:44,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Names Kelderman to Succeed Kummeth as President,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Names Kelderman to Succeed Kummeth as President, CEO"
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 31c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 41c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 41c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $51M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $51M >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $276.9M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $276.9M >TECH
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc
TECH,2023-11-01,16:26:00,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-11-01,16:26:01,85DE00,Bio-Techne Corp.,100,-0.4,price-targets,downgrade,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Stifel
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,-0.86,price-targets,downgrade,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Citigroup
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-19,08:43:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)"
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by UBS
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $80.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $80.00/Share by UBS
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,21:07:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 14,323 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 14,323 Of Bio-Techne Corp >TECH"
TECH,2023-01-06,21:39:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH"
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.62,analyst-ratings,positive,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-22,09:17:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)"
TECH,2023-01-26,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-26,12:09:49,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-31,12:00:13,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:00:17,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:02:58,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel Effective March 3 >TECH"
TECH,2023-01-31,12:03:24,85DE00,Bio-Techne Corp.,100,-0.49,labor-issues,,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring From the Co >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 31c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -3-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 47c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $50M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $50M >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $271.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $271.6M >TECH
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,-0.72,price-targets,downgrade,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink
TECH,2023-02-03,11:54:27,85DE00,Bio-Techne Corp.,100,-0.94,price-targets,downgrade,Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus
TECH,2023-02-03,13:04:55,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,-0.22,price-targets,downgrade,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital
TECH,2023-02-07,17:26:38,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-07,17:29:08,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:07:27,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-15,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-03-15,11:00:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:03:01,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE COMPLETES INVESTMENT in WILSON WOLF MANUFACTURING
TECH,2023-04-05,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-05,11:00:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-13,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-13,11:03:55,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-17,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-17,11:06:48,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-21,20:04:09,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH
TECH,2023-04-22,07:36:41,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)"
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,20:52:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH"
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 43c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 43c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 53c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $70.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $70.2M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $294.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $294.1M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird
TECH,2023-05-04,13:58:39,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-05-04,13:58:40,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital
TECH,2023-05-10,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-10,11:01:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-16,11:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-16,11:01:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-06-01,11:00:06,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-01,11:01:34,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-06,18:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 50,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 50,000 Of Bio-Techne Corp >TECH"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: 9.9 Clinical Trials,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,20:11:16,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Ceo Kummeth Sells 322 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,CEO Kummeth Sells 322 Of Bio-Techne Corp >TECH
TECH,2023-06-19,15:44:36,85DE00,Bio-Techne Corp.,92,0.46,equity-actions,,Bio-Techne company invested up to US$ 50 million in,PRESS-RELEASE,PR Newswire,"Protein Expression, Purification and Isolation Technology Global Market Report 2023: Increase in Investment in Pharmaceutical and Biotechnological R&D"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-TECHNE TO ACQUIRE LUNAPHORE >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE TO ACQUIRE LUNAPHORE >TECH
TECH,2023-07-05,22:39:57,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH"
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:03:37,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-21,20:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 80,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-07-25,21:29:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 80,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 47c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 55c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 55c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $75.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $75.5M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $301.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $301.3M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -5-
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,21:30:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,541 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,541 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:45,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH"
TECH,2023-08-11,20:20:25,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH"
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-17,20:19:56,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH"
TECH,2023-08-19,07:19:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)"
TECH,2023-08-24,11:00:57,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,13:41:07,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by William Blair,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by William Blair
TECH,2023-08-28,20:20:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH"
TECH,2023-08-30,20:18:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-01,20:08:09,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 8,939 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-19,06:00:26,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cizzle Biotechnology Holdings PLC Completion of Evaluation Programme with Bio-Techne
TECH,2023-09-19,06:00:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-19,06:00:52,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-25,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-09-25,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:24:44,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Names Kelderman to Succeed Kummeth as President,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Names Kelderman to Succeed Kummeth as President, CEO"
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 31c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 41c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 41c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $51M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $51M >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $276.9M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $276.9M >TECH
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc
TECH,2023-11-01,16:26:00,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-11-01,16:26:01,85DE00,Bio-Techne Corp.,100,-0.4,price-targets,downgrade,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Stifel
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,-0.86,price-targets,downgrade,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Citigroup
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-19,08:43:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)"
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by UBS
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $80.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $80.00/Share by UBS
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,21:07:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 14,323 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 14,323 Of Bio-Techne Corp >TECH"
TECH,2023-01-06,21:39:03,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 151,527 Of Bio-Techne Corp >TECH"
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,12:01:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE LAUNCHES RNASCOPE PLUS ASSAY TO ADVANCE GENE THERAPY DEVELOPMENT
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.62,analyst-ratings,positive,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Equal-Weight From Underweight by Wells Fargo
TECH,2023-01-10,13:26:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $90.00/Share by Wells Fargo
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:00:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-17,12:01:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 2, 2023, TO ANNOUNCE SECOND QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-01-22,09:17:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2022 (TECH)"
TECH,2023-01-26,12:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-26,12:09:49,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE LAUNCHES THE MauriceFlex(TM) SYSTEM, ADDING cIEF FRACTIONATION CAPABILITY TO THE GOLD STANDARD MAURICE ASSAYS"
TECH,2023-01-31,12:00:13,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,PR Newswire,"BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:00:17,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL"
TECH,2023-01-31,12:02:58,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne: Shane Bohnen Has Been Appointed Senior Vice Pres, General Counsel Effective March 3 >TECH"
TECH,2023-01-31,12:03:24,85DE00,Bio-Techne Corp.,100,-0.49,labor-issues,,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring,NEWS-FLASH,Dow Jones Newswires,Bio-Techne: General Counsel Brenda Furlow Will Be Retiring From the Co >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 31c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -2-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -3-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 -4-
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 47c >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $50M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $50M >TECH
TECH,2023-02-02,11:30:10,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $271.6M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $271.6M >TECH
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:28,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 1% to $271.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2023 increased 9% to $67.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's second quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 2, 2023 at 8:00 a.m. CST",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER FISCAL 2023 RESULTS
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,363,401 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -2-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -3-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 271,581 $ 269,276 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-02,11:30:38,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES SECOND QUARTER -4-
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-02-03,09:42:24,85DE00,Bio-Techne Corp.,100,-0.72,price-targets,downgrade,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $115.00/Share From $125.00 by Keybanc
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by SVB Leerink
TECH,2023-02-03,09:45:44,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $110.00/Share From $125.00 by SVB Leerink
TECH,2023-02-03,11:54:27,85DE00,Bio-Techne Corp.,100,-0.94,price-targets,downgrade,Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus,NEWS-FLASH,MarketWatch,MW Bio-Techne stock price target cut to $103.75 from $415.00 at Stifel Nicolaus
TECH,2023-02-03,13:04:55,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-02-06,14:28:22,85DE00,Bio-Techne Corp.,100,-0.22,price-targets,downgrade,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $88.00/Share From $89.00 by RBC Capital
TECH,2023-02-07,17:26:38,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-07,17:29:08,85DE00,Bio-Techne Corp.,99,0.39,products-services,,Bio-Techne made an agreement with Thermo Fisher Scientific,PRESS-RELEASE,PR Newswire,"Exosome Research Products Market Size to Surpass USD 2.26 Billion with a Growing CAGR of 19.3% by 2030, Size, Share, Trends, Competitive Landscape and Regional Overview"
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP TO VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-14,12:07:27,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE and CELL SIGNALING TECHNOLOGY ANNOUNCE PARTNERSHIP to VALIDATE SIMPLE WESTERN ANTIBODIES
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-22,12:08:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO PRESENT AT THE CITI 2023 HEALTHCARE SERVICES, MEDTECH, TOOLS & HCIT CONFERENCE"
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-02-28,14:59:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE COWEN 43rd ANNUAL HEALTH CARE CONFERENCE
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:00:30,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.62,acquisitions-mergers,,"Bio-Techne Corp.: The acquisition of Wilson Wolf, combined with our world-renowned portfolio",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-01,12:01:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES INVESTMENT IN WILSON WOLF
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-10,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BARCLAYS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-03-15,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-03-15,11:00:24,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES COMPLETION OF CELL AND GENE THERAPY CATAPULT PROCESS ANALYTICAL TECHNOLOGY (PAT) CONSORTIUM
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES INVESTMENT IN WILSON WOLF MANUFACTURING
TECH,2023-04-03,11:03:01,85DE00,Bio-Techne Corp.,100,0.0,equity-actions,,Bio-TECHNE COMPLETES INVESTMENT,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE COMPLETES INVESTMENT in WILSON WOLF MANUFACTURING
TECH,2023-04-05,11:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-05,11:00:22,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE CELEBRATES MILESTONE WITH MORE THAN 1,000 ELLA(TM) INSTRUMENTS NOW IN OPERATION"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-12,11:00:35,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 3, 2023, TO ANNOUNCE THIRD QUARTER 2023 FINANCIAL RESULTS"
TECH,2023-04-13,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-13,11:03:55,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO SHOWCASE INNOVATIVE CANCER RESEARCH, CELL THERAPY AND MANUFACTURING TOOLS AT AACR 2023 CONFERENCE"
TECH,2023-04-17,11:00:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-17,11:06:48,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE AND LUNAPHORE ESTABLISH STRATEGIC PARTNERSHIP TO DEVELOP THE FIRST FULLY AUTOMATED SAME-SLIDE SPATIAL MULTIOMICS SOLUTION
TECH,2023-04-21,20:04:09,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Nusse Gifts 377 Of Bio-Techne Corp >TECH
TECH,2023-04-22,07:36:41,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2023 (TECH)"
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,11:00:24,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE BofA SECURITIES 2023 HEALTH CARE CONFERENCE
TECH,2023-05-02,20:52:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 11,623 Of Bio-Techne Corp >TECH"
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 43c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 43c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 53c >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $70.2M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $70.2M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -3-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $294.1M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $294.1M >TECH
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 -4-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter ended March 31, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 1% to $294.1 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.43,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.53,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's third quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 3, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2023 RESULTS
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:04,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,599,696 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 294,146 $ 290,376 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:05,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-03,10:30:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Biotechne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Baird
TECH,2023-05-04,10:52:39,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $100.00/Share From $99.00 by Baird
TECH,2023-05-04,13:58:39,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-05-04,13:58:40,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $89.00 by RBC Capital
TECH,2023-05-10,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-10,11:01:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES LAUNCH OF KAPPA AND LAMBDA RNAscope ISH PROBES AS ANALYTE SPECIFIC REAGENTS (ASRs) FOR THE DETECTION OF IMMUNOGLOBULIN KAPPA AND LAMBDA LIGHT CHAINS mRNA
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-12,13:08:59,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE
TECH,2023-05-16,11:00:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-16,11:01:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMMERCIALIZES RNASCOPE SPATIAL BIOLOGY WORKFLOW FOR THE STANDARD BIOTOOLS HYPERION IMAGING SYSTEM
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,products-services,,Exosome DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-18,11:00:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: EXOSOME DIAGNOSTICS RELEASES INTERIM RESULTS FROM CLINICAL STUDY OF PROSTATE CANCER RISK TEST
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:00:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-05-25,11:08:44,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE
TECH,2023-06-01,11:00:06,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-01,11:01:34,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2023-06-06,18:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 50,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 50,000 Of Bio-Techne Corp >TECH"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,10:53:00,85DE00,Bio-Techne Corp.,99,0.84,products-services,positive,Bio-Techne Corp.: 9.9 Clinical Trials,PRESS-RELEASE,Business Wire,"Global Exosome Market Research Report 2023-2030: Market Size, Forecasts, Trials, and Trends with Company Profiles of 118 Competitors - ResearchAndMarkets.com"
TECH,2023-06-09,20:11:16,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,Ceo Kummeth Sells 322 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,CEO Kummeth Sells 322 Of Bio-Techne Corp >TECH
TECH,2023-06-19,15:44:36,85DE00,Bio-Techne Corp.,92,0.46,equity-actions,,Bio-Techne company invested up to US$ 50 million in,PRESS-RELEASE,PR Newswire,"Protein Expression, Purification and Isolation Technology Global Market Report 2023: Increase in Investment in Pharmaceutical and Biotechnological R&D"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.57,products-services,granted,Fda-approved diagnostic tests: Bio-Techne,PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.51,products-services,increase,"Growing demand for exosome therapeutics, diagnostics, research tools",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-20,09:59:42,85DE00,Bio-Techne Corp.,99,0.53,assets,awarded,"Exosome patents, grants",PRESS-RELEASE,PR Newswire,"Global Exosome Market Research Report 2023: To Date, 3 Pharma Companies (Takeda, Jazz Pharmaceuticals, and Roche Pharmaceutical Company) have Signed Partnership Deals with Exosome Companies"
TECH,2023-06-22,12:00:04,85DE00,Bio-Techne Corp.,100,0.62,acquisitions-mergers,,Bio-TECHNE TO ACQUIRE LUNAPHORE >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE TO ACQUIRE LUNAPHORE >TECH
TECH,2023-07-05,22:39:57,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 225,949 Of Bio-Techne Corp >TECH"
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,PR Newswire,BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-TECHNE COMPLETES LUNAPHORE ACQUISITION,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE COMPLETES LUNAPHORE ACQUISITION
TECH,2023-07-10,11:03:37,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Completes Acquisition of Lunaphore Technologies >TECH
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-13,11:00:23,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2022,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS"
TECH,2023-07-21,20:36:32,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kummeth Registers 80,000 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kummeth Registers 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-07-25,21:29:21,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kummeth Sells 80,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Sells 80,000 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q EPS 47c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q EPS 47c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 55c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 55c >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Net $75.5M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Net $75.5M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $301.3M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $301.3M >TECH
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -2-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -3-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -4-
TECH,2023-08-08,10:30:14,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 -5-
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 5% to $301.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.47,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.55,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year GAAP EPS was $1.76 versus $1.66,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Full year adjusted EPS was $1.99 versus $1.97,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.57,acquisitions-mergers,completed,"Bio-Techne Corp.: We finalized the acquisition of Lunaphore, which closed on July 7",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for the fourth quarter of fiscal 2023 increased 17% to $94.5 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,-0.65,revenues,down,Bio-Techne Corp.: Adjusted operating margin decreased,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Net sales for the full year fiscal 2023 increased 3% to $1,136.7 million",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Current year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: GAAP operating income for full year fiscal 2023 increased 1% to $298.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Protein Sciences segment's fourth quarter fiscal 2023 net sales,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Fiscal 2023 operating margin,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corp.: Conference Call,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 8, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -2-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,97,0.0,assets,,"Bio-Techne Corp.: Total assets $2,638,692 $2,294,805",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -3-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 301,320 $ 288,229",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -4-
TECH,2023-08-08,10:30:47,85DE00,Bio-Techne Corp.,92,0.59,equity-actions,,Bio-Techne Corp.: 700) Share repurchases,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FOURTH QUARTER -5-
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,10:31:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-08-08,21:30:12,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 3,921 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 6,541 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 6,541 Of Bio-Techne Corp >TECH"
TECH,2023-08-08,21:32:45,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 19,554 Of Bio-Techne Corp >TECH"
TECH,2023-08-11,20:20:25,85DE00,Bio-Techne Corp.,100,0.0,insider-trading,,"Ceo Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Gifts 9,008 Of Bio-Techne Corp >TECH"
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,-0.46,partnerships,terminated,Bio-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-14,11:01:25,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ENDS COLLABORATION PROGRAM WITH AKOYA TO AUTOMATE RNASCOPE ON THE PHENOCYCLER FUSION
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,marketing,,"Bio-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-15,11:00:08,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023"
TECH,2023-08-17,20:19:56,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kummeth Acquires 8,957 Of Bio-Techne Corp >TECH"
TECH,2023-08-19,07:19:30,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2023 (TECH)"
TECH,2023-08-24,11:00:57,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ANNOUNCES 2023 INVESTOR DAY AND WEBCAST
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,11:00:26,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-08-28,13:41:07,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by William Blair,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by William Blair
TECH,2023-08-28,20:20:25,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Kelderman Acquires 2,100 Of Bio-Techne Corp >TECH"
TECH,2023-08-30,20:18:33,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-01,20:08:09,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 8,939 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 8,939 Of Bio-Techne Corp >TECH"
TECH,2023-09-19,06:00:26,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,LSE Regulatory News Service (RNS),Cizzle Biotechnology Holdings PLC Completion of Evaluation Programme with Bio-Techne
TECH,2023-09-19,06:00:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-19,06:00:52,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western(TM) Platform
TECH,2023-09-25,11:00:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-09-25,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE ISSUES 2023 CORPORATE SUSTAINABILITY REPORT
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023",PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-10,11:00:13,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 31, 2023, TO ANNOUNCE FIRST QUARTER FISCAL 2024 FINANCIAL RESULTS"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,"BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-16,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,"Press Release: BIO-TECHNE ACHIEVES ISO 13485 CERTIFICATION FOR ITS WALLINGFORD, CT MANUFACTURING FACILITY"
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER >TECH
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,PR Newswire,BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:00:05,85DE00,Bio-Techne Corp.,100,0.65,revenues,up,Bio-Techne's revenue grew from,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE APPOINTS KIM KELDERMAN AS CHIEF EXECUTIVE OFFICER
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:01:16,85DE00,Bio-Techne Corp.,100,0.53,labor-issues,,Bio-Techne Appoints Kim Kelderman as Pres and CEO,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Kim Kelderman as Pres and CEO Effective Feb 1 >TECH
TECH,2023-10-19,11:24:44,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Names Kelderman to Succeed Kummeth as President,FULL-ARTICLE,Dow Jones Newswires,"Bio-Techne Names Kelderman to Succeed Kummeth as President, CEO"
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q EPS 31c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q EPS 31c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -2-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -3-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Adj EPS 41c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Adj EPS 41c >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 1Q Net $51M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Net $51M >TECH
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 -4-
TECH,2023-10-31,10:30:11,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 1Q Sales $276.9M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 1Q Sales $276.9M >TECH
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:29,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the first quarter ended September 30, 2023",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the first quarter increased 3% to $276.9 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share1) (EPS) was $0.31,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Delivered adjusted EPS1) of $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Prior year GAAP EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,-0.67,earnings,down,Bio-Techne Corp.: Adjusted EPS decreased to $0.41,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,"Bio-Techne Corp.: Protein Sciences segment's first quarter fiscal 2024 net sales were $204.7 million, an increase of 2%",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, October 31, 2023 at 8:00 a.m. CDT",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,755,360 $2,638,692",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -2-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 276,935 $ 269,655",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -3-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-10-31,10:30:39,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES FIRST QUARTER -4-
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2023-11-01,10:02:59,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $115.00 by Keybanc
TECH,2023-11-01,16:26:00,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2023-11-01,16:26:01,85DE00,Bio-Techne Corp.,100,-0.4,price-targets,downgrade,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $83.00/Share From $85.00 by RBC Capital
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Stifel
TECH,2023-11-01,18:50:31,85DE00,Bio-Techne Corp.,100,-0.86,price-targets,downgrade,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $65.00/Share From $104.00 by Stifel
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Citigroup
TECH,2023-11-01,20:22:51,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $80.00/Share From $100.00 by Citigroup
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-13,12:00:05,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
TECH,2023-11-19,08:43:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 3Q 2023 (TECH)"
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-11-27,12:04:16,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI HEALTHCONx CONFERENCE
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by UBS
TECH,2023-12-07,11:17:14,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $80.00/Share by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $80.00/Share by UBS
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:00:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,12:03:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.1 billion in net sales in fiscal 2023,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
TECH,2023-12-21,21:07:38,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 14,323 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 14,323 Of Bio-Techne Corp >TECH"
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-01-31,06:00:00,2E34B2,Anoto Group AB,99,0.46,equity-actions,,Anoto Group AB: Through the rights issue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Change in the total number of shares and votes in Anoto
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-29,06:30:00,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB has entered into a Convertible Loan Agreement,PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB has entered into a Convertible Loan Agreement to raise USD 750,000."
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-04-30,21:30:00,2E34B2,Anoto Group AB,99,0.0,earnings,,Anoto Group AB: our overall results for the year,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto publishes its annual report for 2024 and corrects for changes in the results as reported in the year-end report
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.47,labor-issues,,"Anoto Group AB: Election of Board members, Chairman of the Board of Directors",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-05-28,07:00:01,2E34B2,Anoto Group AB,99,0.39,products-services,,Anoto Group AB: Share swap agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Notice to attend the Annual General Meeting in Anoto Group AB (publ)
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.38,credit,,"Anoto Group AB enters into USD 400,000 bridge loan agreement",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-08-21,06:00:01,2E34B2,Anoto Group AB,100,0.0,equity-actions,,"Anoto Group AB: the Company secures at least USD 600,000 in new convertible financing",PRESS-RELEASE,Hugin GlobeNewswire,"Press Release: Anoto Group AB enters into USD 400,000 bridge loan agreement to accelerate growth of the INQ brand"
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Dow Jones Newswires,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.38,credit,,Anoto Group AB enters secured convertible loan agreement,PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-10-10,17:00:02,2E34B2,Anoto Group AB,100,0.57,equity-actions,listing,"Anoto Group AB: the ""Company""), listed on Nasdaq",PRESS-RELEASE,Hugin GlobeNewswire,Press Release: Anoto Group AB enters secured convertible loan agreement totaling USD 2.4 million to support execution of business plan
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Annual Report for the year ended 31 December 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2024
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,0.0,revenues,,TechFinancials Inc.: No revenues in 2024,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2024
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Pre-tax loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2024
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2024
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,0.0,dividends,,TechFinancials Inc.: Dividend,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2024
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: Operating Loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year ended 31 December 2024
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,0.57,equity-actions,listing,TechFinancials Inc.: The Company is currently listed solely on the Aquis Stock Exchange,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -2-
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,95,-0.62,earnings,negative,TechFinancials Inc.: Loss) before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -5-
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,95,-0.67,earnings,down,TechFinancials Inc.: Loss) multiplied,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -5-
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,95,0.0,earnings,,TechFinancials Inc.: Earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -5-
TECH,2025-06-27,15:35:09,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Basic earnings per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Annual Report for the year -6-
TECH,2025-09-18,06:00:20,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: the Company's Annual General Meeting.,PRESS-RELEASE,LSE Regulatory News Service (RNS),"TechFinancials Inc. Notice of AGM, Placing & Acquisition"
TECH,2025-09-18,06:00:20,72B305,TechFinancials Inc.,99,0.0,equity-actions,,"TechFinancials Inc.: Underwritten Placing to raise GBP250,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"TechFinancials Inc. Notice of AGM, Placing & Acquisition"
TECH,2025-09-18,06:00:20,72B305,TechFinancials Inc.,99,0.0,equity-actions,,Techfinancials INC. (to be renamed,PRESS-RELEASE,LSE Regulatory News Service (RNS),"TechFinancials Inc. Notice of AGM, Placing & Acquisition"
TECH,2025-09-18,06:00:20,72B305,TechFinancials Inc.,99,0.0,equity-actions,,"TechFinancials Inc.: Underwritten Placing to raise GBP250,000",PRESS-RELEASE,LSE Regulatory News Service (RNS),"TechFinancials Inc. Notice of AGM, Placing & -2-"
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Basic loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2025
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,0.62,acquisitions-mergers,,"TechFinancials Inc.: the Company has agreed acquisition terms to acquire up to 60% of Dilotiko Limited, the",PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2025
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,0.0,earnings,,TechFinancials Inc.: Financial Results,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2025
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,-0.63,earnings,negative,TechFinancials Inc.: The operating loss,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2025
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: the Company was US$ 0.064m (H1 2024: loss of,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2025
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,-0.62,earnings,negative,TechFinancials Inc.: Loss before taxation,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six Months to 30 June 2025
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,-0.65,dividends,suspended,TechFinancials Inc.: No dividends,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six -2-
TECH,2025-09-30,06:00:33,72B305,TechFinancials Inc.,99,-0.65,earnings,negative,TechFinancials Inc.: Loss per share,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Interim Report for the Six -2-
TECH,2025-10-16,13:18:19,72B305,TechFinancials Inc.,99,0.0,investor-relations,,TechFinancials Inc.: Result of AGM,PRESS-RELEASE,LSE Regulatory News Service (RNS),TechFinancials Inc. Result of AGM
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-08,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-08,12:04:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-27,21:27:53,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kelderman Registers 13,392 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kelderman Registers 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-01-29,21:36:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kelderman Sells 13,392 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Sells 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:02:13,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors
TECH,2025-02-04,22:28:47,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,22:33:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH"
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 22c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 22c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 42c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $34.9M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $34.9M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $297M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $297M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,21:54:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,860 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,860 Of Bio-Techne Corp >TECH"
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Outperform by Baird
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:03:26,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-24,08:03:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)"
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Evercore ISI Group
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group
TECH,2025-03-24,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-24,11:04:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:02:40,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-07,20:26:13,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH"
TECH,2025-04-09,11:12:48,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Sector Weight From Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Sector Weight From Overweight by Keybanc
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-23,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-23,11:01:50,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-24,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-04-24,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-05-05,20:23:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH"
TECH,2025-05-06,20:30:33,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,approved,"Bio-Techne Corp.: Board of Directors of Bio-Techne Corporation (the ""Company"") authorized a share repurchase program",RNS-SEC8K,Dow Jones Newswires,Bio-Techne Files 8K - Regulation FD >TECH
TECH,2025-05-06,20:38:12,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Authorizes Repurchase Program,RNS-SEC8K,Dow Jones Newswires,Bio-Techne Authorizes Repurchase Program of Up to $500M
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 14c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 14c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 56c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 56c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $22.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $22.6M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $316.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $316.2M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:33:29,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program Authorizing Repurchase of Up to $500M of Common Stk >TECH
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Hold by Stifel
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel
TECH,2025-05-08,14:09:05,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by UBS
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS
TECH,2025-05-12,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-12,11:04:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-23,07:01:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)"
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Overweight by Wells Fargo
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo
TECH,2025-06-09,20:21:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-11,20:21:07,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,280 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:02:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Pdt Development
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by TD Cowen
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen
TECH,2025-07-11,15:25:14,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-07-11,15:25:15,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,21:07:51,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH"
TECH,2025-07-24,20:28:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH"
TECH,2025-07-31,20:28:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 21,189 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 21,189 Of Bio-Techne Corp >TECH"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss/Shr 11c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss/Shr 11c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 53c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss $17.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss $17.7M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $317M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $317M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:40:44,85DE00,Bio-Techne Corp.,100,-0.42,assets,,Bio-Techne to Sell Exosome Diagnostics Business >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Sell Exosome Diagnostics Business >TECH
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,-0.46,price-targets,downgrade,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital
TECH,2025-08-11,23:07:11,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:19,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:23,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:34,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:30:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH
TECH,2025-08-19,21:39:14,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,084 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,084 Of Bio-Techne Corp >TECH"
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup
TECH,2025-08-23,07:01:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)"
TECH,2025-08-25,20:06:34,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-25,20:09:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,11:08:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,20:11:19,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,20:12:03,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,GlobeNewswire,Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Evercore ISI Group
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group
TECH,2025-10-09,11:00:12,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-09,11:00:16,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by TD Cowen
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.68,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen
TECH,2025-10-15,11:00:29,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,11:00:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches ProximityScope(TM) Assay on,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-08,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-08,12:04:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-27,21:27:53,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kelderman Registers 13,392 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kelderman Registers 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-01-29,21:36:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kelderman Sells 13,392 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Sells 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:02:13,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors
TECH,2025-02-04,22:28:47,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,22:33:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH"
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 22c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 22c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 42c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $34.9M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $34.9M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $297M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $297M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,21:54:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,860 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,860 Of Bio-Techne Corp >TECH"
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Outperform by Baird
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:03:26,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-24,08:03:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)"
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Evercore ISI Group
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group
TECH,2025-03-24,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-24,11:04:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:02:40,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-07,20:26:13,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH"
TECH,2025-04-09,11:12:48,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Sector Weight From Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Sector Weight From Overweight by Keybanc
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-23,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-23,11:01:50,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-24,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-04-24,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-05-05,20:23:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH"
TECH,2025-05-06,20:30:33,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,approved,"Bio-Techne Corp.: Board of Directors of Bio-Techne Corporation (the ""Company"") authorized a share repurchase program",RNS-SEC8K,Dow Jones Newswires,Bio-Techne Files 8K - Regulation FD >TECH
TECH,2025-05-06,20:38:12,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Authorizes Repurchase Program,RNS-SEC8K,Dow Jones Newswires,Bio-Techne Authorizes Repurchase Program of Up to $500M
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 14c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 14c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 56c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 56c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $22.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $22.6M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $316.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $316.2M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:33:29,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program Authorizing Repurchase of Up to $500M of Common Stk >TECH
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Hold by Stifel
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel
TECH,2025-05-08,14:09:05,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by UBS
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS
TECH,2025-05-12,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-12,11:04:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-23,07:01:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)"
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Overweight by Wells Fargo
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo
TECH,2025-06-09,20:21:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-11,20:21:07,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,280 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:02:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Pdt Development
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by TD Cowen
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen
TECH,2025-07-11,15:25:14,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-07-11,15:25:15,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,21:07:51,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH"
TECH,2025-07-24,20:28:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH"
TECH,2025-07-31,20:28:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 21,189 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 21,189 Of Bio-Techne Corp >TECH"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss/Shr 11c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss/Shr 11c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 53c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss $17.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss $17.7M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $317M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $317M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:40:44,85DE00,Bio-Techne Corp.,100,-0.42,assets,,Bio-Techne to Sell Exosome Diagnostics Business >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Sell Exosome Diagnostics Business >TECH
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,-0.46,price-targets,downgrade,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital
TECH,2025-08-11,23:07:11,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:19,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:23,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:34,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:30:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH
TECH,2025-08-19,21:39:14,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,084 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,084 Of Bio-Techne Corp >TECH"
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup
TECH,2025-08-23,07:01:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)"
TECH,2025-08-25,20:06:34,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-25,20:09:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,11:08:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,20:11:19,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,20:12:03,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,GlobeNewswire,Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Evercore ISI Group
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group
TECH,2025-10-09,11:00:12,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-09,11:00:16,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by TD Cowen
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.68,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen
TECH,2025-10-15,11:00:29,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,11:00:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches ProximityScope(TM) Assay on,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-08,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-08,12:04:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-27,21:27:53,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kelderman Registers 13,392 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kelderman Registers 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-01-29,21:36:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kelderman Sells 13,392 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Sells 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:02:13,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors
TECH,2025-02-04,22:28:47,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,22:33:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH"
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 22c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 22c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 42c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $34.9M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $34.9M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $297M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $297M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,21:54:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,860 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,860 Of Bio-Techne Corp >TECH"
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Outperform by Baird
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:03:26,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-24,08:03:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)"
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Evercore ISI Group
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group
TECH,2025-03-24,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-24,11:04:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:02:40,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-07,20:26:13,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH"
TECH,2025-04-09,11:12:48,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Sector Weight From Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Sector Weight From Overweight by Keybanc
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-23,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-23,11:01:50,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-24,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-04-24,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-05-05,20:23:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH"
TECH,2025-05-06,20:30:33,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,approved,"Bio-Techne Corp.: Board of Directors of Bio-Techne Corporation (the ""Company"") authorized a share repurchase program",RNS-SEC8K,Dow Jones Newswires,Bio-Techne Files 8K - Regulation FD >TECH
TECH,2025-05-06,20:38:12,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Authorizes Repurchase Program,RNS-SEC8K,Dow Jones Newswires,Bio-Techne Authorizes Repurchase Program of Up to $500M
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 14c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 14c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 56c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 56c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $22.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $22.6M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $316.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $316.2M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:33:29,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program Authorizing Repurchase of Up to $500M of Common Stk >TECH
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Hold by Stifel
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel
TECH,2025-05-08,14:09:05,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by UBS
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS
TECH,2025-05-12,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-12,11:04:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-23,07:01:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)"
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Overweight by Wells Fargo
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo
TECH,2025-06-09,20:21:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-11,20:21:07,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,280 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:02:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Pdt Development
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by TD Cowen
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen
TECH,2025-07-11,15:25:14,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-07-11,15:25:15,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,21:07:51,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH"
TECH,2025-07-24,20:28:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH"
TECH,2025-07-31,20:28:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 21,189 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 21,189 Of Bio-Techne Corp >TECH"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss/Shr 11c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss/Shr 11c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 53c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss $17.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss $17.7M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $317M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $317M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:40:44,85DE00,Bio-Techne Corp.,100,-0.42,assets,,Bio-Techne to Sell Exosome Diagnostics Business >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Sell Exosome Diagnostics Business >TECH
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,-0.46,price-targets,downgrade,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital
TECH,2025-08-11,23:07:11,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:19,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:23,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:34,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:30:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH
TECH,2025-08-19,21:39:14,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,084 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,084 Of Bio-Techne Corp >TECH"
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup
TECH,2025-08-23,07:01:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)"
TECH,2025-08-25,20:06:34,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-25,20:09:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,11:08:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,20:11:19,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,20:12:03,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,GlobeNewswire,Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Evercore ISI Group
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group
TECH,2025-10-09,11:00:12,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-09,11:00:16,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by TD Cowen
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.68,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen
TECH,2025-10-15,11:00:29,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,11:00:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches ProximityScope(TM) Assay on,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-08,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-08,12:04:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-27,21:27:53,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kelderman Registers 13,392 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kelderman Registers 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-01-29,21:36:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kelderman Sells 13,392 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Sells 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:02:13,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors
TECH,2025-02-04,22:28:47,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,22:33:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH"
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 22c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 22c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 42c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $34.9M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $34.9M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $297M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $297M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,21:54:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,860 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,860 Of Bio-Techne Corp >TECH"
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Outperform by Baird
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:03:26,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-24,08:03:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)"
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Evercore ISI Group
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group
TECH,2025-03-24,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-24,11:04:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:02:40,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-07,20:26:13,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH"
TECH,2025-04-09,11:12:48,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Sector Weight From Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Sector Weight From Overweight by Keybanc
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-23,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-23,11:01:50,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-24,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-04-24,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-05-05,20:23:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH"
TECH,2025-05-06,20:30:33,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,approved,"Bio-Techne Corp.: Board of Directors of Bio-Techne Corporation (the ""Company"") authorized a share repurchase program",RNS-SEC8K,Dow Jones Newswires,Bio-Techne Files 8K - Regulation FD >TECH
TECH,2025-05-06,20:38:12,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Authorizes Repurchase Program,RNS-SEC8K,Dow Jones Newswires,Bio-Techne Authorizes Repurchase Program of Up to $500M
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 14c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 14c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 56c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 56c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $22.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $22.6M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $316.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $316.2M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:33:29,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program Authorizing Repurchase of Up to $500M of Common Stk >TECH
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Hold by Stifel
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel
TECH,2025-05-08,14:09:05,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by UBS
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS
TECH,2025-05-12,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-12,11:04:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-23,07:01:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)"
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Overweight by Wells Fargo
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo
TECH,2025-06-09,20:21:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-11,20:21:07,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,280 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:02:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Pdt Development
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by TD Cowen
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen
TECH,2025-07-11,15:25:14,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-07-11,15:25:15,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,21:07:51,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH"
TECH,2025-07-24,20:28:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH"
TECH,2025-07-31,20:28:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 21,189 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 21,189 Of Bio-Techne Corp >TECH"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss/Shr 11c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss/Shr 11c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 53c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss $17.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss $17.7M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $317M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $317M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:40:44,85DE00,Bio-Techne Corp.,100,-0.42,assets,,Bio-Techne to Sell Exosome Diagnostics Business >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Sell Exosome Diagnostics Business >TECH
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,-0.46,price-targets,downgrade,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital
TECH,2025-08-11,23:07:11,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:19,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:23,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:34,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:30:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH
TECH,2025-08-19,21:39:14,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,084 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,084 Of Bio-Techne Corp >TECH"
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup
TECH,2025-08-23,07:01:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)"
TECH,2025-08-25,20:06:34,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-25,20:09:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,11:08:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,20:11:19,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,20:12:03,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,GlobeNewswire,Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Evercore ISI Group
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group
TECH,2025-10-09,11:00:12,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-09,11:00:16,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by TD Cowen
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.68,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen
TECH,2025-10-15,11:00:29,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,11:00:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches ProximityScope(TM) Assay on,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-08,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-08,12:04:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-27,21:27:53,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kelderman Registers 13,392 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kelderman Registers 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-01-29,21:36:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kelderman Sells 13,392 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Sells 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:02:13,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors
TECH,2025-02-04,22:28:47,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,22:33:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH"
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 22c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 22c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 42c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $34.9M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $34.9M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $297M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $297M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,21:54:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,860 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,860 Of Bio-Techne Corp >TECH"
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Outperform by Baird
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:03:26,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-24,08:03:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)"
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Evercore ISI Group
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group
TECH,2025-03-24,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-24,11:04:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:02:40,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-07,20:26:13,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH"
TECH,2025-04-09,11:12:48,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Sector Weight From Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Sector Weight From Overweight by Keybanc
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-23,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-23,11:01:50,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-24,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-04-24,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-05-05,20:23:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH"
TECH,2025-05-06,20:30:33,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,approved,"Bio-Techne Corp.: Board of Directors of Bio-Techne Corporation (the ""Company"") authorized a share repurchase program",RNS-SEC8K,Dow Jones Newswires,Bio-Techne Files 8K - Regulation FD >TECH
TECH,2025-05-06,20:38:12,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Authorizes Repurchase Program,RNS-SEC8K,Dow Jones Newswires,Bio-Techne Authorizes Repurchase Program of Up to $500M
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 14c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 14c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 56c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 56c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $22.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $22.6M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $316.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $316.2M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:33:29,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program Authorizing Repurchase of Up to $500M of Common Stk >TECH
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Hold by Stifel
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel
TECH,2025-05-08,14:09:05,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by UBS
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS
TECH,2025-05-12,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-12,11:04:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-23,07:01:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)"
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Overweight by Wells Fargo
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo
TECH,2025-06-09,20:21:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-11,20:21:07,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,280 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:02:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Pdt Development
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by TD Cowen
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen
TECH,2025-07-11,15:25:14,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-07-11,15:25:15,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,21:07:51,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH"
TECH,2025-07-24,20:28:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH"
TECH,2025-07-31,20:28:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 21,189 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 21,189 Of Bio-Techne Corp >TECH"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss/Shr 11c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss/Shr 11c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 53c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss $17.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss $17.7M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $317M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $317M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:40:44,85DE00,Bio-Techne Corp.,100,-0.42,assets,,Bio-Techne to Sell Exosome Diagnostics Business >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Sell Exosome Diagnostics Business >TECH
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,-0.46,price-targets,downgrade,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital
TECH,2025-08-11,23:07:11,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:19,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:23,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:34,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:30:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH
TECH,2025-08-19,21:39:14,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,084 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,084 Of Bio-Techne Corp >TECH"
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup
TECH,2025-08-23,07:01:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)"
TECH,2025-08-25,20:06:34,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-25,20:09:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,11:08:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,20:11:19,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,20:12:03,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,GlobeNewswire,Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Evercore ISI Group
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group
TECH,2025-10-09,11:00:12,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-09,11:00:16,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by TD Cowen
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.68,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen
TECH,2025-10-15,11:00:29,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,11:00:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches ProximityScope(TM) Assay on,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,-0.48,legal,,Bio-Techne took legal action against Miltenyi,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-07,12:02:25,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC
TECH,2025-01-08,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-08,12:04:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-10,12:00:03,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-21,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results"
TECH,2025-01-27,21:27:53,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Ceo Kelderman Registers 13,392 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"CEO Kelderman Registers 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-01-29,21:36:22,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Ceo Kelderman Sells 13,392 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Sells 13,392 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors
TECH,2025-02-04,12:02:13,85DE00,Bio-Techne Corp.,100,0.47,labor-issues,,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Appoints Dr. Amy E. Herr to Bd of Directors
TECH,2025-02-04,22:28:47,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 2,211 Of Bio-Techne Corp >TECH"
TECH,2025-02-04,22:33:08,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 2,978 Of Bio-Techne Corp >TECH"
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Declares Dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Declares Dividend
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q EPS 22c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q EPS 22c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Adj EPS 42c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Adj EPS 42c >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 2Q Net $34.9M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Net $34.9M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 2Q Sales $297M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 2Q Sales $297M >TECH
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Second Quarter Fiscal 2025 -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Second Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the second quarter increased 9% to $297.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.46,earnings,up,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.22 versus $0.17,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.42 compared to $0.40,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, February 5, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP EPS was $0.22,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.44,earnings,up,Bio-Techne Corp.: GAAP operating income for the second quarter of fiscal 2025 increased 25% to $47.4 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the second quarter of fiscal 2025 increased 8% to $88.7 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,unchanged,Bio-Techne Corp.: Adjusted operating margin remained flat at 30.1%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 8% for the second quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter Fiscal 2025 Results
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.22 $ 0.17 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,670,424 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -2-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -3-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 297,031 $ 272,598 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-05,11:30:07,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Second Quarter -4-
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Overweight by Keybanc
TECH,2025-02-06,15:13:52,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $80.00 by Keybanc
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-02-06,16:00:52,85DE00,Bio-Techne Corp.,100,0.4,price-targets,upgrade,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $90.00/Share From $88.00 by Scotiabank
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-02-06,16:52:12,85DE00,Bio-Techne Corp.,100,0.3,price-targets,upgrade,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $80.00/Share From $79.00 by RBC Capital
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,12:00:16,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Release of GMP TcBuster Non-Viral Genome Engineering System
TECH,2025-02-18,21:54:20,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,860 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,860 Of Bio-Techne Corp >TECH"
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Neutral From Outperform by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Neutral From Outperform by Baird
TECH,2025-02-19,10:23:11,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $68.00/Share From $88.00 by Baird
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.52,products-services,,Bio-Techne Launches Expanded Menu of,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-20,12:03:26,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches Expanded Menu of,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology
TECH,2025-02-24,08:03:10,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 4Q 2024 (TECH)"
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:00:12,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-02-27,12:05:01,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne brand, has teamed up with Oxford Nanopore Technologies",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-03,12:00:07,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Neutral by Citigroup
TECH,2025-03-04,17:43:52,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $80.00 by Citigroup
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Outperform by Evercore ISI Group
TECH,2025-03-18,09:41:53,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $75.00/Share by Evercore ISI Group
TECH,2025-03-24,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-24,11:04:44,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-03-26,11:02:40,85DE00,Bio-Techne Corp.,100,0.41,assets,open,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany",NEWS-FLASH,Dow Jones Newswires,"Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany"
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-02,11:00:08,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument
TECH,2025-04-07,20:26:13,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,513 Of Bio-Techne Corp >TECH"
TECH,2025-04-09,11:12:48,85DE00,Bio-Techne Corp.,100,-0.58,analyst-ratings,negative,Bio-Techne Cut to Sector Weight From Overweight by Keybanc,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Cut to Sector Weight From Overweight by Keybanc
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-15,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results"
TECH,2025-04-23,11:00:10,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-23,11:01:50,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting
TECH,2025-04-24,11:00:05,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-04-24,11:00:06,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection
TECH,2025-05-05,20:23:06,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 12,000 Of Bio-Techne Corp >TECH"
TECH,2025-05-06,20:30:33,85DE00,Bio-Techne Corp.,99,0.59,equity-actions,approved,"Bio-Techne Corp.: Board of Directors of Bio-Techne Corporation (the ""Company"") authorized a share repurchase program",RNS-SEC8K,Dow Jones Newswires,Bio-Techne Files 8K - Regulation FD >TECH
TECH,2025-05-06,20:38:12,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Authorizes Repurchase Program,RNS-SEC8K,Dow Jones Newswires,Bio-Techne Authorizes Repurchase Program of Up to $500M
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,NEWS-FLASH,Dow Jones Newswires,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM >TECH
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND AND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-Techne Corp.: The quarterly dividend,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,,Bio-Techne Corp.: The new share repurchase program,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q EPS 14c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q EPS 14c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Adj EPS 56c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Adj EPS 56c >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 3Q Net $22.6M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Net $22.6M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 3Q Sales $316.2M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 3Q Sales $316.2M >TECH
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the third quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the third quarter increased 4% to $316.2 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: GAAP earnings per share (EPS) was $0.14,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.56 compared to $0.48,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Delivered adjusted operating margin of 34.9%,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, May 7, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for the third quarter of fiscal 2025 increased 11% to $110.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.38,revenues,up,Bio-Techne Corp.: Adjusted operating margin was 34.9% for the third quarter of fiscal 2025 compared to 33.0% in the third quarter of fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Organic revenue growth was 7% for the third quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,100,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.61,earnings,positive,Bio-Techne Corp.: Earnings per share: Basic $ 0.14 $ 0.31 $,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,99,0.0,assets,,"Bio-Techne Corp.: Total assets $2,644,259 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -2-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,96,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -3-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,181 $ 303,428 $",PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:30:09,85DE00,Bio-Techne Corp.,97,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE RELEASES THIRD QUARTER -4-
TECH,2025-05-07,10:33:29,85DE00,Bio-Techne Corp.,100,0.59,equity-actions,approved,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Board of Directors Has Approved New Shr Repurchase Program Authorizing Repurchase of Up to $500M of Common Stk >TECH
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-05-08,17:23:06,85DE00,Bio-Techne Corp.,100,-0.8,price-targets,downgrade,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $63.00/Share From $72.00 by RBC Capital
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at the BofA Securities 2025 Health Care Conference,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,11:07:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Kytopen and Bio-Techne announce partnership,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:30:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Hold by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Hold by Stifel
TECH,2025-05-08,13:55:35,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $60.00/Share From $75.00 by Stifel
TECH,2025-05-08,14:09:05,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by Benchmark,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by Benchmark
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by UBS
TECH,2025-05-09,22:31:38,85DE00,Bio-Techne Corp.,100,-0.84,price-targets,downgrade,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $70.00/Share From $95.00 by UBS
TECH,2025-05-12,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-12,11:04:12,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025
TECH,2025-05-23,07:01:52,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 1Q 2025 (TECH)"
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:00:09,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-29,11:02:57,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Investor Conferences
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Overweight by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Overweight by Wells Fargo
TECH,2025-05-30,13:14:35,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $59.00/Share by Wells Fargo
TECH,2025-06-09,20:21:27,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Herr Registers 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-11,20:21:07,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Herr Sells 1,280 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Herr Sells 1,280 Of Bio-Techne Corp >TECH"
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:00:03,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development
TECH,2025-06-24,11:02:57,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody,NEWS-FLASH,Dow Jones Newswires,Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Pdt Development
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.95,analyst-ratings,positive,Bio-Techne Initiated at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Initiated at Buy by TD Cowen
TECH,2025-07-09,11:20:00,85DE00,Bio-Techne Corp.,100,0.0,price-targets,set,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Announced at $65.00/Share by TD Cowen
TECH,2025-07-11,15:25:14,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Outperform by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Outperform by Scotiabank
TECH,2025-07-11,15:25:15,85DE00,Bio-Techne Corp.,100,-0.82,price-targets,downgrade,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $75.00/Share From $90.00 by Scotiabank
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Bio-Techne Corp.: We collaborated with Bio-Techne's ProteinSimple,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-14,11:00:04,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne's Simple Western(TM) Technology Utilized in Recent FDA Approval of ZEVASKYN(TM) Cell-Based Gene Therapy
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio-Techne Corp.: Our strategic partnership with Bio-Techne,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.68,equity-actions,,Bio-Techne Corp.: The initial offering,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Business Wire,Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Bio Announces Strategic Partnership with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-15,13:03:00,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,11:00:04,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results"
TECH,2025-07-17,21:07:51,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 3,199 Of Bio-Techne Corp >TECH"
TECH,2025-07-24,20:28:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,527 Of Bio-Techne Corp >TECH"
TECH,2025-07-31,20:28:59,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 21,189 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 21,189 Of Bio-Techne Corp >TECH"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:01,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,GlobeNewswire,"Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.55,acquisitions-mergers,,And Announces Acquisition of Exosome Diagnostics Business,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.65,revenues,up,Bio-Techne Corp.: our revenue growth,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.0,revenues,unchanged,Bio-Techne Corp.: we are reaffirming our 2025 revenue guidance of $108-110 million,PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:01:02,85DE00,Bio-Techne Corp.,99,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire the Exosome Diagnostics, Inc. business from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne"
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,PR Newswire,Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.58,acquisitions-mergers,,Mdxhealth SA will acquire its Exosome Diagnostics Inc. business,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-05,20:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Announces Exosome Diagnostics Divestiture
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,PR Newswire,BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,dividends,,Bio-TECHNE DECLARES DIVIDEND,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:02,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: BIO-TECHNE DECLARES DIVIDEND
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss/Shr 11c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss/Shr 11c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne 4Q Adj EPS 53c,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Adj EPS 53c >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,-0.65,earnings,negative,Bio-Techne 4Q Loss $17.7M,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Loss $17.7M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne 4Q Sales $317M >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne 4Q Sales $317M >TECH
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -2-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:14,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,PR Newswire,Bio-Techne Releases Fourth Quarter Fiscal 2025 -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Releases Fourth Quarter Fiscal 2025 Results,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the fourth quarter increased 4% to $317.0 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Full year organic revenue increased 5%,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP earnings per share (EPS),PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.4,earnings,up,Bio-Techne Corp.: Delivered adjusted EPS of $0.53 compared to $0.49,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.61,earnings,positive,Bio-Techne Corp.: Full year GAAP EPS was $0.46,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted EPS,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne will host an earnings conference call today, August 6, 2025",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,earnings,,Bio-Techne Corp.: GAAP operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.6,earnings,positive,Bio-Techne Corp.: Adjusted operating income of $101.3 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.0,revenues,,Bio-Techne Corp.: Adjusted operating margin was 32.0% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.41,revenues,up,Bio-Techne Corp.: Net sales for the full year fiscal 2025 increased 5% to $1.2 billion,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.38,earnings,up,Bio-Techne Corp.: Adjusted operating income for fiscal 2025 increased 4% to $383.6 million,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,100,0.06,revenues,,Bio-Techne Corp.: Organic revenue growth was 4% for the fourth quarter of fiscal 2025,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter Fiscal 2025 Results
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,revenues,,Bio-Techne Corp.: Organic revenue,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted diluted earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,99,0.0,earnings,,"Bio-Techne Corp.: Earnings before interest, taxes, depreciation, and amortization (EBITDA)",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -2-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,assets,,"Bio-Techne Corp.: Total assets $2,557,868 $2,703,867",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,94,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -3-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Earnings per share,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,revenues,,"Bio-Techne Corp.: Consolidated revenue $ 316,964 $ 306,098",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted operating income,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:30:15,85DE00,Bio-Techne Corp.,95,0.0,earnings,,Bio-Techne Corp.: Adjusted EBITDA,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Releases Fourth Quarter -4-
TECH,2025-08-06,10:40:44,85DE00,Bio-Techne Corp.,100,-0.42,assets,,Bio-Techne to Sell Exosome Diagnostics Business >TECH,NEWS-FLASH,Dow Jones Newswires,Bio-Techne to Sell Exosome Diagnostics Business >TECH
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,0.0,analyst-ratings,neutral,Bio-Techne Is Maintained at Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Sector Perform by RBC Capital
TECH,2025-08-07,14:54:06,85DE00,Bio-Techne Corp.,100,-0.46,price-targets,downgrade,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Cut to $61.00/Share From $63.00 by RBC Capital
TECH,2025-08-11,23:07:11,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Dir Higgins Acquires 5,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:19,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer Geist Acquires 1,820 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:23,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"Officer McManus Acquires 1,757 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:34,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Vp Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"VP Bohnen Acquires 1,191 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:29:48,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Ceo Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CEO Kelderman Acquires 4,238 Of Bio-Techne Corp >TECH"
TECH,2025-08-19,21:30:16,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH,FULL-ARTICLE,Dow Jones Newswires,Dir Herr Acquires 178 Of Bio-Techne Corp >TECH
TECH,2025-08-19,21:39:14,85DE00,Bio-Techne Corp.,100,0.52,insider-trading,,"Cfo Hippel Acquires 2,084 Of Bio-Techne Corp >TECH",FULL-ARTICLE,Dow Jones Newswires,"CFO Hippel Acquires 2,084 Of Bio-Techne Corp >TECH"
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Buy From Neutral by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Buy From Neutral by Citigroup
TECH,2025-08-21,12:54:48,85DE00,Bio-Techne Corp.,100,0.8,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $55.00 by Citigroup
TECH,2025-08-23,07:01:50,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)",RNS-SEC13F,Dow Jones Newswires,"Bio-Techne Corporation, Inst Holders, 2Q 2025 (TECH)"
TECH,2025-08-25,20:06:34,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Chmn Baumgartner Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-25,20:09:45,85DE00,Bio-Techne Corp.,100,-0.48,insider-trading,,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH",RNS-SEC144,Dow Jones Newswires,"Dir Nusse Registers 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,11:00:06,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,PR Newswire,Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,11:08:12,85DE00,Bio-Techne Corp.,100,0.0,marketing,,Bio-Techne to Present at Upcoming Investor Conferences,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne to Present at Upcoming Investor Conferences
TECH,2025-08-27,20:11:19,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Chmn Baumgartner Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-08-27,20:12:03,85DE00,Bio-Techne Corp.,100,-0.49,insider-trading,,"Dir Nusse Sells 17,040 Of Bio-Techne Corp",FULL-ARTICLE,Dow Jones Newswires,"Dir Nusse Sells 17,040 Of Bio-Techne Corp >TECH"
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.94,analyst-ratings,positive,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Raised to Outperform From Sector Perform by RBC Capital
TECH,2025-09-03,14:07:29,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $73.00/Share From $61.00 by RBC Capital
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,GlobeNewswire,Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-09-15,21:29:23,85DE00,Bio-Techne Corp.,100,0.5,acquisitions-mergers,completed,"Mdxhealth signed a definitive agreement to acquire Exosome Diagnostics, Inc. from Bio-Techne",PRESS-RELEASE,Dow Jones Newswires,Press Release: Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Outperform by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Outperform by Evercore ISI Group
TECH,2025-10-07,18:08:08,85DE00,Bio-Techne Corp.,100,0.78,price-targets,upgrade,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $72.00/Share From $60.00 by Evercore ISI Group
TECH,2025-10-09,11:00:12,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,PR Newswire,Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-09,11:00:16,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,"Bio-Techne Corp.: our collaboration with Oxford Nanopore, we are accelerating",PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne and Oxford Nanopore Technologies Expand Agreement to Accelerate Development of Genetics Portfolio Through 2032
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.34,analyst-ratings,neutral,Bio-Techne Is Maintained at Buy by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Is Maintained at Buy by TD Cowen
TECH,2025-10-14,13:08:43,85DE00,Bio-Techne Corp.,100,0.68,price-targets,upgrade,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen,NEWS-FLASH,Dow Jones Newswires,Bio-Techne Price Target Raised to $70.00/Share From $65.00 by TD Cowen
TECH,2025-10-15,11:00:29,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,PR Newswire,"Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,11:00:32,85DE00,Bio-Techne Corp.,100,0.0,investor-relations,,"Bio-Techne to Host Conference Call on November 5, 2025",PRESS-RELEASE,Dow Jones Newswires,"Press Release: Bio-Techne to Host Conference Call on November 5, 2025, to Announce First Quarter Fiscal 2026 Financial Results"
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:01,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Business Wire,Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Biosciences Partners with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-15,13:00:04,85DE00,Bio-Techne Corp.,100,0.39,products-services,,Bio-Techne Corp.: This distribution agreement,PRESS-RELEASE,Dow Jones Newswires,Press Release: Saguaro Biosciences Partners with Bio-Techne to Distribute Innovative Live-Cell Imaging Reagents
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.52,products-services,,Bio-Techne Launches ProximityScope(TM) Assay on,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:01,85DE00,Bio-Techne Corp.,100,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,PR Newswire,Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
TECH,2025-10-28,10:30:04,85DE00,Bio-Techne Corp.,99,0.49,partnerships,,Leica Biosystems Nussloch GmbH: We are proud to partner with Bio-Techne to,PRESS-RELEASE,Dow Jones Newswires,Press Release: Bio-Techne Launches ProximityScope(TM) Assay on the BOND RX platform from Leica Biosystems to Advance Spatial Protein-Protein Interactions Research
